Cayman公司成立于1980年，在过去20多年的发展过程中，始终保持着为科研工作者提供高质、优价研究产品的宗旨。该公司目前可以提供2,138 多种生化和免疫试剂，涉及肿瘤、氧化氮、神经学、凋亡、氧化性损伤、内分泌学等研究领域。非常有特色的检测试剂盒包括类花生酸类物质、游离的生物标志、环核苷、激素及氧化氮等。此外，还提供多种高质量试剂，如类花生酸类物质、氧化氮试剂及许多相关脂质、脂肪酸、酶和抗体等。Cayman非常愿意接受各地客户的要求，合成复杂和不稳定分子。
品牌商名称：Cayman Chemical
：(734) 971-3335
地址：1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
公司：http://www.caymanchem。。ｃｏｍ/
世界*实验材料供应商Cayman正式授权上海起发为其中国代理，Cayman在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海起发一直秉承为中国科研客户带来的产品，的服务， 签约Cayman就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
Cayman中国代理，Cayman上海代理，Cayman北京代理，Cayman广东代理，Cayman江苏代理 Cayman湖北代理, Cayman天津, Cayman黑龙江代理, Cayman内蒙古代理, Cayman吉林代理, Cayman福建代理, Cayman江苏代理, Cayman浙江代理, Cayman四川代理,
部分报价5
| 品牌 | 目录号 | 产品 | 规格 | 2015目录价 |
| Cayman2015 | 14189 | Chrysomycin B | 1 mg | 5265 |
| Cayman2015 | 14189 | Chrysomycin B | 250 μg | 2025 |
| Cayman2015 | 14190 | Gilvocarcin V | 1 mg | 11400 |
| Cayman2015 | 14190 | Gilvocarcin V | 100 μg | 1425 |
| Cayman2015 | 14190 | Gilvocarcin V | 250 μg | 3390 |
| Cayman2015 | 14191 | SB-FI-26 | 1 mg | 910 |
| Cayman2015 | 14191 | SB-FI-26 | 10 mg | 4550 |
| Cayman2015 | 14191 | SB-FI-26 | 5 mg | 2954 |
| Cayman2015 | 14192 | PX 12 | 1 mg | 490 |
| Cayman2015 | 14192 | PX 12 | 10 mg | 2450 |
| Cayman2015 | 14192 | PX 12 | 5 mg | 1470 |
| Cayman2015 | 14193 | GANT 58 | 10 mg | 1344 |
| Cayman2015 | 14193 | GANT 58 | 25 mg | 3150 |
| Cayman2015 | 14193 | GANT 58 | 5 mg | 840 |
| Cayman2015 | 14193 | GANT 58 | 50 mg | 5880 |
| Cayman2015 | 14196 | HMA (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14196 | HMA (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14196 | HMA (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 14204 | D-Amphetamine (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 14204 | D-Amphetamine (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 14204 | D-Amphetamine (hydrochloride) | 50 mg | 784 |
| Cayman2015 | 14205 | N-Propylamphetamine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 14205 | N-Propylamphetamine (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 14205 | N-Propylamphetamine (hydrochloride) | 50 mg | 700 |
| Cayman2015 | 14206 | 2-Phenethylamine (hydrochloride) | 10 mg | 406 |
| Cayman2015 | 14206 | 2-Phenethylamine (hydrochloride) | 100 mg | 1302 |
| Cayman2015 | 14206 | 2-Phenethylamine (hydrochloride) | 50 mg | 812 |
| Cayman2015 | 14210 | 5-trans Prostaglandin E2 | 1 mg | 714 |
| Cayman2015 | 14210 | 5-trans Prostaglandin E2 | 10 mg | 5712 |
| Cayman2015 | 14210 | 5-trans Prostaglandin E2 | 5 mg | 3220 |
| Cayman2015 | 14212 | DL-Norephedrine (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 14212 | DL-Norephedrine (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 14212 | DL-Norephedrine (hydrochloride) | 50 mg | 784 |
| Cayman2015 | 14213 | BDB (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14213 | BDB (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14213 | BDB (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 14217 | MDDMA (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14217 | MDDMA (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14217 | MDDMA (hydrochloride) | 50 mg | 3780 |
| Cayman2015 | 14218 | MBDB (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14218 | MBDB (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14218 | MBDB (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 14219 | Multiubiquitin Chain Monoclonal Antibody (Clone FK1) | 100 μg | 1386 |
| Cayman2015 | 14219 | Multiubiquitin Chain Monoclonal Antibody (Clone FK1) | 500 μg | 4858 |
| Cayman2015 | 14220 | Multiubiquitin Chain Monoclonal Antibody (Clone FK2) | 100 μg | 1260 |
| Cayman2015 | 14220 | Multiubiquitin Chain Monoclonal Antibody (Clone FK2) | 500 μg | 4410 |
| Cayman2015 | 14221 | AKB48 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14221 | AKB48 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14221 | AKB48 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14222 | 5-fluoro-AKB48 N-(4-hydroxypentyl) metabolite | 1 mg | 5460 |
| Cayman2015 | 14222 | 5-fluoro-AKB48 N-(4-hydroxypentyl) metabolite | 100 μg | 910 |
| Cayman2015 | 14222 | 5-fluoro-AKB48 N-(4-hydroxypentyl) metabolite | 500 μg | 3416 |
| Cayman2015 | 14223 | AKB48 N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14223 | AKB48 N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14223 | AKB48 N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14224 | AKB48 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 14224 | AKB48 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 14224 | AKB48 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 14227 | JWH 203 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14227 | JWH 203 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14227 | JWH 203 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14228 | JWH 203 N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14228 | JWH 203 N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14228 | JWH 203 N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14229 | JWH 203 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 14229 | JWH 203 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 14229 | JWH 203 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 14231 | UR-144 N-heptyl analog | 1 mg | 910 |
| Cayman2015 | 14231 | UR-144 N-heptyl analog | 10 mg | 7280 |
| Cayman2015 | 14231 | UR-144 N-heptyl analog | 5 mg | 4102 |
| Cayman2015 | 14232 | JWH 146 | 1 mg | 686 |
| Cayman2015 | 14232 | JWH 146 | 10 mg | 4970 |
| Cayman2015 | 14232 | JWH 146 | 5 mg | 3080 |
| Cayman2015 | 14233 | Magnolol | 10 mg | 770 |
| Cayman2015 | 14233 | Magnolol | 25 mg | 1624 |
| Cayman2015 | 14233 | Magnolol | 5 mg | 406 |
| Cayman2015 | 14234 | Tetrahydromagnolol | 10 mg | 938 |
| Cayman2015 | 14234 | Tetrahydromagnolol | 25 mg | 1960 |
| Cayman2015 | 14234 | Tetrahydromagnolol | 5 mg | 490 |
| Cayman2015 | 14237 | JWH 073 N-(2-hydroxybutyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14237 | JWH 073 N-(2-hydroxybutyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14237 | JWH 073 N-(2-hydroxybutyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14238 | THCA-A | 1 mg | 546 |
| Cayman2015 | 14238 | THCA-A | 5 mg | 2590 |
| Cayman2015 | 14244 | PP1 (Src Inhibitor) | 1 mg | 585 |
| Cayman2015 | 14244 | PP1 (Src Inhibitor) | 10 mg | 2100 |
| Cayman2015 | 14244 | PP1 (Src Inhibitor) | 25 mg | 4395 |
| Cayman2015 | 14244 | PP1 (Src Inhibitor) | 5 mg | 1470 |
| Cayman2015 | 14245 | Thiazovivin | 1 mg | 630 |
| Cayman2015 | 14245 | Thiazovivin | 10 mg | 2772 |
| Cayman2015 | 14245 | Thiazovivin | 5 mg | 1526 |
| Cayman2015 | 14247 | 6-Formylpterin | 1 mg | 1736 |
| Cayman2015 | 14247 | 6-Formylpterin | 5 mg | 7280 |
| Cayman2015 | 14247 | 6-Formylpterin | 500 μg | 910 |
| Cayman2015 | 14248 | Wogonin | 10 mg | 1395 |
| Cayman2015 | 14248 | Wogonin | 25 mg | 3120 |
| Cayman2015 | 14248 | Wogonin | 5 mg | 735 |
| Cayman2015 | 14249 | MN-25 | 1 mg | 910 |
| Cayman2015 | 14249 | MN-25 | 10 mg | 7280 |
| Cayman2015 | 14249 | MN-25 | 5 mg | 4102 |
| Cayman2015 | 14250 | Bicalutamide | 100 mg | 532 |
| Cayman2015 | 14250 | Bicalutamide | 250 mg | 1134 |
| Cayman2015 | 14250 | Bicalutamide | 50 mg | 350 |
| Cayman2015 | 14250 | Bicalutamide | 500 mg | 1932 |
| Cayman2015 | 14252 | Flumazenil | 10 mg | 350 |
| Cayman2015 | 14252 | Flumazenil | 100 mg | 2072 |
| Cayman2015 | 14252 | Flumazenil | 25 mg | 672 |
| Cayman2015 | 14252 | Flumazenil | 50 mg | 1232 |
| Cayman2015 | 14253 | Luotonin A | 1 mg | 350 |
| Cayman2015 | 14253 | Luotonin A | 10 mg | 1330 |
| Cayman2015 | 14253 | Luotonin A | 25 mg | 2632 |
| Cayman2015 | 14253 | Luotonin A | 5 mg | 882 |
| Cayman2015 | 14254 | Luotonin F | 1 mg | 490 |
| Cayman2015 | 14254 | Luotonin F | 10 mg | 3430 |
| Cayman2015 | 14254 | Luotonin F | 25 mg | 7966 |
| Cayman2015 | 14254 | Luotonin F | 5 mg | 1960 |
| Cayman2015 | 14260 | Bromazepam | 10 mg | 350 |
| Cayman2015 | 14260 | Bromazepam | 100 mg | 1232 |
| Cayman2015 | 14260 | Bromazepam | 50 mg | 700 |
| Cayman2015 | 14265 | GPR120 (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 14266 | GPR12 (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 14267 | GPR12 (N-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 14268 | StemRegenin 1 (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 14268 | StemRegenin 1 (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 14268 | StemRegenin 1 (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 14269 | Pemetrexed (sodium salt hydrate) | 10 mg | 1274 |
| Cayman2015 | 14269 | Pemetrexed (sodium salt hydrate) | 100 mg | 9408 |
| Cayman2015 | 14269 | Pemetrexed (sodium salt hydrate) | 5 mg | 672 |
| Cayman2015 | 14269 | Pemetrexed (sodium salt hydrate) | 50 mg | 5376 |
| Cayman2015 | 14270 | Rivastigmine (tartrate) | 1 g | 9310 |
| Cayman2015 | 14270 | Rivastigmine (tartrate) | 100 mg | 1330 |
| Cayman2015 | 14270 | Rivastigmine (tartrate) | 250 mg | 2996 |
| Cayman2015 | 14270 | Rivastigmine (tartrate) | 500 mg | 5320 |
| Cayman2015 | 14271 | W-5 (hydrochloride) | 25 mg | 1680 |
| Cayman2015 | 14271 | W-5 (hydrochloride) | 5 mg | 885 |
| Cayman2015 | 14272 | Bilobalide | 10 mg | 870 |
| Cayman2015 | 14272 | Bilobalide | 50 mg | 3720 |
| Cayman2015 | 14273 | MS-1020 | 1 mg | 1125 |
| Cayman2015 | 14277 | W-13 (hydrochloride) | 1 mg | 336 |
| Cayman2015 | 14277 | W-13 (hydrochloride) | 10 mg | 1680 |
| Cayman2015 | 14277 | W-13 (hydrochloride) | 5 mg | 1092 |
| Cayman2015 | 14278 | Prasugrel | 10 mg | 910 |
| Cayman2015 | 14278 | Prasugrel | 100 mg | 5012 |
| Cayman2015 | 14278 | Prasugrel | 25 mg | 1596 |
| Cayman2015 | 14278 | Prasugrel | 50 mg | 2954 |
| Cayman2015 | 14279 | (±)-para-Octopamine (hydrochloride) | 1 g | 350 |
| Cayman2015 | 14279 | (±)-para-Octopamine (hydrochloride) | 5 g | 1050 |
| Cayman2015 | 14280 | α-Ethylaminopentiophenone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14280 | α-Ethylaminopentiophenone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14280 | α-Ethylaminopentiophenone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 14281 | 4-APB (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14281 | 4-APB (hydrochloride) | 10 mg | 3192 |
| Cayman2015 | 14281 | 4-APB (hydrochloride) | 5 mg | 2044 |
| Cayman2015 | 14282 | 7-APB (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14282 | 7-APB (hydrochloride) | 10 mg | 3192 |
| Cayman2015 | 14282 | 7-APB (hydrochloride) | 5 mg | 2044 |
| Cayman2015 | 14283 | Calpain Inhibitor III | 10 mg | 672 |
| Cayman2015 | 14283 | Calpain Inhibitor III | 25 mg | 1582 |
| Cayman2015 | 14283 | Calpain Inhibitor III | 5 mg | 350 |
| Cayman2015 | 14283 | Calpain Inhibitor III | 50 mg | 2800 |
| Cayman2015 | 14284 | 25I-NBOMe-d3 (hydrochloride) | 1 mg | 1736 |
| Cayman2015 | 14284 | 25I-NBOMe-d3 (hydrochloride) | 5 mg | 7280 |
| Cayman2015 | 14284 | 25I-NBOMe-d3 (hydrochloride) | 500 μg | 910 |
| Cayman2015 | 14285 | DAPI (hydrochloride) | 10 mg | 1260 |
| Cayman2015 | 14285 | DAPI (hydrochloride) | 25 mg | 1680 |
| Cayman2015 | 14285 | DAPI (hydrochloride) | 5 mg | 840 |
| Cayman2015 | 14286 | Ciprofloxacin (hydrochloride) | 10 g | 672 |
| Cayman2015 | 14286 | Ciprofloxacin (hydrochloride) | 25 g | 1050 |
| Cayman2015 | 14286 | Ciprofloxacin (hydrochloride) | 5 g | 350 |
| Cayman2015 | 14286 | Ciprofloxacin (hydrochloride) | 50 g | 1750 |
| Cayman2015 | 14287 | Neomycin (sulfate) | 100 g | 532 |
| Cayman2015 | 14287 | Neomycin (sulfate) | 500 g | 1008 |
| Cayman2015 | 14288 | Verapamil (hydrochloride) | 1 g | 350 |
| Cayman2015 | 14288 | Verapamil (hydrochloride) | 25 g | 5684 |
| Cayman2015 | 14288 | Verapamil (hydrochloride) | 5 g | 1232 |
| Cayman2015 | 14289 | Propidium Iodide | 10 mg | 350 |
| Cayman2015 | 14289 | Propidium Iodide | 100 mg | 1750 |
| Cayman2015 | 14289 | Propidium Iodide | 25 mg | 616 |
| Cayman2015 | 14289 | Propidium Iodide | 50 mg | 1050 |
| Cayman2015 | 14290 | Gatifloxacin | 1 g | 490 |
| Cayman2015 | 14290 | Gatifloxacin | 10 g | 3920 |
| Cayman2015 | 14290 | Gatifloxacin | 5 g | 2212 |
| Cayman2015 | 14291 | Hygromycin B | 1 g | 1162 |
| Cayman2015 | 14291 | Hygromycin B | 500 mg | 840 |
| Cayman2015 | 14292 | ADB-FUBINACA | 10 mg | 2310 |
| Cayman2015 | 14292 | ADB-FUBINACA | 25 mg | 4620 |
| Cayman2015 | 14292 | ADB-FUBINACA | 50 mg | 6930 |
| Cayman2015 | 14293 | ADBICA | 1 mg | 490 |
| Cayman2015 | 14293 | ADBICA | 10 mg | 3920 |
| Cayman2015 | 14293 | ADBICA | 5 mg | 2212 |
| Cayman2015 | 14294 | 4-hydroxy DET | 10 mg | 1484 |
| Cayman2015 | 14294 | 4-hydroxy DET | 25 mg | 3528 |
| Cayman2015 | 14294 | 4-hydroxy DET | 5 mg | 784 |
| Cayman2015 | 14295 | 5-Fluoropentyl-3-pyridinoylindole (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14295 | 5-Fluoropentyl-3-pyridinoylindole (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 14295 | 5-Fluoropentyl-3-pyridinoylindole (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 14296 | 2,3-Dichlorophenylpiperazine (hydrochloride) | 10 mg | 378 |
| Cayman2015 | 14296 | 2,3-Dichlorophenylpiperazine (hydrochloride) | 100 mg | 1512 |
| Cayman2015 | 14296 | 2,3-Dichlorophenylpiperazine (hydrochloride) | 50 mg | 952 |
| Cayman2015 | 14298 | PB-22-d9 | 1 mg | 1708 |
| Cayman2015 | 14298 | PB-22-d9 | 5 mg | 2646 |
| Cayman2015 | 14298 | PB-22-d9 | 500 μg | 896 |
| Cayman2015 | 14308 | Phenamil (methanesulfonate) | 10 mg | 966 |
| Cayman2015 | 14308 | Phenamil (methanesulfonate) | 5 mg | 686 |
| Cayman2015 | 14308 | Phenamil (methanesulfonate) | 50 mg | 4116 |
| Cayman2015 | 14315 | KY 02111 | 10 mg | 1386 |
| Cayman2015 | 14315 | KY 02111 | 25 mg | 3276 |
| Cayman2015 | 14315 | KY 02111 | 5 mg | 770 |
| Cayman2015 | 14315 | KY 02111 | 50 mg | 5012 |
| Cayman2015 | 14317 | (S)-Duloxetine (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 14317 | (S)-Duloxetine (hydrochloride) | 100 mg | 2030 |
| Cayman2015 | 14317 | (S)-Duloxetine (hydrochloride) | 25 mg | 658 |
| Cayman2015 | 14317 | (S)-Duloxetine (hydrochloride) | 50 mg | 1134 |
| Cayman2015 | 14318 | 5-fluoro NNEI 2'-naphthyl isomer | 1 mg | 910 |
| Cayman2015 | 14318 | 5-fluoro NNEI 2'-naphthyl isomer | 10 mg | 7280 |
| Cayman2015 | 14318 | 5-fluoro NNEI 2'-naphthyl isomer | 5 mg | 4130 |
| Cayman2015 | 14320 | Brilliant Blue G | 25 g | 490 |
| Cayman2015 | 14320 | Brilliant Blue G | 50 g | 938 |
| Cayman2015 | 14321 | AEBSF (hydrochloride) | 100 mg | 952 |
| Cayman2015 | 14321 | AEBSF (hydrochloride) | 250 mg | 2002 |
| Cayman2015 | 14321 | AEBSF (hydrochloride) | 50 mg | 532 |
| Cayman2015 | 14322 | Resazurin (sodium salt) | 10 g | 1330 |
| Cayman2015 | 14322 | Resazurin (sodium salt) | 25 g | 2632 |
| Cayman2015 | 14322 | Resazurin (sodium salt) | 5 g | 700 |
| Cayman2015 | 14323 | Tanshinone IIA | 10 mg | 952 |
| Cayman2015 | 14323 | Tanshinone IIA | 25 mg | 1890 |
| Cayman2015 | 14323 | Tanshinone IIA | 5 mg | 630 |
| Cayman2015 | 14323 | Tanshinone IIA | 50 mg | 3472 |
| Cayman2015 | 14324 | Spectinomycin (hydrochloride hydrate) | 1 g | 420 |
| Cayman2015 | 14324 | Spectinomycin (hydrochloride hydrate) | 10 g | 1204 |
| Cayman2015 | 14324 | Spectinomycin (hydrochloride hydrate) | 5 g | 630 |
| Cayman2015 | 14325 | 2-deoxy-D-Glucose | 1 g | 560 |
| Cayman2015 | 14325 | 2-deoxy-D-Glucose | 10 g | 4480 |
| Cayman2015 | 14325 | 2-deoxy-D-Glucose | 25 g | 9800 |
| Cayman2015 | 14325 | 2-deoxy-D-Glucose | 5 g | 2520 |
| Cayman2015 | 14326 | Dantrolene (sodium salt) | 1 g | 3850 |
| Cayman2015 | 14326 | Dantrolene (sodium salt) | 100 mg | 700 |
| Cayman2015 | 14326 | Dantrolene (sodium salt) | 250 mg | 1316 |
| Cayman2015 | 14327 | n-Octylglucoside | 1 g | 490 |
| Cayman2015 | 14327 | n-Octylglucoside | 10 g | 3430 |
| Cayman2015 | 14327 | n-Octylglucoside | 5 g | 1834 |
| Cayman2015 | 14328 | Tetracycline (hydrochloride) | 10 g | 420 |
| Cayman2015 | 14328 | Tetracycline (hydrochloride) | 25 g | 574 |
| Cayman2015 | 14328 | Tetracycline (hydrochloride) | 50 g | 1050 |
| Cayman2015 | 14329 | TCEP (hydrochloride) | 1 g | 490 |
| Cayman2015 | 14330 | Ponceau S (sodium salt) | 100 g | 910 |
| Cayman2015 | 14330 | Ponceau S (sodium salt) | 25 g | 350 |
| Cayman2015 | 14330 | Ponceau S (sodium salt) | 50 g | 630 |
| Cayman2015 | 14331 | Bromophenol Blue | 100 g | 1666 |
| Cayman2015 | 14331 | Bromophenol Blue | 25 g | 490 |
| Cayman2015 | 14331 | Bromophenol Blue | 50 g | 882 |
| Cayman2015 | 14332 | Serotonin (hydrochloride) | 100 mg | 770 |
| Cayman2015 | 14332 | Serotonin (hydrochloride) | 50 mg | 406 |
| Cayman2015 | 14333 | Phenylmethylsulfonyl fluoride | 10 g | 798 |
| Cayman2015 | 14333 | Phenylmethylsulfonyl fluoride | 25 g | 1792 |
| Cayman2015 | 14333 | Phenylmethylsulfonyl fluoride | 5 g | 420 |
| Cayman2015 | 14334 | Chloramphenicol | 100 g | 770 |
| Cayman2015 | 14334 | Chloramphenicol | 25 g | 350 |
| Cayman2015 | 14334 | Chloramphenicol | 50 g | 602 |
| Cayman2015 | 14335 | Fast Green FCF | 10 g | 798 |
| Cayman2015 | 14335 | Fast Green FCF | 100 g | 5880 |
| Cayman2015 | 14335 | Fast Green FCF | 25 g | 1680 |
| Cayman2015 | 14335 | Fast Green FCF | 5 g | 420 |
| Cayman2015 | 14336 | S3I-201 | 10 mg | 1274 |
| Cayman2015 | 14336 | S3I-201 | 25 mg | 2688 |
| Cayman2015 | 14336 | S3I-201 | 5 mg | 672 |
| Cayman2015 | 14336 | S3I-201 | 50 mg | 3696 |
| Cayman2015 | 14338 | Acridine Orange | 10 g | 1064 |
| Cayman2015 | 14338 | Acridine Orange | 25 g | 2380 |
| Cayman2015 | 14338 | Acridine Orange | 5 g | 560 |
| Cayman2015 | 14339 | Ruthenium Red | 100 mg | 350 |
| Cayman2015 | 14339 | Ruthenium Red | 250 mg | 700 |
| Cayman2015 | 14339 | Ruthenium Red | 500 mg | 910 |
| Cayman2015 | 14345 | RCS-4 4-hydroxyphenyl metabolite | 1 mg | 1330 |
| Cayman2015 | 14345 | RCS-4 4-hydroxyphenyl metabolite | 10 mg | 4900 |
| Cayman2015 | 14345 | RCS-4 4-hydroxyphenyl metabolite | 5 mg | 3150 |
| Cayman2015 | 14347 | JWH 081 4-hydroxynaphthyl metabolite | 1 mg | 1330 |
| Cayman2015 | 14347 | JWH 081 4-hydroxynaphthyl metabolite | 10 mg | 4900 |
| Cayman2015 | 14347 | JWH 081 4-hydroxynaphthyl metabolite | 5 mg | 3150 |
| Cayman2015 | 14348 | JWH 081 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14348 | JWH 081 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14348 | JWH 081 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14350 | 8-iso Prostaglandin E2 | 1 mg | 1176 |
| Cayman2015 | 14350 | 8-iso Prostaglandin E2 | 10 mg | 8624 |
| Cayman2015 | 14350 | 8-iso Prostaglandin E2 | 5 mg | 4928 |
| Cayman2015 | 14350 | 8-iso Prostaglandin E2 | 500 μg | 616 |
| Cayman2015 | 14351 | Yangonin | 1 mg | 686 |
| Cayman2015 | 14351 | Yangonin | 10 mg | 3094 |
| Cayman2015 | 14351 | Yangonin | 25 mg | 6860 |
| Cayman2015 | 14351 | Yangonin | 5 mg | 2058 |
| Cayman2015 | 14352 | 8-iso Prostaglandin E2 isopropyl ester | 1 mg | 1344 |
| Cayman2015 | 14352 | 8-iso Prostaglandin E2 isopropyl ester | 100 μg | 560 |
| Cayman2015 | 14352 | 8-iso Prostaglandin E2 isopropyl ester | 5 mg | 5320 |
| Cayman2015 | 14353 | JWH 081 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 14353 | JWH 081 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 14353 | JWH 081 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 14354 | XLR11 6-hydroxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 14354 | XLR11 6-hydroxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 14354 | XLR11 6-hydroxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 14358 | AM694 N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14358 | AM694 N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14358 | AM694 N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14359 | AM694 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 14359 | AM694 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 14359 | AM694 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 14360 | JWH 081 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 3332 |
| Cayman2015 | 14360 | JWH 081 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 1750 |
| Cayman2015 | 14361 | JWH 081 N-(5-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14361 | JWH 081 N-(5-hydroxypentyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 14361 | JWH 081 N-(5-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14362 | JWH 081 N-pentanoic acid metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14362 | JWH 081 N-pentanoic acid metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 14362 | JWH 081 N-pentanoic acid metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14363 | RCS-4 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 3332 |
| Cayman2015 | 14363 | RCS-4 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 1750 |
| Cayman2015 | 14364 | RCS-4 N-(5-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14364 | RCS-4 N-(5-hydroxypentyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 14364 | RCS-4 N-(5-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14365 | RCS-4 N-pentanoic acid metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14365 | RCS-4 N-pentanoic acid metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 14365 | RCS-4 N-pentanoic acid metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14366 | MAM2201 N-pentanoic acid metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14366 | MAM2201 N-pentanoic acid metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 14366 | MAM2201 N-pentanoic acid metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14367 | JWH 203 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14367 | JWH 203 N-(4-hydroxypentyl) metabolite-d5 | 100 μg | 952 |
| Cayman2015 | 14367 | JWH 203 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14368 | JWH 203 N-(5-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14368 | JWH 203 N-(5-hydroxypentyl) metabolite-d5 | 100 μg | 952 |
| Cayman2015 | 14368 | JWH 203 N-(5-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14369 | JWH 203 N-pentanoic acid metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14369 | JWH 203 N-pentanoic acid metabolite-d5 | 100 μg | 952 |
| Cayman2015 | 14369 | JWH 203 N-pentanoic acid metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14370 | (±)-JWH 398 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 3332 |
| Cayman2015 | 14370 | (±)-JWH 398 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 1750 |
| Cayman2015 | 14371 | JWH 398 N-(5-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14371 | JWH 398 N-(5-hydroxypentyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 14371 | JWH 398 N-(5-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14372 | JWH 398 N-pentanoic acid metabolite-d5 | 1 mg | 4900 |
| Cayman2015 | 14372 | JWH 398 N-pentanoic acid metabolite-d5 | 100 μg | 910 |
| Cayman2015 | 14372 | JWH 398 N-pentanoic acid metabolite-d5 | 500 μg | 2590 |
| Cayman2015 | 14373 | AM694 N-pentanoic acid metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14373 | AM694 N-pentanoic acid metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14374 | UR-144 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14374 | UR-144 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14375 | UR-144 N-(5-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14375 | UR-144 N-(5-hydroxypentyl) metabolite-d5 | 100 μg | 952 |
| Cayman2015 | 14375 | UR-144 N-(5-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14376 | UR-144 N-pentanoic acid metabolite-d5 | 1 mg | 1736 |
| Cayman2015 | 14376 | UR-144 N-pentanoic acid metabolite-d5 | 5 mg | 7280 |
| Cayman2015 | 14376 | UR-144 N-pentanoic acid metabolite-d5 | 500 μg | 910 |
| Cayman2015 | 14377 | XLR11 N-(4-hydroxypentyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14377 | XLR11 N-(4-hydroxypentyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14378 | BB-22 3-carboxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 14378 | BB-22 3-carboxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 14378 | BB-22 3-carboxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 14381 | 5-fluoro PB-22 3-carboxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 14381 | 5-fluoro PB-22 3-carboxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 14381 | 5-fluoro PB-22 3-carboxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 14385 | PB-22 3-carboxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 14385 | PB-22 3-carboxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 14385 | PB-22 3-carboxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 14386 | PB-22 N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14386 | PB-22 N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14386 | PB-22 N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14387 | PB-22 N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14387 | PB-22 N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14387 | PB-22 N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14389 | PB-22 N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 14389 | PB-22 N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 14389 | PB-22 N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 14390 | 8-iso-15-keto Prostaglandin E2 | 1 mg | 1792 |
| Cayman2015 | 14390 | 8-iso-15-keto Prostaglandin E2 | 100 μg | 224 |
| Cayman2015 | 14390 | 8-iso-15-keto Prostaglandin E2 | 5 mg | 7840 |
| Cayman2015 | 14390 | 8-iso-15-keto Prostaglandin E2 | 500 μg | 1008 |
| Cayman2015 | 14397 | G-36 | 1 mg | 350 |
| Cayman2015 | 14397 | G-36 | 10 mg | 2100 |
| Cayman2015 | 14397 | G-36 | 5 mg | 1316 |
| Cayman2015 | 14397 | G-36 | 50 mg | 9632 |
| Cayman2015 | 14398 | Amifostine (hydrate) | 100 mg | 1232 |
| Cayman2015 | 14398 | Amifostine (hydrate) | 50 mg | 686 |
| Cayman2015 | 14398 | Amifostine (hydrate) | 500 mg | 4116 |
| Cayman2015 | 14399 | MK2 Inhibitor IV | 10 mg | 1736 |
| Cayman2015 | 14399 | MK2 Inhibitor IV | 25 mg | 4102 |
| Cayman2015 | 14399 | MK2 Inhibitor IV | 5 mg | 910 |
| Cayman2015 | 14400 | Thioridazine (hydrochloride) | 1 g | 350 |
| Cayman2015 | 14400 | Thioridazine (hydrochloride) | 10 g | 1372 |
| Cayman2015 | 14400 | Thioridazine (hydrochloride) | 25 g | 3066 |
| Cayman2015 | 14400 | Thioridazine (hydrochloride) | 5 g | 742 |
| Cayman2015 | 14404 | A-771726 | 10 mg | 1302 |
| Cayman2015 | 14404 | A-771726 | 25 mg | 2744 |
| Cayman2015 | 14404 | A-771726 | 5 mg | 686 |
| Cayman2015 | 14405 | β-Glycerophosphate (sodium salt hydrate) | 100 g | 784 |
| Cayman2015 | 14405 | β-Glycerophosphate (sodium salt hydrate) | 50 g | 490 |
| Cayman2015 | 14406 | 5-(N-ethyl-N-isopropyl)-Amiloride | 10 mg | 1204 |
| Cayman2015 | 14406 | 5-(N-ethyl-N-isopropyl)-Amiloride | 25 mg | 2044 |
| Cayman2015 | 14406 | 5-(N-ethyl-N-isopropyl)-Amiloride | 5 mg | 630 |
| Cayman2015 | 14407 | SIRT1/2 Inhibitor IV | 1 mg | 350 |
| Cayman2015 | 14407 | SIRT1/2 Inhibitor IV | 10 mg | 2450 |
| Cayman2015 | 14407 | SIRT1/2 Inhibitor IV | 25 mg | 5250 |
| Cayman2015 | 14407 | SIRT1/2 Inhibitor IV | 5 mg | 1316 |
| Cayman2015 | 14408 | Bucladesine (sodium salt) | 100 mg | 1190 |
| Cayman2015 | 14408 | Bucladesine (sodium salt) | 25 mg | 392 |
| Cayman2015 | 14408 | Bucladesine (sodium salt) | 250 mg | 2772 |
| Cayman2015 | 14408 | Bucladesine (sodium salt) | 50 mg | 630 |
| Cayman2015 | 14409 | Amiloride (hydrochloride) | 1 g | 448 |
| Cayman2015 | 14409 | Amiloride (hydrochloride) | 5 g | 2128 |
| Cayman2015 | 14410 | 9-deoxy-9-methylene Prostaglandin E2 | 1 mg | 826 |
| Cayman2015 | 14410 | 9-deoxy-9-methylene Prostaglandin E2 | 10 mg | 6608 |
| Cayman2015 | 14410 | 9-deoxy-9-methylene Prostaglandin E2 | 5 mg | 3724 |
| Cayman2015 | 14411 | (S)-3,5-DHPG | 1 mg | 700 |
| Cayman2015 | 14411 | (S)-3,5-DHPG | 10 mg | 2492 |
| Cayman2015 | 14411 | (S)-3,5-DHPG | 5 mg | 1386 |
| Cayman2015 | 14412 | Efavirenz | 10 mg | 1302 |
| Cayman2015 | 14412 | Efavirenz | 25 mg | 3094 |
| Cayman2015 | 14412 | Efavirenz | 5 mg | 686 |
| Cayman2015 | 14412 | Efavirenz | 50 mg | 5488 |
| Cayman2015 | 14413 | HA-1100 (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 14413 | HA-1100 (hydrochloride) | 10 mg | 1582 |
| Cayman2015 | 14413 | HA-1100 (hydrochloride) | 25 mg | 3500 |
| Cayman2015 | 14413 | HA-1100 (hydrochloride) | 5 mg | 1316 |
| Cayman2015 | 14414 | Z-DEVD-FMK | 1 mg | 2394 |
| Cayman2015 | 14414 | Z-DEVD-FMK | 5 mg | 9450 |
| Cayman2015 | 14414 | Z-DEVD-FMK | 500 μg | 1260 |
| Cayman2015 | 14415 | LE 135 | 1 mg | 350 |
| Cayman2015 | 14415 | LE 135 | 10 mg | 1582 |
| Cayman2015 | 14415 | LE 135 | 5 mg | 1134 |
| Cayman2015 | 14416 | Fluorouracil | 10 g | 672 |
| Cayman2015 | 14416 | Fluorouracil | 25 g | 1484 |
| Cayman2015 | 14416 | Fluorouracil | 5 g | 350 |
| Cayman2015 | 14416 | Fluorouracil | 50 g | 2800 |
| Cayman2015 | 14417 | Ampicillin (sodium salt) | 100 g | 1512 |
| Cayman2015 | 14417 | Ampicillin (sodium salt) | 25 g | 420 |
| Cayman2015 | 14417 | Ampicillin (sodium salt) | 50 g | 798 |
| Cayman2015 | 14417 | Ampicillin (sodium salt) | 500 g | 6300 |
| Cayman2015 | 14418 | Fluoxetine (hydrochloride) | 100 mg | 1470 |
| Cayman2015 | 14418 | Fluoxetine (hydrochloride) | 250 mg | 2506 |
| Cayman2015 | 14418 | Fluoxetine (hydrochloride) | 50 mg | 770 |
| Cayman2015 | 14418 | Fluoxetine (hydrochloride) | 500 mg | 4620 |
| Cayman2015 | 14419 | Oil Red O | 100 g | 350 |
| Cayman2015 | 14419 | Oil Red O | 250 g | 798 |
| Cayman2015 | 14419 | Oil Red O | 500 g | 1470 |
| Cayman2015 | 14420 | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 | 1 mg | 980 |
| Cayman2015 | 14420 | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 | 10 mg | 7252 |
| Cayman2015 | 14420 | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 | 5 mg | 4144 |
| Cayman2015 | 14420 | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 | 500 μg | 518 |
| Cayman2015 | 14422 | Doxycycline (hyclate) | 1 g | 350 |
| Cayman2015 | 14422 | Doxycycline (hyclate) | 10 g | 1582 |
| Cayman2015 | 14422 | Doxycycline (hyclate) | 5 g | 882 |
| Cayman2015 | 14423 | Rifampicin | 1 g | 882 |
| Cayman2015 | 14423 | Rifampicin | 100 mg | 350 |
| Cayman2015 | 14423 | Rifampicin | 5 g | 3500 |
| Cayman2015 | 14423 | Rifampicin | 500 mg | 616 |
| Cayman2015 | 14424 | Darifenacin (hydrobromide) | 10 mg | 910 |
| Cayman2015 | 14424 | Darifenacin (hydrobromide) | 100 mg | 6832 |
| Cayman2015 | 14424 | Darifenacin (hydrobromide) | 25 mg | 2156 |
| Cayman2015 | 14424 | Darifenacin (hydrobromide) | 50 mg | 4102 |
| Cayman2015 | 14425 | Teniposide | 10 mg | 350 |
| Cayman2015 | 14425 | Teniposide | 100 mg | 2100 |
| Cayman2015 | 14425 | Teniposide | 25 mg | 658 |
| Cayman2015 | 14425 | Teniposide | 50 mg | 1232 |
| Cayman2015 | 14426 | Cordycepin | 10 mg | 616 |
| Cayman2015 | 14426 | Cordycepin | 25 mg | 1470 |
| Cayman2015 | 14426 | Cordycepin | 50 mg | 2772 |
| Cayman2015 | 14427 | Melatonin | 1 g | 490 |
| Cayman2015 | 14427 | Melatonin | 10 g | 2702 |
| Cayman2015 | 14427 | Melatonin | 5 g | 1470 |
| Cayman2015 | 14427 | Melatonin | 50 g | 12250 |
| Cayman2015 | 14428 | Alsterpaullone | 1 mg | 825 |
| Cayman2015 | 14428 | Alsterpaullone | 5 mg | 3720 |
| Cayman2015 | 14429 | AM2201 N-(3-chloropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 14429 | AM2201 N-(3-chloropentyl) isomer | 100 μg | 448 |
| Cayman2015 | 14429 | AM2201 N-(3-chloropentyl) isomer | 500 μg | 1988 |
| Cayman2015 | 14430 | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 (potassium salt) | 1 mg | 826 |
| Cayman2015 | 14430 | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 (potassium salt) | 10 mg | 6608 |
| Cayman2015 | 14430 | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 (potassium salt) | 5 mg | 3724 |
| Cayman2015 | 14431 | 8-bromo-Cyclic AMP (sodium salt) | 10 mg | 672 |
| Cayman2015 | 14431 | 8-bromo-Cyclic AMP (sodium salt) | 25 mg | 1232 |
| Cayman2015 | 14431 | 8-bromo-Cyclic AMP (sodium salt) | 5 mg | 350 |
| Cayman2015 | 14432 | 5-fluoro JWH 018 adamantyl analog | 1 mg | 910 |
| Cayman2015 | 14432 | 5-fluoro JWH 018 adamantyl analog | 10 mg | 7280 |
| Cayman2015 | 14432 | 5-fluoro JWH 018 adamantyl analog | 5 mg | 4102 |
| Cayman2015 | 14433 | bpV(HOpic) (potassium salt) | 25 mg | 4140 |
| Cayman2015 | 14433 | bpV(HOpic) (potassium salt) | 5 mg | 975 |
| Cayman2015 | 14434 | bpV(pic) (potassium hydrate) | 25 mg | 4335 |
| Cayman2015 | 14434 | bpV(pic) (potassium hydrate) | 5 mg | 975 |
| Cayman2015 | 14435 | Asperlactone | 1 mg | 2175 |
| Cayman2015 | 14435 | Asperlactone | 5 mg | 9795 |
| Cayman2015 | 14436 | Borrelidin | 1 mg | 3570 |
| Cayman2015 | 14436 | Borrelidin | 500 μg | 1875 |
| Cayman2015 | 14437 | Chetomin | 1 mg | 2250 |
| Cayman2015 | 14437 | Chetomin | 5 mg | 7320 |
| Cayman2015 | 14438 | 1,5-Isoquinolinediol | 100 mg | 3375 |
| Cayman2015 | 14438 | 1,5-Isoquinolinediol | 25 mg | 1410 |
| Cayman2015 | 14438 | 1,5-Isoquinolinediol | 5 mg | 375 |
| Cayman2015 | 14439 | Obscurolide A1 | 1 mg | 1275 |
| Cayman2015 | 14439 | Obscurolide A1 | 5 mg | 5415 |
| Cayman2015 | 14440 | PJ-34 (hydrochloride) | 1 mg | 525 |
| Cayman2015 | 14440 | PJ-34 (hydrochloride) | 25 mg | 4590 |
| Cayman2015 | 14440 | PJ-34 (hydrochloride) | 5 mg | 1320 |
| Cayman2015 | 14441 | Pseurotin A | 1 mg | 1125 |
| Cayman2015 | 14441 | Pseurotin A | 5 mg | 3945 |
| Cayman2015 | 14442 | Calmidazolium (chloride) | 10 mg | 1190 |
| Cayman2015 | 14445 | RH-34 | 1 mg | 686 |
| Cayman2015 | 14445 | RH-34 | 10 mg | 5488 |
| Cayman2015 | 14445 | RH-34 | 5 mg | 3094 |
| Cayman2015 | 14447 | 3'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 14447 | 3'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 14447 | 3'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 14448 | 4'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 14448 | 4'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 14448 | 4'-fluoro-α-Pyrrolidinopropiophenone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 14449 | tetrahydro-Harmine | 10 mg | 1484 |
| Cayman2015 | 14449 | tetrahydro-Harmine | 25 mg | 3528 |
| Cayman2015 | 14449 | tetrahydro-Harmine | 5 mg | 784 |
| Cayman2015 | 14450 | DPQ | 1 mg | 660 |
| Cayman2015 | 14450 | DPQ | 5 mg | 2970 |
| Cayman2015 | 14451 | J 147 | 1 mg | 490 |
| Cayman2015 | 14451 | J 147 | 10 mg | 3920 |
| Cayman2015 | 14451 | J 147 | 5 mg | 2212 |
| Cayman2015 | 14452 | Phloretin | 1 g | 1386 |
| Cayman2015 | 14452 | Phloretin | 250 mg | 462 |
| Cayman2015 | 14452 | Phloretin | 500 mg | 882 |
| Cayman2015 | 14453 | TBB | 10 mg | 798 |
| Cayman2015 | 14453 | TBB | 25 mg | 1470 |
| Cayman2015 | 14453 | TBB | 5 mg | 420 |
| Cayman2015 | 14453 | TBB | 50 mg | 2730 |
| Cayman2015 | 14454 | Minocycline (hydrochloride) | 100 mg | 910 |
| Cayman2015 | 14454 | Minocycline (hydrochloride) | 25 mg | 350 |
| Cayman2015 | 14454 | Minocycline (hydrochloride) | 50 mg | 532 |
| Cayman2015 | 14455 | Cilostamide | 10 mg | 1596 |
| Cayman2015 | 14455 | Cilostamide | 25 mg | 3360 |
| Cayman2015 | 14455 | Cilostamide | 5 mg | 840 |
| Cayman2015 | 14456 | CFSE | 10 mg | 826 |
| Cayman2015 | 14456 | CFSE | 100 mg | 6202 |
| Cayman2015 | 14456 | CFSE | 25 mg | 1750 |
| Cayman2015 | 14456 | CFSE | 50 mg | 3304 |
| Cayman2015 | 14459 | Ac-DEVD-AFC | 1 mg | 560 |
| Cayman2015 | 14459 | Ac-DEVD-AFC | 10 mg | 3920 |
| Cayman2015 | 14459 | Ac-DEVD-AFC | 5 mg | 2100 |
| Cayman2015 | 14460 | Ac-DEVD-pNA | 1 mg | 350 |
| Cayman2015 | 14460 | Ac-DEVD-pNA | 10 mg | 1750 |
| Cayman2015 | 14460 | Ac-DEVD-pNA | 5 mg | 966 |
| Cayman2015 | 14461 | AAF-CMK (trifluoroacetate salt) | 10 mg | 1302 |
| Cayman2015 | 14461 | AAF-CMK (trifluoroacetate salt) | 25 mg | 2912 |
| Cayman2015 | 14461 | AAF-CMK (trifluoroacetate salt) | 5 mg | 686 |
| Cayman2015 | 14462 | Z-FA-FMK | 1 mg | 910 |
| Cayman2015 | 14462 | Z-FA-FMK | 5 mg | 3192 |
| Cayman2015 | 14463 | Z-VAD(OMe)-FMK | 1 mg | 1386 |
| Cayman2015 | 14463 | Z-VAD(OMe)-FMK | 5 mg | 5894 |
| Cayman2015 | 14464 | Caspase-3/7 Inhibitor I | 1 mg | 1330 |
| Cayman2015 | 14464 | Caspase-3/7 Inhibitor I | 5 mg | 5600 |
| Cayman2015 | 14465 | Ac-DEVD-CMK | 1 mg | 910 |
| Cayman2015 | 14465 | Ac-DEVD-CMK | 5 mg | 4102 |
| Cayman2015 | 14466 | Calpain Inhibitor XII | 1 mg | 826 |
| Cayman2015 | 14466 | Calpain Inhibitor XII | 10 mg | 6706 |
| Cayman2015 | 14466 | Calpain Inhibitor XII | 5 mg | 3724 |
| Cayman2015 | 14467 | Z-VAD(OH)-FMK | 1 mg | 1540 |
| Cayman2015 | 14467 | Z-VAD(OH)-FMK | 5 mg | 3976 |
| Cayman2015 | 14467 | Z-VAD(OH)-FMK | 500 μg | 812 |
| Cayman2015 | 14468 | I-CBP112 (hydrochloride) | 1 mg | 490 |
| Cayman2015 | 14468 | I-CBP112 (hydrochloride) | 10 mg | 2940 |
| Cayman2015 | 14468 | I-CBP112 (hydrochloride) | 5 mg | 1960 |
| Cayman2015 | 14469 | SGC-CBP30 | 10 mg | 2366 |
| Cayman2015 | 14469 | SGC-CBP30 | 5 mg | 1246 |
| Cayman2015 | 14469 | SGC-CBP30 | 50 mg | 9352 |
| Cayman2015 | 14470 | UR-144 N-(2-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14470 | UR-144 N-(2-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14470 | UR-144 N-(2-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14471 | 2C-TFM (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 14471 | 2C-TFM (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 14471 | 2C-TFM (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 14482 | Gossypol | 100 mg | 1176 |
| Cayman2015 | 14482 | Gossypol | 250 mg | 2310 |
| Cayman2015 | 14482 | Gossypol | 50 mg | 840 |
| Cayman2015 | 14482 | Gossypol | 500 mg | 4200 |
| Cayman2015 | 14483 | Zinc Protoporphyrin-9 | 10 mg | 350 |
| Cayman2015 | 14483 | Zinc Protoporphyrin-9 | 100 mg | 2282 |
| Cayman2015 | 14483 | Zinc Protoporphyrin-9 | 25 mg | 742 |
| Cayman2015 | 14483 | Zinc Protoporphyrin-9 | 50 mg | 1316 |
| Cayman2015 | 14484 | Buthionine Sulfoximine | 1 g | 3276 |
| Cayman2015 | 14484 | Buthionine Sulfoximine | 250 mg | 910 |
| Cayman2015 | 14484 | Buthionine Sulfoximine | 500 mg | 1736 |
| Cayman2015 | 14485 | FAK Inhibitor 14 | 1 g | 672 |
| Cayman2015 | 14485 | FAK Inhibitor 14 | 5 g | 2800 |
| Cayman2015 | 14485 | FAK Inhibitor 14 | 500 mg | 350 |
| Cayman2015 | 14486 | Carbamoylcholine (chloride) | 1 g | 350 |
| Cayman2015 | 14486 | Carbamoylcholine (chloride) | 5 g | 1050 |
| Cayman2015 | 14487 | (+)-Pilocarpine (hydrochloride) | 1 g | 462 |
| Cayman2015 | 14487 | (+)-Pilocarpine (hydrochloride) | 10 g | 3850 |
| Cayman2015 | 14487 | (+)-Pilocarpine (hydrochloride) | 5 g | 2100 |
| Cayman2015 | 14487 | (+)-Pilocarpine (hydrochloride) | 500 mg | 350 |
| Cayman2015 | 14488 | Pyronin Y | 1 g | 350 |
| Cayman2015 | 14488 | Pyronin Y | 10 g | 1400 |
| Cayman2015 | 14488 | Pyronin Y | 5 g | 784 |
| Cayman2015 | 14489 | ASH1L bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14489 | ASH1L bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14489 | ASH1L bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14490 | ATAD2 bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14490 | ATAD2 bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14490 | ATAD2 bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14491 | BRD7 bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14491 | BRD7 bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14491 | BRD7 bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14492 | BRDT bromodomains 1 and 2 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14492 | BRDT bromodomains 1 and 2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14492 | BRDT bromodomains 1 and 2 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14493 | MIF (human recombinant) | 100 μg | 2898 |
| Cayman2015 | 14493 | MIF (human recombinant) | 25 μg | 966 |
| Cayman2015 | 14493 | MIF (human recombinant) | 50 μg | 1736 |
| Cayman2015 | 14494 | TAF1 bromodomains 1 and 2 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14494 | TAF1 bromodomains 1 and 2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14494 | TAF1 bromodomains 1 and 2 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14495 | TAF1 bromodomain 2 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14495 | TAF1 bromodomain 2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14495 | TAF1 bromodomain 2 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14496 | N-Phenylacetyl-L-prolylglycine ethyl ester | 1 mg | 686 |
| Cayman2015 | 14496 | N-Phenylacetyl-L-prolylglycine ethyl ester | 10 mg | 5488 |
| Cayman2015 | 14496 | N-Phenylacetyl-L-prolylglycine ethyl ester | 5 mg | 3094 |
| Cayman2015 | 14497 | JNJ-1661010 | 10 mg | 1246 |
| Cayman2015 | 14497 | JNJ-1661010 | 25 mg | 2268 |
| Cayman2015 | 14497 | JNJ-1661010 | 5 mg | 826 |
| Cayman2015 | 14497 | JNJ-1661010 | 50 mg | 4130 |
| Cayman2015 | 14498 | Adenosine 5'-triphosphate (sodium salt) | 10 g | 1050 |
| Cayman2015 | 14498 | Adenosine 5'-triphosphate (sodium salt) | 25 g | 2492 |
| Cayman2015 | 14498 | Adenosine 5'-triphosphate (sodium salt) | 5 g | 546 |
| Cayman2015 | 14498 | Adenosine 5'-triphosphate (sodium salt) | 50 g | 4732 |
| Cayman2015 | 14500 | Coomassie Blue R-250 | 10 g | 350 |
| Cayman2015 | 14500 | Coomassie Blue R-250 | 100 g | 1932 |
| Cayman2015 | 14500 | Coomassie Blue R-250 | 25 g | 616 |
| Cayman2015 | 14500 | Coomassie Blue R-250 | 50 g | 1134 |
| Cayman2015 | 14501 | RGD Peptide | 1 mg | 392 |
| Cayman2015 | 14501 | RGD Peptide | 10 mg | 2744 |
| Cayman2015 | 14501 | RGD Peptide | 25 mg | 5880 |
| Cayman2015 | 14501 | RGD Peptide | 5 mg | 1568 |
| Cayman2015 | 14502 | Trypsin Inhibitor (soybean) | 100 mg | 924 |
| Cayman2015 | 14502 | Trypsin Inhibitor (soybean) | 250 mg | 1960 |
| Cayman2015 | 14502 | Trypsin Inhibitor (soybean) | 50 mg | 546 |
| Cayman2015 | 14503 | Virginiamycin complex | 1 mg | 770 |
| Cayman2015 | 14503 | Virginiamycin complex | 10 mg | 6160 |
| Cayman2015 | 14503 | Virginiamycin complex | 5 mg | 3472 |
| Cayman2015 | 14505 | BB-22 3-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14505 | BB-22 3-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14505 | BB-22 3-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14506 | BB-22 4-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14506 | BB-22 4-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14506 | BB-22 4-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14507 | BB-22 5-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14507 | BB-22 5-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14507 | BB-22 5-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14508 | BB-22 6-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14508 | BB-22 6-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14508 | BB-22 6-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14509 | BB-22 7-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14509 | BB-22 7-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14509 | BB-22 7-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14510 | 11β-Prostaglandin E2 | 1 mg | 686 |
| Cayman2015 | 14510 | 11β-Prostaglandin E2 | 10 mg | 5096 |
| Cayman2015 | 14510 | 11β-Prostaglandin E2 | 5 mg | 2912 |
| Cayman2015 | 14510 | 11β-Prostaglandin E2 | 500 μg | 364 |
| Cayman2015 | 14511 | 5-fluoro PB-22 3-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14511 | 5-fluoro PB-22 3-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14511 | 5-fluoro PB-22 3-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14512 | 5-fluoro PB-22 4-hydroxyquinoline isomer | 1 mg | 686 |
| Cayman2015 | 14512 | 5-fluoro PB-22 4-hydroxyquinoline isomer | 10 mg | 5488 |
| Cayman2015 | 14512 | 5-fluoro PB-22 4-hydroxyquinoline isomer | 5 mg | 3094 |
| Cayman2015 | 14513 | 5-fluoro PB-22 5-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14513 | 5-fluoro PB-22 5-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14513 | 5-fluoro PB-22 5-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14514 | 5-fluoro PB-22 6-hydroxyquinoline isomer | 1 mg | 686 |
| Cayman2015 | 14514 | 5-fluoro PB-22 6-hydroxyquinoline isomer | 10 mg | 5488 |
| Cayman2015 | 14514 | 5-fluoro PB-22 6-hydroxyquinoline isomer | 5 mg | 3094 |
| Cayman2015 | 14515 | 5-fluoro PB-22 7-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14515 | 5-fluoro PB-22 7-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14515 | 5-fluoro PB-22 7-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14516 | PB-22 3-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14516 | PB-22 3-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14516 | PB-22 3-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14517 | PB-22 4-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14517 | PB-22 4-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14517 | PB-22 4-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14518 | PB-22 5-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14518 | PB-22 5-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14518 | PB-22 5-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14519 | PB-22 6-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14519 | PB-22 6-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14519 | PB-22 6-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14520 | 11-deoxy Prostaglandin E2 | 1 mg | 714 |
| Cayman2015 | 14520 | 11-deoxy Prostaglandin E2 | 10 mg | 5712 |
| Cayman2015 | 14520 | 11-deoxy Prostaglandin E2 | 5 mg | 3220 |
| Cayman2015 | 14521 | PB-22 7-hydroxyquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14521 | PB-22 7-hydroxyquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14521 | PB-22 7-hydroxyquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14522 | ONO-AE3-208 | 1 mg | 490 |
| Cayman2015 | 14522 | ONO-AE3-208 | 10 mg | 2450 |
| Cayman2015 | 14522 | ONO-AE3-208 | 5 mg | 1470 |
| Cayman2015 | 14522 | ONO-AE3-208 | 50 mg | 10290 |
| Cayman2015 | 14523 | LY2183240 2’-isomer | 1 mg | 1050 |
| Cayman2015 | 14523 | LY2183240 2’-isomer | 10 mg | 5180 |
| Cayman2015 | 14523 | LY2183240 2’-isomer | 5 mg | 2884 |
| Cayman2015 | 14524 | (+)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14524 | (+)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 14524 | (+)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 14525 | (?)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14525 | (?)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 14525 | (?)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 14528 | 30C-NBOMe (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 14528 | 30C-NBOMe (hydrochloride) | 10 mg | 1330 |
| Cayman2015 | 14528 | 30C-NBOMe (hydrochloride) | 5 mg | 966 |
| Cayman2015 | 14528 | 30C-NBOMe (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 14529 | AG-1295 | 1 mg | 350 |
| Cayman2015 | 14529 | AG-1295 | 10 mg | 2100 |
| Cayman2015 | 14529 | AG-1295 | 25 mg | 4382 |
| Cayman2015 | 14529 | AG-1295 | 5 mg | 1134 |
| Cayman2015 | 14530 | Bicyclo Prostaglandin E2 | 1 mg | 826 |
| Cayman2015 | 14530 | Bicyclo Prostaglandin E2 | 10 mg | 6608 |
| Cayman2015 | 14530 | Bicyclo Prostaglandin E2 | 5 mg | 3724 |
| Cayman2015 | 14531 | N-(p-amylcinnamoyl) Anthranilic Acid | 100 mg | 1918 |
| Cayman2015 | 14531 | N-(p-amylcinnamoyl) Anthranilic Acid | 25 mg | 686 |
| Cayman2015 | 14531 | N-(p-amylcinnamoyl) Anthranilic Acid | 250 mg | 3780 |
| Cayman2015 | 14531 | N-(p-amylcinnamoyl) Anthranilic Acid | 50 mg | 1036 |
| Cayman2015 | 14532 | Apafant | 1 mg | 560 |
| Cayman2015 | 14532 | Apafant | 5 mg | 1400 |
| Cayman2015 | 14533 | GM 6001 | 1 mg | 672 |
| Cayman2015 | 14533 | GM 6001 | 5 mg | 2800 |
| Cayman2015 | 14533 | GM 6001 | 500 μg | 350 |
| Cayman2015 | 14534 | NU 1025 | 1 mg | 336 |
| Cayman2015 | 14534 | NU 1025 | 25 mg | 3920 |
| Cayman2015 | 14534 | NU 1025 | 5 mg | 1316 |
| Cayman2015 | 14534 | NU 1025 | 50 mg | 7420 |
| Cayman2015 | 14535 | N-Acetylserotonin | 100 mg | 770 |
| Cayman2015 | 14535 | N-Acetylserotonin | 250 mg | 1834 |
| Cayman2015 | 14535 | N-Acetylserotonin | 50 mg | 406 |
| Cayman2015 | 14536 | MPEP (hydrochloride) | 10 mg | 924 |
| Cayman2015 | 14536 | MPEP (hydrochloride) | 25 mg | 2184 |
| Cayman2015 | 14536 | MPEP (hydrochloride) | 5 mg | 546 |
| Cayman2015 | 14536 | MPEP (hydrochloride) | 50 mg | 3556 |
| Cayman2015 | 14537 | PPADS (sodium salt) | 10 mg | 406 |
| Cayman2015 | 14537 | PPADS (sodium salt) | 250 mg | 8624 |
| Cayman2015 | 14537 | PPADS (sodium salt) | 50 mg | 1834 |
| Cayman2015 | 14538 | L-AP4 | 1 mg | 686 |
| Cayman2015 | 14538 | L-AP4 | 10 mg | 1778 |
| Cayman2015 | 14538 | L-AP4 | 5 mg | 1092 |
| Cayman2015 | 14538 | L-AP4 | 50 mg | 7896 |
| Cayman2015 | 14539 | D-AP5 | 1 mg | 490 |
| Cayman2015 | 14539 | D-AP5 | 10 mg | 1372 |
| Cayman2015 | 14539 | D-AP5 | 100 mg | 8820 |
| Cayman2015 | 14539 | D-AP5 | 50 mg | 6622 |
| Cayman2015 | 14540 | DL-AP5 | 10 mg | 812 |
| Cayman2015 | 14540 | DL-AP5 | 50 mg | 3654 |
| Cayman2015 | 14541 | BB-22 4-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14541 | BB-22 4-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14541 | BB-22 4-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14542 | BB-22 5-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14542 | BB-22 5-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14542 | BB-22 5-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14543 | BB-22 6-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14543 | BB-22 6-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14543 | BB-22 6-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14544 | BB-22 7-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14544 | BB-22 7-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14544 | BB-22 7-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14545 | BB-22 8-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14545 | BB-22 8-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14545 | BB-22 8-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14546 | 5-fluoro PB-22 N-(2-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 14546 | 5-fluoro PB-22 N-(2-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 14546 | 5-fluoro PB-22 N-(2-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 14547 | 5-fluoro PB-22 N-(3-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 14547 | 5-fluoro PB-22 N-(3-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 14547 | 5-fluoro PB-22 N-(3-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 14548 | 5-fluoro PB-22 N-(4-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 14548 | 5-fluoro PB-22 N-(4-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 14548 | 5-fluoro PB-22 N-(4-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 14549 | 5-fluoro PB-22 4-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14549 | 5-fluoro PB-22 4-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14549 | 5-fluoro PB-22 4-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14550 | 5-fluoro PB-22 5-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14550 | 5-fluoro PB-22 5-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14550 | 5-fluoro PB-22 5-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14551 | 5-fluoro PB-22 6-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14551 | 5-fluoro PB-22 6-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14551 | 5-fluoro PB-22 6-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14552 | 5-fluoro PB-22 7-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14552 | 5-fluoro PB-22 7-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14552 | 5-fluoro PB-22 7-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14553 | 5-fluoro PB-22 8-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14553 | 5-fluoro PB-22 8-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14553 | 5-fluoro PB-22 8-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14554 | PB-22 4-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14554 | PB-22 4-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14554 | PB-22 4-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14555 | PB-22 5-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14555 | PB-22 5-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14555 | PB-22 5-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14556 | PB-22 6-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14556 | PB-22 6-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14556 | PB-22 6-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14557 | PB-22 7-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14557 | PB-22 7-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14557 | PB-22 7-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14558 | PB-22 8-hydroxyisoquinoline isomer | 1 mg | 910 |
| Cayman2015 | 14558 | PB-22 8-hydroxyisoquinoline isomer | 10 mg | 7280 |
| Cayman2015 | 14558 | PB-22 8-hydroxyisoquinoline isomer | 5 mg | 4102 |
| Cayman2015 | 14562 | 25T2-NBOMe (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 14562 | 25T2-NBOMe (hydrochloride) | 10 mg | 1330 |
| Cayman2015 | 14562 | 25T2-NBOMe (hydrochloride) | 5 mg | 966 |
| Cayman2015 | 14562 | 25T2-NBOMe (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 14563 | PB-22 N-(4-hydroxypentyl)-3-carboxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 14563 | PB-22 N-(4-hydroxypentyl)-3-carboxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 14563 | PB-22 N-(4-hydroxypentyl)-3-carboxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 14564 | PB-22 N-(5-hydroxypentyl)-3-carboxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 14564 | PB-22 N-(5-hydroxypentyl)-3-carboxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 14564 | PB-22 N-(5-hydroxypentyl)-3-carboxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 14565 | PB-22 N-pentanoic acid-3-carboxyindole metabolite | 1 mg | 1330 |
| Cayman2015 | 14565 | PB-22 N-pentanoic acid-3-carboxyindole metabolite | 10 mg | 4900 |
| Cayman2015 | 14565 | PB-22 N-pentanoic acid-3-carboxyindole metabolite | 5 mg | 3150 |
| Cayman2015 | 14568 | ML-228 | 1 mg | 350 |
| Cayman2015 | 14568 | ML-228 | 10 mg | 2632 |
| Cayman2015 | 14568 | ML-228 | 5 mg | 1484 |
| Cayman2015 | 14568 | ML-228 | 50 mg | 11382 |
| Cayman2015 | 14570 | 11-deoxy-16,16-dimethyl Prostaglandin E2 | 1 mg | 714 |
| Cayman2015 | 14570 | 11-deoxy-16,16-dimethyl Prostaglandin E2 | 10 mg | 5712 |
| Cayman2015 | 14570 | 11-deoxy-16,16-dimethyl Prostaglandin E2 | 5 mg | 3220 |
| Cayman2015 | 14571 | (R,S)-AMPA | 10 mg | 1540 |
| Cayman2015 | 14571 | (R,S)-AMPA | 50 mg | 6930 |
| Cayman2015 | 14572 | Citalopram (hydrobromide) | 1 g | 13230 |
| Cayman2015 | 14572 | Citalopram (hydrobromide) | 100 mg | 3780 |
| Cayman2015 | 14572 | Citalopram (hydrobromide) | 500 mg | 9450 |
| Cayman2015 | 14573 | Nimodipine | 1 g | 1680 |
| Cayman2015 | 14573 | Nimodipine | 100 mg | 532 |
| Cayman2015 | 14573 | Nimodipine | 500 mg | 938 |
| Cayman2015 | 14574 | 4-DAMP | 100 mg | 1610 |
| Cayman2015 | 14574 | 4-DAMP | 25 mg | 448 |
| Cayman2015 | 14574 | 4-DAMP | 50 mg | 812 |
| Cayman2015 | 14575 | 1-EBIO | 10 mg | 560 |
| Cayman2015 | 14575 | 1-EBIO | 100 mg | 4060 |
| Cayman2015 | 14575 | 1-EBIO | 5 mg | 350 |
| Cayman2015 | 14575 | 1-EBIO | 50 mg | 2212 |
| Cayman2015 | 14576 | Diazoxide | 100 mg | 700 |
| Cayman2015 | 14577 | Riluzole (hydrochloride) | 10 mg | 406 |
| Cayman2015 | 14577 | Riluzole (hydrochloride) | 50 mg | 1932 |
| Cayman2015 | 14578 | Ro 25-6981 Maleate | 1 mg | 630 |
| Cayman2015 | 14578 | Ro 25-6981 Maleate | 10 mg | 1890 |
| Cayman2015 | 14578 | Ro 25-6981 Maleate | 50 mg | 9450 |
| Cayman2015 | 14579 | Purvalanol A | 1 mg | 686 |
| Cayman2015 | 14579 | Purvalanol A | 10 mg | 2408 |
| Cayman2015 | 14579 | Purvalanol A | 50 mg | 10290 |
| Cayman2015 | 14580 | A-438079 (hydrochloride) | 10 mg | 1820 |
| Cayman2015 | 14580 | A-438079 (hydrochloride) | 50 mg | 8190 |
| Cayman2015 | 14581 | NMDA | 100 mg | 1148 |
| Cayman2015 | 14581 | NMDA | 250 mg | 2688 |
| Cayman2015 | 14581 | NMDA | 50 mg | 672 |
| Cayman2015 | 14581 | NMDA | 500 mg | 3696 |
| Cayman2015 | 14582 | XE 991 (hydrochloride) | 10 mg | 1246 |
| Cayman2015 | 14582 | XE 991 (hydrochloride) | 50 mg | 4984 |
| Cayman2015 | 14583 | DNQX | 10 mg | 490 |
| Cayman2015 | 14583 | DNQX | 50 mg | 1596 |
| Cayman2015 | 14584 | Ibotenic Acid | 1 mg | 1050 |
| Cayman2015 | 14584 | Ibotenic Acid | 25 mg | 10500 |
| Cayman2015 | 14584 | Ibotenic Acid | 5 mg | 2884 |
| Cayman2015 | 14585 | SR 95531 (hydrobromide) | 10 mg | 1246 |
| Cayman2015 | 14585 | SR 95531 (hydrobromide) | 25 mg | 2898 |
| Cayman2015 | 14585 | SR 95531 (hydrobromide) | 5 mg | 826 |
| Cayman2015 | 14585 | SR 95531 (hydrobromide) | 50 mg | 5376 |
| Cayman2015 | 14587 | 9-cis-Retinoic Acid | 1 mg | 490 |
| Cayman2015 | 14587 | 9-cis-Retinoic Acid | 10 mg | 2450 |
| Cayman2015 | 14587 | 9-cis-Retinoic Acid | 25 mg | 5516 |
| Cayman2015 | 14587 | 9-cis-Retinoic Acid | 5 mg | 1302 |
| Cayman2015 | 14588 | PF-670462 (hydrochloride) | 10 mg | 1750 |
| Cayman2015 | 14588 | PF-670462 (hydrochloride) | 50 mg | 7434 |
| Cayman2015 | 14589 | Cantharidin | 100 mg | 1512 |
| Cayman2015 | 14589 | Cantharidin | 25 mg | 504 |
| Cayman2015 | 14590 | Stattic | 10 mg | 630 |
| Cayman2015 | 14590 | Stattic | 25 mg | 1330 |
| Cayman2015 | 14590 | Stattic | 50 mg | 2366 |
| Cayman2015 | 14591 | Fura-2-Acetoxymethyl ester | 1 mg | 1680 |
| Cayman2015 | 14592 | Src Kinase Inhibitor I | 1 mg | 350 |
| Cayman2015 | 14592 | Src Kinase Inhibitor I | 10 mg | 1372 |
| Cayman2015 | 14592 | Src Kinase Inhibitor I | 5 mg | 770 |
| Cayman2015 | 14592 | Src Kinase Inhibitor I | 50 mg | 6174 |
| Cayman2015 | 14593 | Calpeptin | 10 mg | 1274 |
| Cayman2015 | 14593 | Calpeptin | 25 mg | 2954 |
| Cayman2015 | 14593 | Calpeptin | 5 mg | 910 |
| Cayman2015 | 14593 | Calpeptin | 50 mg | 5460 |
| Cayman2015 | 14594 | 2-furoyl-LIGRLO amide | 1 mg | 1050 |
| Cayman2015 | 14595 | Deferoxamine (mesylate) | 1 g | 812 |
| Cayman2015 | 14595 | Deferoxamine (mesylate) | 5 g | 3654 |
| Cayman2015 | 14596 | Tobramycin | 100 mg | 672 |
| Cayman2015 | 14596 | Tobramycin | 50 mg | 350 |
| Cayman2015 | 14596 | Tobramycin | 500 mg | 1484 |
| Cayman2015 | 14597 | Honokiol | 10 mg | 826 |
| Cayman2015 | 14597 | Honokiol | 25 mg | 1960 |
| Cayman2015 | 14598 | Bromocriptine (mesylate) | 100 mg | 952 |
| Cayman2015 | 14598 | Bromocriptine (mesylate) | 500 mg | 3094 |
| Cayman2015 | 14599 | WAY-100635 Maleate | 10 mg | 1372 |
| Cayman2015 | 14599 | WAY-100635 Maleate | 5 mg | 686 |
| Cayman2015 | 14599 | WAY-100635 Maleate | 50 mg | 5152 |
| Cayman2015 | 14600 | Sumatriptan (succinate) | 10 mg | 658 |
| Cayman2015 | 14600 | Sumatriptan (succinate) | 50 mg | 1484 |
| Cayman2015 | 14601 | (±)-Cromakalim | 10 mg | 1260 |
| Cayman2015 | 14601 | (±)-Cromakalim | 50 mg | 5362 |
| Cayman2015 | 14602 | Mecamylamine (hydrochloride) | 10 mg | 742 |
| Cayman2015 | 14602 | Mecamylamine (hydrochloride) | 25 mg | 1722 |
| Cayman2015 | 14602 | Mecamylamine (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 14602 | Mecamylamine (hydrochloride) | 50 mg | 3192 |
| Cayman2015 | 14606 | FBBBE | 1 mg | 350 |
| Cayman2015 | 14606 | FBBBE | 5 mg | 784 |
| Cayman2015 | 14607 | Philanthotoxin 74 (hydrochloride) | 1 mg | 630 |
| Cayman2015 | 14607 | Philanthotoxin 74 (hydrochloride) | 10 mg | 1582 |
| Cayman2015 | 14608 | Iberiotoxin | 100 μg | 2212 |
| Cayman2015 | 14609 | (±)-Anatoxin A (fumarate) | 1 mg | 1386 |
| Cayman2015 | 14610 | (±)-Thalidomide | 100 mg | 546 |
| Cayman2015 | 14611 | AY 9944 | 1 mg | 350 |
| Cayman2015 | 14611 | AY 9944 | 10 mg | 1932 |
| Cayman2015 | 14611 | AY 9944 | 25 mg | 4382 |
| Cayman2015 | 14611 | AY 9944 | 5 mg | 1050 |
| Cayman2015 | 14612 | 7-dehydro Cholesterol | 10 g | 770 |
| Cayman2015 | 14612 | 7-dehydro Cholesterol | 25 g | 1834 |
| Cayman2015 | 14612 | 7-dehydro Cholesterol | 5 g | 406 |
| Cayman2015 | 14612 | 7-dehydro Cholesterol | 50 g | 3248 |
| Cayman2015 | 14614 | Acetyl * (hydrochloride) | 10 mg | 1960 |
| Cayman2015 | 14614 | Acetyl * (hydrochloride) | 25 mg | 4172 |
| Cayman2015 | 14614 | Acetyl * (hydrochloride) | 50 mg | 7350 |
| Cayman2015 | 14615 | Meclizine (hydrochloride) | 10 mg | 1372 |
| Cayman2015 | 14615 | Meclizine (hydrochloride) | 25 mg | 3150 |
| Cayman2015 | 14615 | Meclizine (hydrochloride) | 5 mg | 1050 |
| Cayman2015 | 14615 | Meclizine (hydrochloride) | 50 mg | 5782 |
| Cayman2015 | 14616 | Dorzolamide (hydrochloride) | 10 mg | 1372 |
| Cayman2015 | 14616 | Dorzolamide (hydrochloride) | 100 mg | 5782 |
| Cayman2015 | 14616 | Dorzolamide (hydrochloride) | 5 mg | 826 |
| Cayman2015 | 14616 | Dorzolamide (hydrochloride) | 50 mg | 3724 |
| Cayman2015 | 14617 | DMXAA | 1 mg | 350 |
| Cayman2015 | 14617 | DMXAA | 10 mg | 2450 |
| Cayman2015 | 14617 | DMXAA | 25 mg | 4816 |
| Cayman2015 | 14617 | DMXAA | 5 mg | 1316 |
| Cayman2015 | 14618 | CNQX | 10 mg | 868 |
| Cayman2015 | 14618 | CNQX | 25 mg | 1918 |
| Cayman2015 | 14618 | CNQX | 5 mg | 546 |
| Cayman2015 | 14618 | CNQX | 50 mg | 3276 |
| Cayman2015 | 14619 | Amisulpride | 100 mg | 1568 |
| Cayman2015 | 14619 | Amisulpride | 25 mg | 490 |
| Cayman2015 | 14619 | Amisulpride | 50 mg | 938 |
| Cayman2015 | 14619 | Amisulpride | 500 mg | 4900 |
| Cayman2015 | 14621 | UNC1999 | 1 mg | 686 |
| Cayman2015 | 14621 | UNC1999 | 10 mg | 2268 |
| Cayman2015 | 14621 | UNC1999 | 25 mg | 3948 |
| Cayman2015 | 14621 | UNC1999 | 5 mg | 1302 |
| Cayman2015 | 14624 | AGI-5198 | 1 mg | 1050 |
| Cayman2015 | 14624 | AGI-5198 | 10 mg | 4732 |
| Cayman2015 | 14624 | AGI-5198 | 25 mg | 9184 |
| Cayman2015 | 14624 | AGI-5198 | 5 mg | 2884 |
| Cayman2015 | 14625 | Irisin Polyclonal Antibody | 1 ea | 4830 |
| Cayman2015 | 14627 | DBZ | 1 mg | 490 |
| Cayman2015 | 14627 | DBZ | 10 mg | 2702 |
| Cayman2015 | 14627 | DBZ | 5 mg | 2212 |
| Cayman2015 | 14629 | Citicoline (sodium salt) | 1 g | 2100 |
| Cayman2015 | 14629 | Citicoline (sodium salt) | 100 mg | 630 |
| Cayman2015 | 14629 | Citicoline (sodium salt) | 50 mg | 350 |
| Cayman2015 | 14629 | Citicoline (sodium salt) | 500 mg | 1400 |
| Cayman2015 | 14630 | Bumetanide | 1 g | 798 |
| Cayman2015 | 14630 | Bumetanide | 10 g | 4200 |
| Cayman2015 | 14630 | Bumetanide | 5 g | 2310 |
| Cayman2015 | 14630 | Bumetanide | 500 mg | 420 |
| Cayman2015 | 14632 | Dexrazoxane | 10 mg | 938 |
| Cayman2015 | 14632 | Dexrazoxane | 25 mg | 2184 |
| Cayman2015 | 14632 | Dexrazoxane | 5 mg | 672 |
| Cayman2015 | 14632 | Dexrazoxane | 50 mg | 3024 |
| Cayman2015 | 14633 | SCH 79797 (hydrochloride) | 1 mg | 420 |
| Cayman2015 | 14633 | SCH 79797 (hydrochloride) | 10 mg | 1890 |
| Cayman2015 | 14633 | SCH 79797 (hydrochloride) | 5 mg | 1372 |
| Cayman2015 | 14634 | Gly-Phe-β-naphthylamide | 100 mg | 1372 |
| Cayman2015 | 14634 | Gly-Phe-β-naphthylamide | 50 mg | 700 |
| Cayman2015 | 14634 | Gly-Phe-β-naphthylamide | 500 mg | 5488 |
| Cayman2015 | 14635 | (S)-10-hydroxy-Camptothecin | 100 mg | 1638 |
| Cayman2015 | 14635 | (S)-10-hydroxy-Camptothecin | 25 mg | 630 |
| Cayman2015 | 14635 | (S)-10-hydroxy-Camptothecin | 50 mg | 1134 |
| Cayman2015 | 14635 | (S)-10-hydroxy-Camptothecin | 500 mg | 6300 |
| Cayman2015 | 14636 | Ginkgolide B | 10 mg | 532 |
| Cayman2015 | 14636 | Ginkgolide B | 25 mg | 966 |
| Cayman2015 | 14636 | Ginkgolide B | 5 mg | 350 |
| Cayman2015 | 14636 | Ginkgolide B | 50 mg | 1750 |
| Cayman2015 | 14637 | Clemastine (fumarate) | 1 g | 4704 |
| Cayman2015 | 14637 | Clemastine (fumarate) | 100 mg | 784 |
| Cayman2015 | 14637 | Clemastine (fumarate) | 250 mg | 1372 |
| Cayman2015 | 14637 | Clemastine (fumarate) | 500 mg | 2548 |
| Cayman2015 | 14638 | Thioredoxin Reductase 1 (rat recombinant) | 10 U | 9198 |
| Cayman2015 | 14638 | Thioredoxin Reductase 1 (rat recombinant) | 5 U | 5418 |
| Cayman2015 | 14639 | AGI-6780 | 1 mg | 490 |
| Cayman2015 | 14639 | AGI-6780 | 10 mg | 2310 |
| Cayman2015 | 14639 | AGI-6780 | 5 mg | 1274 |
| Cayman2015 | 14640 | Lonidamine | 10 mg | 868 |
| Cayman2015 | 14640 | Lonidamine | 100 mg | 3276 |
| Cayman2015 | 14640 | Lonidamine | 5 mg | 546 |
| Cayman2015 | 14640 | Lonidamine | 50 mg | 1918 |
| Cayman2015 | 14641 | Maraviroc | 10 mg | 1736 |
| Cayman2015 | 14641 | Maraviroc | 25 mg | 3416 |
| Cayman2015 | 14641 | Maraviroc | 5 mg | 910 |
| Cayman2015 | 14641 | Maraviroc | 50 mg | 5012 |
| Cayman2015 | 14642 | Myoseverin | 1 mg | 350 |
| Cayman2015 | 14642 | Myoseverin | 5 mg | 966 |
| Cayman2015 | 14643 | Lenalidomide | 1 g | 4382 |
| Cayman2015 | 14643 | Lenalidomide | 100 mg | 1750 |
| Cayman2015 | 14643 | Lenalidomide | 500 mg | 2632 |
| Cayman2015 | 14646 | JWH 018 N-propanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 14646 | JWH 018 N-propanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 14646 | JWH 018 N-propanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 14647 | (-)-Indolactam V | 1 mg | 2820 |
| Cayman2015 | 14647 | (-)-Indolactam V | 300 μg | 1875 |
| Cayman2015 | 14648 | JFD00244 | 1 mg | 350 |
| Cayman2015 | 14648 | JFD00244 | 10 mg | 1232 |
| Cayman2015 | 14648 | JFD00244 | 5 mg | 784 |
| Cayman2015 | 14649 | Aloesin | 1 mg | 1568 |
| Cayman2015 | 14649 | Aloesin | 5 mg | 6608 |
| Cayman2015 | 14649 | Aloesin | 500 μg | 826 |
| Cayman2015 | 14650 | 13,14-dihydro-15-keto Prostaglandin E2 | 1 mg | 826 |
| Cayman2015 | 14650 | 13,14-dihydro-15-keto Prostaglandin E2 | 10 mg | 6608 |
| Cayman2015 | 14650 | 13,14-dihydro-15-keto Prostaglandin E2 | 5 mg | 3724 |
| Cayman2015 | 14653 | α-Ethyltryptamine | 10 mg | 952 |
| Cayman2015 | 14653 | α-Ethyltryptamine | 25 mg | 2310 |
| Cayman2015 | 14653 | α-Ethyltryptamine | 5 mg | 616 |
| Cayman2015 | 14655 | JWH 081-N-(cyclohexylmethyl) analog | 1 mg | 910 |
| Cayman2015 | 14655 | JWH 081-N-(cyclohexylmethyl) analog | 10 mg | 7280 |
| Cayman2015 | 14655 | JWH 081-N-(cyclohexylmethyl) analog | 5 mg | 4102 |
| Cayman2015 | 14656 | L-Ascorbic Acid | 100 g | 434 |
| Cayman2015 | 14656 | L-Ascorbic Acid | 250 g | 1008 |
| Cayman2015 | 14656 | L-Ascorbic Acid | 50 g | 336 |
| Cayman2015 | 14658 | BRD3 bromodomain 2 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14658 | BRD3 bromodomain 2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14658 | BRD3 bromodomain 2 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14659 | SP140 PHD and bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14659 | SP140 PHD and bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14659 | SP140 PHD and bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14660 | TRIM28 PHD and bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14660 | TRIM28 PHD and bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14660 | TRIM28 PHD and bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14661 | TRIM33 PHD and bromodomain (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14661 | TRIM33 PHD and bromodomain (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14661 | TRIM33 PHD and bromodomain (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14662 | Zaltoprofen | 10 mg | 966 |
| Cayman2015 | 14662 | Zaltoprofen | 100 mg | 2604 |
| Cayman2015 | 14662 | Zaltoprofen | 250 mg | 4830 |
| Cayman2015 | 14662 | Zaltoprofen | 50 mg | 1932 |
| Cayman2015 | 14667 | CYM 50308 | 1 mg | 490 |
| Cayman2015 | 14667 | CYM 50308 | 10 mg | 1722 |
| Cayman2015 | 14667 | CYM 50308 | 5 mg | 1106 |
| Cayman2015 | 14667 | CYM 50308 | 50 mg | 7350 |
| Cayman2015 | 14668 | Xanthorrhizol | 1 mg | 1470 |
| Cayman2015 | 14669 | Horseradish Peroxidase | 10 kU | 1078 |
| Cayman2015 | 14669 | Horseradish Peroxidase | 25 kU | 2212 |
| Cayman2015 | 14669 | Horseradish Peroxidase | 5 kU | 630 |
| Cayman2015 | 14670 | Alkaline Phosphatase | 10 kU | 3962 |
| Cayman2015 | 14670 | Alkaline Phosphatase | 25 kU | 9394 |
| Cayman2015 | 14670 | Alkaline Phosphatase | 5 kU | 2086 |
| Cayman2015 | 14671 | Diaphorase (Clostridium kluyveri) | 1 kU | 2310 |
| Cayman2015 | 14671 | Diaphorase (Clostridium kluyveri) | 2 kU | 4158 |
| Cayman2015 | 14671 | Diaphorase (Clostridium kluyveri) | 5 kU | 9240 |
| Cayman2015 | 14673 | G-15 | 1 mg | 910 |
| Cayman2015 | 14673 | G-15 | 10 mg | 2730 |
| Cayman2015 | 14673 | G-15 | 25 mg | 6370 |
| Cayman2015 | 14674 | methyl-1-(cyclohexylmethyl)-1H-indole-3-Carboxylate | 1 mg | 1330 |
| Cayman2015 | 14674 | methyl-1-(cyclohexylmethyl)-1H-indole-3-Carboxylate | 10 mg | 4900 |
| Cayman2015 | 14674 | methyl-1-(cyclohexylmethyl)-1H-indole-3-Carboxylate | 5 mg | 3150 |
| Cayman2015 | 14675 | methyl-1-(5-fluoropentyl)-1H-indole-3-Carboxylate | 1 mg | 1330 |
| Cayman2015 | 14675 | methyl-1-(5-fluoropentyl)-1H-indole-3-Carboxylate | 10 mg | 4900 |
| Cayman2015 | 14675 | methyl-1-(5-fluoropentyl)-1H-indole-3-Carboxylate | 5 mg | 3150 |
| Cayman2015 | 14676 | methyl-1-pentyl-1H-indole-3-Carboxylate | 1 mg | 1330 |
| Cayman2015 | 14676 | methyl-1-pentyl-1H-indole-3-Carboxylate | 10 mg | 4900 |
| Cayman2015 | 14676 | methyl-1-pentyl-1H-indole-3-Carboxylate | 5 mg | 3150 |
| Cayman2015 | 14677 | AKB48-d9 | 1 mg | 1736 |
| Cayman2015 | 14677 | AKB48-d9 | 500 μg | 910 |
| Cayman2015 | 14678 | (-)-PFI-2 (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 14678 | (-)-PFI-2 (hydrochloride) | 10 mg | 3780 |
| Cayman2015 | 14678 | (-)-PFI-2 (hydrochloride) | 5 mg | 2744 |
| Cayman2015 | 14679 | Acetyl *-d5 (hydrochloride) | 10 mg | 3136 |
| Cayman2015 | 14679 | Acetyl *-d5 (hydrochloride) | 5 mg | 1960 |
| Cayman2015 | 14681 | D-Luciferin (potassium salt) | 1 g | 3248 |
| Cayman2015 | 14681 | D-Luciferin (potassium salt) | 100 mg | 616 |
| Cayman2015 | 14681 | D-Luciferin (potassium salt) | 50 mg | 406 |
| Cayman2015 | 14681 | D-Luciferin (potassium salt) | 500 mg | 2240 |
| Cayman2015 | 14682 | D-Luciferin (sodium salt) | 1 g | 3248 |
| Cayman2015 | 14682 | D-Luciferin (sodium salt) | 100 mg | 616 |
| Cayman2015 | 14682 | D-Luciferin (sodium salt) | 50 mg | 406 |
| Cayman2015 | 14682 | D-Luciferin (sodium salt) | 500 mg | 2240 |
| Cayman2015 | 14687 | JWH 019 N-(5-hydroxyhexyl) metabolite-d5 | 1 mg | 5572 |
| Cayman2015 | 14687 | JWH 019 N-(5-hydroxyhexyl) metabolite-d5 | 100 μg | 1330 |
| Cayman2015 | 14687 | JWH 019 N-(5-hydroxyhexyl) metabolite-d5 | 500 μg | 4102 |
| Cayman2015 | 14692 | Tegaserod Maleate | 10 mg | 1316 |
| Cayman2015 | 14692 | Tegaserod Maleate | 25 mg | 2478 |
| Cayman2015 | 14692 | Tegaserod Maleate | 5 mg | 826 |
| Cayman2015 | 14692 | Tegaserod Maleate | 50 mg | 4130 |
| Cayman2015 | 14693 | LY341495 | 1 mg | 490 |
| Cayman2015 | 14693 | LY341495 | 10 mg | 2086 |
| Cayman2015 | 14693 | LY341495 | 50 mg | 8582 |
| Cayman2015 | 14694 | TAPI-0 | 1 mg | 3304 |
| Cayman2015 | 14694 | TAPI-0 | 5 mg | 13622 |
| Cayman2015 | 14694 | TAPI-0 | 500 μg | 1946 |
| Cayman2015 | 14695 | TAPI-2 | 1 mg | 2744 |
| Cayman2015 | 14695 | TAPI-2 | 500 μg | 1610 |
| Cayman2015 | 14696 | TG101209 | 1 mg | 490 |
| Cayman2015 | 14696 | TG101209 | 10 mg | 3682 |
| Cayman2015 | 14696 | TG101209 | 25 mg | 6734 |
| Cayman2015 | 14696 | TG101209 | 5 mg | 2212 |
| Cayman2015 | 14697 | SUMO Polyclonal Antibody | 1 ea | 3150 |
| Cayman2015 | 14701 | JARID1B/PLU1 (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 14702 | PORCN Polyclonal Antibody | 1 ea | 4130 |
| Cayman2015 | 14703 | PHA 665752 | 1 mg | 546 |
| Cayman2015 | 14703 | PHA 665752 | 10 mg | 1526 |
| Cayman2015 | 14703 | PHA 665752 | 25 mg | 3276 |
| Cayman2015 | 14703 | PHA 665752 | 5 mg | 868 |
| Cayman2015 | 14704 | GSK3β Inhibitor VIII | 10 mg | 1540 |
| Cayman2015 | 14704 | GSK3β Inhibitor VIII | 5 mg | 812 |
| Cayman2015 | 14704 | GSK3β Inhibitor VIII | 50 mg | 6496 |
| Cayman2015 | 14705 | Vildagliptin | 10 mg | 630 |
| Cayman2015 | 14705 | Vildagliptin | 100 mg | 3150 |
| Cayman2015 | 14705 | Vildagliptin | 25 mg | 1260 |
| Cayman2015 | 14705 | Vildagliptin | 50 mg | 2044 |
| Cayman2015 | 14706 | Vandetanib | 10 mg | 728 |
| Cayman2015 | 14706 | Vandetanib | 100 mg | 3556 |
| Cayman2015 | 14706 | Vandetanib | 25 mg | 1218 |
| Cayman2015 | 14706 | Vandetanib | 5 mg | 406 |
| Cayman2015 | 14707 | Dinaciclib | 10 mg | 2002 |
| Cayman2015 | 14707 | Dinaciclib | 25 mg | 4732 |
| Cayman2015 | 14707 | Dinaciclib | 5 mg | 1050 |
| Cayman2015 | 14708 | BX-912 | 1 mg | 770 |
| Cayman2015 | 14708 | BX-912 | 10 mg | 2310 |
| Cayman2015 | 14708 | BX-912 | 25 mg | 4816 |
| Cayman2015 | 14708 | BX-912 | 5 mg | 1540 |
| Cayman2015 | 14709 | FSLLRY-amide | 1 mg | 966 |
| Cayman2015 | 14709 | FSLLRY-amide | 10 mg | 4130 |
| Cayman2015 | 14709 | FSLLRY-amide | 25 mg | 8260 |
| Cayman2015 | 14709 | FSLLRY-amide | 5 mg | 2660 |
| Cayman2015 | 14710 | 15(R)-Prostaglandin E2 | 1 mg | 714 |
| Cayman2015 | 14710 | 15(R)-Prostaglandin E2 | 10 mg | 5852 |
| Cayman2015 | 14710 | 15(R)-Prostaglandin E2 | 5 mg | 3220 |
| Cayman2015 | 14711 | Acetyl nor* (hydrochloride) | 10 mg | 1960 |
| Cayman2015 | 14711 | Acetyl nor* (hydrochloride) | 25 mg | 4172 |
| Cayman2015 | 14711 | Acetyl nor* (hydrochloride) | 50 mg | 7350 |
| Cayman2015 | 14712 | Acetyl nor*-d5 (hydrochloride) | 10 mg | 3136 |
| Cayman2015 | 14712 | Acetyl nor*-d5 (hydrochloride) | 5 mg | 1960 |
| Cayman2015 | 14713 | CysLT1 Receptor Polyclonal FITC Antibody | 1 ea | 3486 |
| Cayman2015 | 14714 | Dimethyl fumarate | 100 mg | 938 |
| Cayman2015 | 14714 | Dimethyl fumarate | 50 mg | 490 |
| Cayman2015 | 14714 | Dimethyl fumarate | 500 mg | 3920 |
| Cayman2015 | 14715 | AMG 9810 | 10 mg | 1110 |
| Cayman2015 | 14715 | AMG 9810 | 25 mg | 2340 |
| Cayman2015 | 14715 | AMG 9810 | 5 mg | 585 |
| Cayman2015 | 14716 | Aprotinin | 10 mg | 630 |
| Cayman2015 | 14716 | Aprotinin | 100 mg | 4732 |
| Cayman2015 | 14716 | Aprotinin | 25 mg | 1498 |
| Cayman2015 | 14716 | Aprotinin | 50 mg | 2842 |
| Cayman2015 | 14717 | Sophorose | 10 mg | 2310 |
| Cayman2015 | 14717 | Sophorose | 100 mg | 13860 |
| Cayman2015 | 14717 | Sophorose | 25 mg | 4914 |
| Cayman2015 | 14718 | 1',4"-Sophorolactone 6',6"-diacetate | 1 g | 2800 |
| Cayman2015 | 14718 | 1',4"-Sophorolactone 6',6"-diacetate | 500 mg | 1750 |
| Cayman2015 | 14719 | * (hydrochloride) | 10 mg | 420 |
| Cayman2015 | 14719 | * (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 14719 | * (hydrochloride) | 50 mg | 812 |
| Cayman2015 | 14720 | 15-keto Prostaglandin E2 | 1 mg | 1386 |
| Cayman2015 | 14720 | 15-keto Prostaglandin E2 | 10 mg | 10192 |
| Cayman2015 | 14720 | 15-keto Prostaglandin E2 | 5 mg | 5824 |
| Cayman2015 | 14720 | 15-keto Prostaglandin E2 | 500 μg | 728 |
| Cayman2015 | 14721 | *-d5 (hydrochloride) | 1 mg | 672 |
| Cayman2015 | 14721 | *-d5 (hydrochloride) | 5 mg | 1582 |
| Cayman2015 | 14721 | *-d5 (hydrochloride) | 500 μg | 350 |
| Cayman2015 | 14723 | 4(Z),7(Z),10(Z),13(Z),16(Z)-N-(2-hydroxyethyl)-Docosapentaenamide | 1 mg | 1036 |
| Cayman2015 | 14723 | 4(Z),7(Z),10(Z),13(Z),16(Z)-N-(2-hydroxyethyl)-Docosapentaenamide | 5 mg | 4368 |
| Cayman2015 | 14723 | 4(Z),7(Z),10(Z),13(Z),16(Z)-N-(2-hydroxyethyl)-Docosapentaenamide | 500 μg | 546 |
| Cayman2015 | 14724 | 7(Z),10(Z),13(Z),16(Z),19(Z)-N-(2-hydroxyethyl)-Docosapentaenamide | 1 mg | 1036 |
| Cayman2015 | 14724 | 7(Z),10(Z),13(Z),16(Z),19(Z)-N-(2-hydroxyethyl)-Docosapentaenamide | 5 mg | 4368 |
| Cayman2015 | 14724 | 7(Z),10(Z),13(Z),16(Z),19(Z)-N-(2-hydroxyethyl)-Docosapentaenamide | 500 μg | 546 |
| Cayman2015 | 14725 | 15(R)-15-methyl Prostaglandin E2 | 1 mg | 826 |
| Cayman2015 | 14725 | 15(R)-15-methyl Prostaglandin E2 | 10 mg | 6608 |
| Cayman2015 | 14725 | 15(R)-15-methyl Prostaglandin E2 | 5 mg | 3724 |
| Cayman2015 | 14726 | Stearoyl Ethanolamide-d3 | 1 mg | 2282 |
| Cayman2015 | 14726 | Stearoyl Ethanolamide-d3 | 10 mg | 16856 |
| Cayman2015 | 14726 | Stearoyl Ethanolamide-d3 | 5 mg | 9632 |
| Cayman2015 | 14726 | Stearoyl Ethanolamide-d3 | 500 μg | 1204 |
| Cayman2015 | 14727 | 25E-NBOMe (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 14727 | 25E-NBOMe (hydrochloride) | 10 mg | 1330 |
| Cayman2015 | 14727 | 25E-NBOMe (hydrochloride) | 5 mg | 966 |
| Cayman2015 | 14727 | 25E-NBOMe (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 14728 | Butyryl * (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 14728 | Butyryl * (hydrochloride) | 10 mg | 6370 |
| Cayman2015 | 14728 | Butyryl * (hydrochloride) | 5 mg | 3640 |
| Cayman2015 | 14730 | 15(S)-15-methyl Prostaglandin E2 | 1 mg | 1176 |
| Cayman2015 | 14730 | 15(S)-15-methyl Prostaglandin E2 | 10 mg | 8624 |
| Cayman2015 | 14730 | 15(S)-15-methyl Prostaglandin E2 | 5 mg | 4928 |
| Cayman2015 | 14730 | 15(S)-15-methyl Prostaglandin E2 | 500 μg | 616 |
| Cayman2015 | 14734 | DC4 Crosslinker | 10 mg | 1330 |
| Cayman2015 | 14734 | DC4 Crosslinker | 25 mg | 3150 |
| Cayman2015 | 14734 | DC4 Crosslinker | 5 mg | 700 |
| Cayman2015 | 14734 | DC4 Crosslinker | 50 mg | 5250 |
| Cayman2015 | 14735 | Salubrinal | 1 mg | 364 |
| Cayman2015 | 14735 | Salubrinal | 10 mg | 2184 |
| Cayman2015 | 14735 | Salubrinal | 25 mg | 4550 |
| Cayman2015 | 14735 | Salubrinal | 5 mg | 1274 |
| Cayman2015 | 14736 | WP1066 | 1 mg | 350 |
| Cayman2015 | 14736 | WP1066 | 10 mg | 1232 |
| Cayman2015 | 14736 | WP1066 | 25 mg | 2520 |
| Cayman2015 | 14736 | WP1066 | 5 mg | 882 |
| Cayman2015 | 14737 | Posaconazole | 1 mg | 1050 |
| Cayman2015 | 14737 | Posaconazole | 10 mg | 3570 |
| Cayman2015 | 14737 | Posaconazole | 5 mg | 1890 |
| Cayman2015 | 14738 | NNEI 2'-naphthyl isomer | 1 mg | 910 |
| Cayman2015 | 14738 | NNEI 2'-naphthyl isomer | 10 mg | 7280 |
| Cayman2015 | 14738 | NNEI 2'-naphthyl isomer | 5 mg | 4130 |
| Cayman2015 | 14741 | AMPK activator | 1 mg | 630 |
| Cayman2015 | 14741 | AMPK activator | 10 mg | 3780 |
| Cayman2015 | 14741 | AMPK activator | 5 mg | 2212 |
| Cayman2015 | 14742 | Batimastat | 1 mg | 686 |
| Cayman2015 | 14742 | Batimastat | 10 mg | 3360 |
| Cayman2015 | 14742 | Batimastat | 5 mg | 1890 |
| Cayman2015 | 14743 | Costunolide | 1 mg | 490 |
| Cayman2015 | 14743 | Costunolide | 10 mg | 1470 |
| Cayman2015 | 14743 | Costunolide | 25 mg | 3066 |
| Cayman2015 | 14743 | Costunolide | 5 mg | 854 |
| Cayman2015 | 14744 | CAY10677 | 1 mg | 588 |
| Cayman2015 | 14744 | CAY10677 | 10 mg | 3822 |
| Cayman2015 | 14744 | CAY10677 | 5 mg | 2352 |
| Cayman2015 | 14745 | Cysmethynil | 10 mg | 1736 |
| Cayman2015 | 14745 | Cysmethynil | 25 mg | 4102 |
| Cayman2015 | 14745 | Cysmethynil | 5 mg | 910 |
| Cayman2015 | 14746 | Abacavir (sulfate) | 10 mg | 938 |
| Cayman2015 | 14746 | Abacavir (sulfate) | 25 mg | 2212 |
| Cayman2015 | 14746 | Abacavir (sulfate) | 5 mg | 490 |
| Cayman2015 | 14746 | Abacavir (sulfate) | 50 mg | 3682 |
| Cayman2015 | 14747 | Cucurbitacin I | 1 mg | 952 |
| Cayman2015 | 14747 | Cucurbitacin I | 10 mg | 6664 |
| Cayman2015 | 14747 | Cucurbitacin I | 5 mg | 4046 |
| Cayman2015 | 14748 | Cyclic Pifithrin-α (hydrobromide) | 10 mg | 1316 |
| Cayman2015 | 14748 | Cyclic Pifithrin-α (hydrobromide) | 25 mg | 3080 |
| Cayman2015 | 14748 | Cyclic Pifithrin-α (hydrobromide) | 5 mg | 770 |
| Cayman2015 | 14748 | Cyclic Pifithrin-α (hydrobromide) | 50 mg | 5390 |
| Cayman2015 | 14749 | Fostriecin | 100 μg | 4485 |
| Cayman2015 | 14749 | Fostriecin | 500 μg | 14580 |
| Cayman2015 | 14750 | 16,16-dimethyl Prostaglandin E2 | 1 mg | 966 |
| Cayman2015 | 14750 | 16,16-dimethyl Prostaglandin E2 | 10 mg | 8694 |
| Cayman2015 | 14750 | 16,16-dimethyl Prostaglandin E2 | 5 mg | 4592 |
| Cayman2015 | 14751 | Shikonin | 10 mg | 672 |
| Cayman2015 | 14751 | Shikonin | 100 mg | 4900 |
| Cayman2015 | 14751 | Shikonin | 5 mg | 350 |
| Cayman2015 | 14751 | Shikonin | 50 mg | 2632 |
| Cayman2015 | 14753 | 16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester | 1 mg | 1652 |
| Cayman2015 | 14753 | 16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester | 10 mg | 12152 |
| Cayman2015 | 14753 | 16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester | 5 mg | 6944 |
| Cayman2015 | 14753 | 16,16-dimethyl Prostaglandin E2 p-(p-acetamidobenzamido) phenyl ester | 500 μg | 868 |
| Cayman2015 | 14755 | 5-fluoro AB-PINACA | 10 mg | 2310 |
| Cayman2015 | 14755 | 5-fluoro AB-PINACA | 25 mg | 4620 |
| Cayman2015 | 14755 | 5-fluoro AB-PINACA | 50 mg | 6930 |
| Cayman2015 | 14756 | Mephedrone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 1 mg | 1582 |
| Cayman2015 | 14756 | Mephedrone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 5 mg | 7350 |
| Cayman2015 | 14756 | Mephedrone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 500 μg | 1050 |
| Cayman2015 | 14757 | 4-Fluoromethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 1 mg | 1582 |
| Cayman2015 | 14757 | 4-Fluoromethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 5 mg | 7350 |
| Cayman2015 | 14757 | 4-Fluoromethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 500 μg | 1050 |
| Cayman2015 | 14758 | 4-Methylethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 1 mg | 1582 |
| Cayman2015 | 14758 | 4-Methylethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 5 mg | 7350 |
| Cayman2015 | 14758 | 4-Methylethcathinone metabolite (hydrochloride) ((±)-Ephedrine stereochemistry) | 500 μg | 1050 |
| Cayman2015 | 14759 | IPA-3 | 10 mg | 1008 |
| Cayman2015 | 14759 | IPA-3 | 25 mg | 2366 |
| Cayman2015 | 14759 | IPA-3 | 5 mg | 630 |
| Cayman2015 | 14759 | IPA-3 | 50 mg | 3780 |
| Cayman2015 | 14760 | 16-phenoxy tetranor Prostaglandin E2 | 1 mg | 714 |
| Cayman2015 | 14760 | 16-phenoxy tetranor Prostaglandin E2 | 10 mg | 5712 |
| Cayman2015 | 14760 | 16-phenoxy tetranor Prostaglandin E2 | 5 mg | 3220 |
| Cayman2015 | 14761 | Gambogic Acid | 1 mg | 350 |
| Cayman2015 | 14761 | Gambogic Acid | 10 mg | 1372 |
| Cayman2015 | 14761 | Gambogic Acid | 25 mg | 2100 |
| Cayman2015 | 14761 | Gambogic Acid | 5 mg | 966 |
| Cayman2015 | 14762 | PV8 (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 14762 | PV8 (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 14762 | PV8 (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 14763 | ADB-PINACA | 10 mg | 2310 |
| Cayman2015 | 14763 | ADB-PINACA | 25 mg | 4620 |
| Cayman2015 | 14763 | ADB-PINACA | 50 mg | 6930 |
| Cayman2015 | 14764 | 5-fluoro ADB-PINACA | 10 mg | 2310 |
| Cayman2015 | 14764 | 5-fluoro ADB-PINACA | 25 mg | 4620 |
| Cayman2015 | 14764 | 5-fluoro ADB-PINACA | 50 mg | 6930 |
| Cayman2015 | 14765 | Sulprostone | 1 mg | 1204 |
| Cayman2015 | 14765 | Sulprostone | 10 mg | 8820 |
| Cayman2015 | 14765 | Sulprostone | 5 mg | 5040 |
| Cayman2015 | 14765 | Sulprostone | 500 μg | 630 |
| Cayman2015 | 14766 | 5-fluoro ADBICA | 1 mg | 490 |
| Cayman2015 | 14766 | 5-fluoro ADBICA | 10 mg | 3920 |
| Cayman2015 | 14766 | 5-fluoro ADBICA | 5 mg | 2212 |
| Cayman2015 | 14768 | CBX1 (human recombinant) | 100 μg | 3486 |
| Cayman2015 | 14768 | CBX1 (human recombinant) | 25 μg | 1246 |
| Cayman2015 | 14768 | CBX1 (human recombinant) | 50 μg | 2114 |
| Cayman2015 | 14769 | CBX2 chromodomain (human recombinant) | 100 μg | 3486 |
| Cayman2015 | 14769 | CBX2 chromodomain (human recombinant) | 25 μg | 1246 |
| Cayman2015 | 14769 | CBX2 chromodomain (human recombinant) | 50 μg | 2114 |
| Cayman2015 | 14770 | 16-phenyl tetranor Prostaglandin E2 | 1 mg | 714 |
| Cayman2015 | 14770 | 16-phenyl tetranor Prostaglandin E2 | 10 mg | 5712 |
| Cayman2015 | 14770 | 16-phenyl tetranor Prostaglandin E2 | 5 mg | 3220 |
| Cayman2015 | 14772 | CHD1 chromodomains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14772 | CHD1 chromodomains (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14772 | CHD1 chromodomains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14773 | CHD2 chromodomains (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14773 | CHD2 chromodomains (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14773 | CHD2 chromodomains (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14775 | L3MBTL1 MBT domains (human recombinant; GST-tagged) | 100 μg | 5236 |
| Cayman2015 | 14775 | L3MBTL1 MBT domains (human recombinant; GST-tagged) | 25 μg | 1750 |
| Cayman2015 | 14775 | L3MBTL1 MBT domains (human recombinant; GST-tagged) | 50 μg | 2772 |
| Cayman2015 | 14777 | UHRF1 PHD domain (human recombinant) | 100 μg | 5236 |
| Cayman2015 | 14777 | UHRF1 PHD domain (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 14777 | UHRF1 PHD domain (human recombinant) | 50 μg | 2772 |
| Cayman2015 | 14778 | UHRF1 tudor-like region (human recombinant; GST-tagged) | 100 μg | 5236 |
| Cayman2015 | 14778 | UHRF1 tudor-like region (human recombinant; GST-tagged) | 25 μg | 1750 |
| Cayman2015 | 14778 | UHRF1 tudor-like region (human recombinant; GST-tagged) | 50 μg | 2772 |
| Cayman2015 | 14779 | UHRF1 tudor-like region (human recombinant; His-tagged) | 100 μg | 5236 |
| Cayman2015 | 14779 | UHRF1 tudor-like region (human recombinant; His-tagged) | 25 μg | 1750 |
| Cayman2015 | 14779 | UHRF1 tudor-like region (human recombinant; His-tagged) | 50 μg | 2772 |
| Cayman2015 | 14783 | Pipradrol (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 14783 | Pipradrol (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 14783 | Pipradrol (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 14784 | 25I-NBOMe 3-methoxy isomer (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 14784 | 25I-NBOMe 3-methoxy isomer (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 14784 | 25I-NBOMe 3-methoxy isomer (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 14785 | 25I-NBOMe 4-methoxy isomer (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 14785 | 25I-NBOMe 4-methoxy isomer (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 14785 | 25I-NBOMe 4-methoxy isomer (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 14787 | (S)-Dibutyl 3-Hydroxybutyl Phosphate | 1 mg | 686 |
| Cayman2015 | 14787 | (S)-Dibutyl 3-Hydroxybutyl Phosphate | 10 mg | 5488 |
| Cayman2015 | 14787 | (S)-Dibutyl 3-Hydroxybutyl Phosphate | 25 mg | 12012 |
| Cayman2015 | 14787 | (S)-Dibutyl 3-Hydroxybutyl Phosphate | 5 mg | 3094 |
| Cayman2015 | 14788 | 4-bromo-2,5-DMMA | 1 mg | 910 |
| Cayman2015 | 14788 | 4-bromo-2,5-DMMA | 10 mg | 7280 |
| Cayman2015 | 14788 | 4-bromo-2,5-DMMA | 5 mg | 4102 |
| Cayman2015 | 14789 | THJ 2201 | 1 mg | 910 |
| Cayman2015 | 14789 | THJ 2201 | 10 mg | 7280 |
| Cayman2015 | 14789 | THJ 2201 | 5 mg | 4102 |
| Cayman2015 | 14790 | 25(R)-27-hydroxy Cholesterol | 1 mg | 630 |
| Cayman2015 | 14790 | 25(R)-27-hydroxy Cholesterol | 10 mg | 5670 |
| Cayman2015 | 14790 | 25(R)-27-hydroxy Cholesterol | 5 mg | 2996 |
| Cayman2015 | 14791 | 25(S)-27-hydroxy Cholesterol | 1 mg | 630 |
| Cayman2015 | 14791 | 25(S)-27-hydroxy Cholesterol | 10 mg | 5670 |
| Cayman2015 | 14791 | 25(S)-27-hydroxy Cholesterol | 5 mg | 2996 |
| Cayman2015 | 14792 | ML-297 | 1 mg | 546 |
| Cayman2015 | 14792 | ML-297 | 10 mg | 4368 |
| Cayman2015 | 14792 | ML-297 | 25 mg | 9562 |
| Cayman2015 | 14792 | ML-297 | 5 mg | 2464 |
| Cayman2015 | 14793 | 2C-B-BZP (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 14793 | 2C-B-BZP (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 14793 | 2C-B-BZP (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 14794 | ALK5 Inhibitor II | 1 mg | 490 |
| Cayman2015 | 14794 | ALK5 Inhibitor II | 10 mg | 1722 |
| Cayman2015 | 14794 | ALK5 Inhibitor II | 25 mg | 3682 |
| Cayman2015 | 14794 | ALK5 Inhibitor II | 5 mg | 980 |
| Cayman2015 | 14795 | BAY-11-7085 | 10 mg | 1008 |
| Cayman2015 | 14795 | BAY-11-7085 | 25 mg | 2366 |
| Cayman2015 | 14795 | BAY-11-7085 | 5 mg | 630 |
| Cayman2015 | 14795 | BAY-11-7085 | 50 mg | 4410 |
| Cayman2015 | 14796 | SU 9516 | 1 mg | 350 |
| Cayman2015 | 14796 | SU 9516 | 10 mg | 1582 |
| Cayman2015 | 14796 | SU 9516 | 25 mg | 3500 |
| Cayman2015 | 14796 | SU 9516 | 5 mg | 1050 |
| Cayman2015 | 14797 | L-Sulforaphane | 1 mg | 350 |
| Cayman2015 | 14797 | L-Sulforaphane | 10 mg | 2282 |
| Cayman2015 | 14797 | L-Sulforaphane | 5 mg | 1316 |
| Cayman2015 | 14801 | 1'-Naphthoyl-2-methylindole | 10 mg | 1484 |
| Cayman2015 | 14801 | 1'-Naphthoyl-2-methylindole | 25 mg | 3528 |
| Cayman2015 | 14801 | 1'-Naphthoyl-2-methylindole | 5 mg | 784 |
| Cayman2015 | 14803 | Cyanidin (chloride) | 1 mg | 770 |
| Cayman2015 | 14803 | Cyanidin (chloride) | 10 mg | 2310 |
| Cayman2015 | 14803 | Cyanidin (chloride) | 25 mg | 4816 |
| Cayman2015 | 14803 | Cyanidin (chloride) | 5 mg | 1344 |
| Cayman2015 | 14804 | Atractyloside (potassium salt) | 1 mg | 2632 |
| Cayman2015 | 14804 | Atractyloside (potassium salt) | 500 μg | 1386 |
| Cayman2015 | 14805 | DPPH | 100 mg | 1106 |
| Cayman2015 | 14805 | DPPH | 50 mg | 616 |
| Cayman2015 | 14805 | DPPH | 500 mg | 4004 |
| Cayman2015 | 14806 | R-848 | 10 mg | 924 |
| Cayman2015 | 14806 | R-848 | 25 mg | 1918 |
| Cayman2015 | 14806 | R-848 | 5 mg | 546 |
| Cayman2015 | 14806 | R-848 | 50 mg | 3276 |
| Cayman2015 | 14807 | 3-oxo Stearic Acid | 1 mg | 3402 |
| Cayman2015 | 14807 | 3-oxo Stearic Acid | 100 μg | 630 |
| Cayman2015 | 14807 | 3-oxo Stearic Acid | 500 μg | 1890 |
| Cayman2015 | 14810 | 17-phenyl trinor Prostaglandin E2 | 1 mg | 882 |
| Cayman2015 | 14810 | 17-phenyl trinor Prostaglandin E2 | 10 mg | 6468 |
| Cayman2015 | 14810 | 17-phenyl trinor Prostaglandin E2 | 5 mg | 3696 |
| Cayman2015 | 14810 | 17-phenyl trinor Prostaglandin E2 | 500 μg | 462 |
| Cayman2015 | 14813 | Clomiphene | 1 g | 630 |
| Cayman2015 | 14813 | Clomiphene | 10 g | 1890 |
| Cayman2015 | 14813 | Clomiphene | 5 g | 1260 |
| Cayman2015 | 14814 | JWH 019 N-(5-hydroxyhexyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 14814 | JWH 019 N-(5-hydroxyhexyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 14814 | JWH 019 N-(5-hydroxyhexyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 14815 | 25C-NBOH (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 14815 | 25C-NBOH (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 14815 | 25C-NBOH (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 14816 | 5-fluoro MN-18 | 1 mg | 910 |
| Cayman2015 | 14816 | 5-fluoro MN-18 | 10 mg | 7280 |
| Cayman2015 | 14816 | 5-fluoro MN-18 | 5 mg | 4102 |
| Cayman2015 | 14817 | MN-18 | 1 mg | 910 |
| Cayman2015 | 14817 | MN-18 | 10 mg | 7280 |
| Cayman2015 | 14817 | MN-18 | 5 mg | 4102 |
| Cayman2015 | 14822 | BRD4 bromodomains 1 and 2 (human recombinant; aa 2-477) | 100 μg | 3990 |
| Cayman2015 | 14822 | BRD4 bromodomains 1 and 2 (human recombinant; aa 2-477) | 25 μg | 1330 |
| Cayman2015 | 14822 | BRD4 bromodomains 1 and 2 (human recombinant; aa 2-477) | 50 μg | 2394 |
| Cayman2015 | 14823 | SMYD2 (human recombinant) | 10 μg | 840 |
| Cayman2015 | 14823 | SMYD2 (human recombinant) | 25 μg | 2002 |
| Cayman2015 | 14823 | SMYD2 (human recombinant) | 50 μg | 3780 |
| Cayman2015 | 14825 | Fusidic Acid (sodium salt) | 1 g | 2450 |
| Cayman2015 | 14825 | Fusidic Acid (sodium salt) | 100 mg | 532 |
| Cayman2015 | 14825 | Fusidic Acid (sodium salt) | 250 mg | 882 |
| Cayman2015 | 14825 | Fusidic Acid (sodium salt) | 50 mg | 350 |
| Cayman2015 | 14826 | W-7 (hydrochloride) | 10 mg | 630 |
| Cayman2015 | 14826 | W-7 (hydrochloride) | 100 mg | 1582 |
| Cayman2015 | 14826 | W-7 (hydrochloride) | 50 mg | 952 |
| Cayman2015 | 14828 | Ceftazidime (hydrate) | 1 g | 1218 |
| Cayman2015 | 14828 | Ceftazidime (hydrate) | 10 g | 6496 |
| Cayman2015 | 14828 | Ceftazidime (hydrate) | 5 g | 4060 |
| Cayman2015 | 14828 | Ceftazidime (hydrate) | 500 mg | 812 |
| Cayman2015 | 14829 | Syk Inhibitor | 1 mg | 630 |
| Cayman2015 | 14829 | Syk Inhibitor | 10 mg | 2800 |
| Cayman2015 | 14829 | Syk Inhibitor | 5 mg | 1582 |
| Cayman2015 | 14829 | Syk Inhibitor | 500 μg | 350 |
| Cayman2015 | 14830 | Moxifloxacin (hydrochloride) | 1 g | 6300 |
| Cayman2015 | 14830 | Moxifloxacin (hydrochloride) | 100 mg | 1470 |
| Cayman2015 | 14830 | Moxifloxacin (hydrochloride) | 50 mg | 1050 |
| Cayman2015 | 14830 | Moxifloxacin (hydrochloride) | 500 mg | 3416 |
| Cayman2015 | 14831 | TBCA | 1 mg | 406 |
| Cayman2015 | 14831 | TBCA | 10 mg | 2436 |
| Cayman2015 | 14831 | TBCA | 25 mg | 5586 |
| Cayman2015 | 14831 | TBCA | 5 mg | 1316 |
| Cayman2015 | 14832 | Ibudilast | 1 mg | 350 |
| Cayman2015 | 14832 | Ibudilast | 10 mg | 1232 |
| Cayman2015 | 14832 | Ibudilast | 25 mg | 2632 |
| Cayman2015 | 14832 | Ibudilast | 5 mg | 700 |
| Cayman2015 | 14833 | AG-1024 | 1 mg | 546 |
| Cayman2015 | 14833 | AG-1024 | 10 mg | 1638 |
| Cayman2015 | 14833 | AG-1024 | 5 mg | 952 |
| Cayman2015 | 14834 | Azaserine | 10 mg | 420 |
| Cayman2015 | 14834 | Azaserine | 100 mg | 3570 |
| Cayman2015 | 14834 | Azaserine | 25 mg | 994 |
| Cayman2015 | 14834 | Azaserine | 50 mg | 1890 |
| Cayman2015 | 14835 | Gemfibrozil | 1 g | 350 |
| Cayman2015 | 14835 | Gemfibrozil | 10 g | 1232 |
| Cayman2015 | 14835 | Gemfibrozil | 25 g | 2184 |
| Cayman2015 | 14835 | Gemfibrozil | 5 g | 700 |
| Cayman2015 | 14837 | Nafamostat (mesylate) | 10 mg | 770 |
| Cayman2015 | 14837 | Nafamostat (mesylate) | 5 mg | 406 |
| Cayman2015 | 14837 | Nafamostat (mesylate) | 50 mg | 3430 |
| Cayman2015 | 14838 | Amlodipine | 1 g | 1232 |
| Cayman2015 | 14838 | Amlodipine | 5 g | 4620 |
| Cayman2015 | 14838 | Amlodipine | 500 mg | 770 |
| Cayman2015 | 14839 | Sertraline (hydrochloride) | 10 mg | 840 |
| Cayman2015 | 14839 | Sertraline (hydrochloride) | 25 mg | 1960 |
| Cayman2015 | 14839 | Sertraline (hydrochloride) | 5 mg | 560 |
| Cayman2015 | 14839 | Sertraline (hydrochloride) | 50 mg | 3360 |
| Cayman2015 | 14840 | tetranor-PGEM | 100 μg | 5446 |
| Cayman2015 | 14840 | tetranor-PGEM | 25 μg | 1512 |
| Cayman2015 | 14840 | tetranor-PGEM | 50 μg | 2870 |
| Cayman2015 | 14841 | Rocaglamide | 1 mg | 6650 |
| Cayman2015 | 14841 | Rocaglamide | 500 μg | 3500 |
| Cayman2015 | 14842 | Mitoxantrone (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 14842 | Mitoxantrone (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 14842 | Mitoxantrone (hydrochloride) | 50 mg | 700 |
| Cayman2015 | 14842 | Mitoxantrone (hydrochloride) | 500 mg | 5250 |
| Cayman2015 | 14843 | Busulfan | 100 g | 1960 |
| Cayman2015 | 14843 | Busulfan | 25 g | 546 |
| Cayman2015 | 14843 | Busulfan | 250 g | 4648 |
| Cayman2015 | 14843 | Busulfan | 50 g | 1036 |
| Cayman2015 | 14844 | Sulfaphenazole | 1 g | 2660 |
| Cayman2015 | 14844 | Sulfaphenazole | 250 mg | 1330 |
| Cayman2015 | 14844 | Sulfaphenazole | 5 g | 10640 |
| Cayman2015 | 14844 | Sulfaphenazole | 500 mg | 1862 |
| Cayman2015 | 14845 | 4-Aminobenzoic acid hydrazide | 1 g | 714 |
| Cayman2015 | 14845 | 4-Aminobenzoic acid hydrazide | 500 mg | 420 |
| Cayman2015 | 14860 | Leflunomide | 100 mg | 980 |
| Cayman2015 | 14860 | Leflunomide | 25 mg | 350 |
| Cayman2015 | 14860 | Leflunomide | 50 mg | 532 |
| Cayman2015 | 14860 | Leflunomide | 500 mg | 4550 |
| Cayman2015 | 14861 | SU 11274 | 1 mg | 938 |
| Cayman2015 | 14861 | SU 11274 | 5 mg | 1470 |
| Cayman2015 | 14861 | SU 11274 | 500 μg | 490 |
| Cayman2015 | 14862 | PS-1145 (hydrochloride) | 1 mg | 672 |
| Cayman2015 | 14862 | PS-1145 (hydrochloride) | 5 mg | 1750 |
| Cayman2015 | 14862 | PS-1145 (hydrochloride) | 500 μg | 350 |
| Cayman2015 | 14863 | Akt Inhibitor X | 1 mg | 910 |
| Cayman2015 | 14863 | Akt Inhibitor X | 10 mg | 5012 |
| Cayman2015 | 14863 | Akt Inhibitor X | 5 mg | 3192 |
| Cayman2015 | 14864 | BRD3 bromodomains 1 and 2 (human recombinant) | 100 μg | 3990 |
| Cayman2015 | 14864 | BRD3 bromodomains 1 and 2 (human recombinant) | 25 μg | 1330 |
| Cayman2015 | 14864 | BRD3 bromodomains 1 and 2 (human recombinant) | 50 μg | 2394 |
| Cayman2015 | 14865 | α-Truxillic Acid | 10 mg | 350 |
| Cayman2015 | 14865 | α-Truxillic Acid | 100 mg | 2100 |
| Cayman2015 | 14865 | α-Truxillic Acid | 50 mg | 1232 |
| Cayman2015 | 14865 | α-Truxillic Acid | 500 mg | 8750 |
| Cayman2015 | 14866 | Silodosin | 1 mg | 546 |
| Cayman2015 | 14866 | Silodosin | 10 mg | 4102 |
| Cayman2015 | 14866 | Silodosin | 25 mg | 9562 |
| Cayman2015 | 14866 | Silodosin | 5 mg | 2184 |
| Cayman2015 | 14867 | Aprepitant | 1 mg | 910 |
| Cayman2015 | 14867 | Aprepitant | 10 mg | 2282 |
| Cayman2015 | 14867 | Aprepitant | 25 mg | 4550 |
| Cayman2015 | 14867 | Aprepitant | 5 mg | 1190 |
| Cayman2015 | 14868 | Vatalanib (hydrochloride) | 10 mg | 910 |
| Cayman2015 | 14868 | Vatalanib (hydrochloride) | 100 mg | 5012 |
| Cayman2015 | 14868 | Vatalanib (hydrochloride) | 25 mg | 1708 |
| Cayman2015 | 14868 | Vatalanib (hydrochloride) | 50 mg | 2730 |
| Cayman2015 | 14870 | Akt Inhibitor VIII | 1 mg | 1540 |
| Cayman2015 | 14870 | Akt Inhibitor VIII | 10 mg | 3864 |
| Cayman2015 | 14870 | Akt Inhibitor VIII | 5 mg | 2422 |
| Cayman2015 | 14870 | Akt Inhibitor VIII | 500 μg | 966 |
| Cayman2015 | 14871 | KRN 633 | 1 mg | 686 |
| Cayman2015 | 14871 | KRN 633 | 10 mg | 4116 |
| Cayman2015 | 14871 | KRN 633 | 5 mg | 2226 |
| Cayman2015 | 14871 | KRN 633 | 50 mg | 12012 |
| Cayman2015 | 14872 | Lucigenin | 1 g | 1190 |
| Cayman2015 | 14872 | Lucigenin | 100 mg | 532 |
| Cayman2015 | 14872 | Lucigenin | 50 mg | 350 |
| Cayman2015 | 14872 | Lucigenin | 500 mg | 882 |
| Cayman2015 | 14873 | Debromohymenialdisine | 100 μg | 1335 |
| Cayman2015 | 14874 | Levamisole (hydrochloride) | 10 mg | 560 |
| Cayman2015 | 14874 | Levamisole (hydrochloride) | 100 mg | 2100 |
| Cayman2015 | 14874 | Levamisole (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 14874 | Levamisole (hydrochloride) | 50 mg | 1232 |
| Cayman2015 | 14875 | Loperamide (hydrochloride) | 10 mg | 560 |
| Cayman2015 | 14875 | Loperamide (hydrochloride) | 25 mg | 784 |
| Cayman2015 | 14875 | Loperamide (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 14875 | Loperamide (hydrochloride) | 50 mg | 1232 |
| Cayman2015 | 14877 | TEMPONE | 1 g | 350 |
| Cayman2015 | 14877 | TEMPONE | 10 g | 1932 |
| Cayman2015 | 14877 | TEMPONE | 25 g | 3934 |
| Cayman2015 | 14877 | TEMPONE | 5 g | 1134 |
| Cayman2015 | 14878 | Pentostatin | 1 mg | 420 |
| Cayman2015 | 14878 | Pentostatin | 10 mg | 1260 |
| Cayman2015 | 14878 | Pentostatin | 5 mg | 952 |
| Cayman2015 | 14879 | PD 153035 (hydrochloride) | 10 mg | 826 |
| Cayman2015 | 14879 | PD 153035 (hydrochloride) | 25 mg | 1890 |
| Cayman2015 | 14879 | PD 153035 (hydrochloride) | 5 mg | 630 |
| Cayman2015 | 14879 | PD 153035 (hydrochloride) | 50 mg | 3472 |
| Cayman2015 | 14880 | Omeprazole | 100 mg | 770 |
| Cayman2015 | 14880 | Omeprazole | 25 mg | 350 |
| Cayman2015 | 14880 | Omeprazole | 50 mg | 532 |
| Cayman2015 | 14880 | Omeprazole | 500 mg | 1400 |
| Cayman2015 | 14881 | NU 7441 | 1 mg | 350 |
| Cayman2015 | 14881 | NU 7441 | 10 mg | 1582 |
| Cayman2015 | 14881 | NU 7441 | 25 mg | 3500 |
| Cayman2015 | 14881 | NU 7441 | 5 mg | 882 |
| Cayman2015 | 14889 | THJ | 1 mg | 910 |
| Cayman2015 | 14889 | THJ | 10 mg | 7280 |
| Cayman2015 | 14889 | THJ | 5 mg | 4102 |
| Cayman2015 | 14890 | 5-fluoro-THJ | 1 mg | 910 |
| Cayman2015 | 14890 | 5-fluoro-THJ | 10 mg | 7280 |
| Cayman2015 | 14890 | 5-fluoro-THJ | 5 mg | 4102 |
| Cayman2015 | 14891 | JWH 018 8-quinolinyl carboxamide | 1 mg | 910 |
| Cayman2015 | 14891 | JWH 018 8-quinolinyl carboxamide | 10 mg | 7280 |
| Cayman2015 | 14891 | JWH 018 8-quinolinyl carboxamide | 5 mg | 4102 |
| Cayman2015 | 14892 | AM2201 8-quinolinyl carboxamide | 1 mg | 910 |
| Cayman2015 | 14892 | AM2201 8-quinolinyl carboxamide | 10 mg | 7280 |
| Cayman2015 | 14892 | AM2201 8-quinolinyl carboxamide | 5 mg | 4102 |
| Cayman2015 | 14893 | 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic Acid-d5 | 1 mg | 4704 |
| Cayman2015 | 14893 | 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic Acid-d5 | 100 μg | 1078 |
| Cayman2015 | 14893 | 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic Acid-d5 | 50 μg | 672 |
| Cayman2015 | 14893 | 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic Acid-d5 | 500 μg | 4032 |
| Cayman2015 | 14894 | 4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic Acid-d5 | 1 mg | 4704 |
| Cayman2015 | 14894 | 4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic Acid-d5 | 100 μg | 1078 |
| Cayman2015 | 14894 | 4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic Acid-d5 | 50 μg | 672 |
| Cayman2015 | 14894 | 4(Z),7(Z),10(Z),13(Z)-Hexadecatetraenoic Acid-d5 | 500 μg | 4032 |
| Cayman2015 | 14895 | 4(Z),7(Z),10(Z)-Tridecatrienoic Acid-d5 | 1 mg | 4704 |
| Cayman2015 | 14895 | 4(Z),7(Z),10(Z)-Tridecatrienoic Acid-d5 | 100 μg | 1078 |
| Cayman2015 | 14895 | 4(Z),7(Z),10(Z)-Tridecatrienoic Acid-d5 | 50 μg | 672 |
| Cayman2015 | 14895 | 4(Z),7(Z),10(Z)-Tridecatrienoic Acid-d5 | 500 μg | 4032 |
| Cayman2015 | 14896 | 4(Z),7(Z)-Decadienoic Acid-d5 | 1 mg | 4704 |
| Cayman2015 | 14896 | 4(Z),7(Z)-Decadienoic Acid-d5 | 100 μg | 1078 |
| Cayman2015 | 14896 | 4(Z),7(Z)-Decadienoic Acid-d5 | 50 μg | 672 |
| Cayman2015 | 14896 | 4(Z),7(Z)-Decadienoic Acid-d5 | 500 μg | 4032 |
| Cayman2015 | 14897 | N-methyl-2-AI (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 14897 | N-methyl-2-AI (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 14897 | N-methyl-2-AI (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 14898 | W-15 | 1 mg | 686 |
| Cayman2015 | 14898 | W-15 | 10 mg | 5488 |
| Cayman2015 | 14898 | W-15 | 5 mg | 3094 |
| Cayman2015 | 14900 | Nitracaine | 1 mg | 686 |
| Cayman2015 | 14900 | Nitracaine | 10 mg | 5488 |
| Cayman2015 | 14900 | Nitracaine | 5 mg | 3094 |
| Cayman2015 | 14901 | Pyrazolam | 1 mg | 1190 |
| Cayman2015 | 14901 | Pyrazolam | 10 mg | 9520 |
| Cayman2015 | 14901 | Pyrazolam | 5 mg | 5362 |
| Cayman2015 | 14902 | Luffariellolide | 1 mg | 1680 |
| Cayman2015 | 14903 | Manoalide | 1 mg | 2240 |
| Cayman2015 | 14904 | GPR120 (Internal) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 14905 | L-(+)-Ergothioneine | 10 mg | 1302 |
| Cayman2015 | 14905 | L-(+)-Ergothioneine | 25 mg | 2912 |
| Cayman2015 | 14905 | L-(+)-Ergothioneine | 5 mg | 686 |
| Cayman2015 | 14905 | L-(+)-Ergothioneine | 50 mg | 5152 |
| Cayman2015 | 14906 | Meloxicam | 100 mg | 910 |
| Cayman2015 | 14906 | Meloxicam | 25 mg | 350 |
| Cayman2015 | 14906 | Meloxicam | 50 mg | 630 |
| Cayman2015 | 14906 | Meloxicam | 500 mg | 3150 |
| Cayman2015 | 14907 | MeOSuc-Ala-Ala-Pro-Val-AMC | 1 mg | 350 |
| Cayman2015 | 14907 | MeOSuc-Ala-Ala-Pro-Val-AMC | 10 mg | 1932 |
| Cayman2015 | 14907 | MeOSuc-Ala-Ala-Pro-Val-AMC | 5 mg | 1050 |
| Cayman2015 | 14908 | NSC 87877 | 10 mg | 406 |
| Cayman2015 | 14908 | NSC 87877 | 100 mg | 2436 |
| Cayman2015 | 14908 | NSC 87877 | 25 mg | 812 |
| Cayman2015 | 14908 | NSC 87877 | 50 mg | 1316 |
| Cayman2015 | 14909 | 25I-NBOH (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 14909 | 25I-NBOH (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 14909 | 25I-NBOH (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 14910 | 19(R)-hydroxy Prostaglandin E2 | 1 mg | 8624 |
| Cayman2015 | 14910 | 19(R)-hydroxy Prostaglandin E2 | 100 μg | 1176 |
| Cayman2015 | 14910 | 19(R)-hydroxy Prostaglandin E2 | 50 μg | 616 |
| Cayman2015 | 14910 | 19(R)-hydroxy Prostaglandin E2 | 500 μg | 4928 |
| Cayman2015 | 14911 | 25N-NBOMe (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 14911 | 25N-NBOMe (hydrochloride) | 10 mg | 1330 |
| Cayman2015 | 14911 | 25N-NBOMe (hydrochloride) | 5 mg | 966 |
| Cayman2015 | 14911 | 25N-NBOMe (hydrochloride) | 50 mg | 3850 |
| Cayman2015 | 14913 | Arctigenin | 10 mg | 686 |
| Cayman2015 | 14913 | Arctigenin | 100 mg | 3094 |
| Cayman2015 | 14913 | Arctigenin | 25 mg | 938 |
| Cayman2015 | 14913 | Arctigenin | 50 mg | 1722 |
| Cayman2015 | 14914 | NBQX (sodium salt) | 1 mg | 686 |
| Cayman2015 | 14914 | NBQX (sodium salt) | 10 mg | 2408 |
| Cayman2015 | 14914 | NBQX (sodium salt) | 50 mg | 10290 |
| Cayman2015 | 14915 | Oxymatrine | 1 g | 2730 |
| Cayman2015 | 14915 | Oxymatrine | 100 mg | 924 |
| Cayman2015 | 14915 | Oxymatrine | 50 mg | 546 |
| Cayman2015 | 14915 | Oxymatrine | 500 mg | 1918 |
| Cayman2015 | 14916 | Protocatechuic Acid | 100 g | 1568 |
| Cayman2015 | 14916 | Protocatechuic Acid | 25 g | 490 |
| Cayman2015 | 14916 | Protocatechuic Acid | 50 g | 882 |
| Cayman2015 | 14917 | Rasagiline | 10 mg | 364 |
| Cayman2015 | 14917 | Rasagiline | 100 mg | 1092 |
| Cayman2015 | 14917 | Rasagiline | 25 mg | 462 |
| Cayman2015 | 14917 | Rasagiline | 50 mg | 644 |
| Cayman2015 | 14918 | Spermidine | 1 g | 350 |
| Cayman2015 | 14918 | Spermidine | 10 g | 1750 |
| Cayman2015 | 14918 | Spermidine | 25 g | 3934 |
| Cayman2015 | 14918 | Spermidine | 5 g | 966 |
| Cayman2015 | 14919 | XTT (sodium salt) | 100 mg | 1414 |
| Cayman2015 | 14919 | XTT (sodium salt) | 25 mg | 546 |
| Cayman2015 | 14919 | XTT (sodium salt) | 250 mg | 3010 |
| Cayman2015 | 14919 | XTT (sodium salt) | 50 mg | 868 |
| Cayman2015 | 14920 | 15(R),19(R)-hydroxy Prostaglandin E2 | 1 mg | 6076 |
| Cayman2015 | 14920 | 15(R),19(R)-hydroxy Prostaglandin E2 | 100 μg | 826 |
| Cayman2015 | 14920 | 15(R),19(R)-hydroxy Prostaglandin E2 | 50 μg | 434 |
| Cayman2015 | 14920 | 15(R),19(R)-hydroxy Prostaglandin E2 | 500 μg | 3472 |
| Cayman2015 | 14921 | Calpain Inhibitor I | 1 mg | 350 |
| Cayman2015 | 14921 | Calpain Inhibitor I | 10 mg | 1582 |
| Cayman2015 | 14921 | Calpain Inhibitor I | 25 mg | 2632 |
| Cayman2015 | 14921 | Calpain Inhibitor I | 5 mg | 882 |
| Cayman2015 | 14922 | Neutrophil Elastase Inhibitor | 10 mg | 1302 |
| Cayman2015 | 14922 | Neutrophil Elastase Inhibitor | 25 mg | 3094 |
| Cayman2015 | 14922 | Neutrophil Elastase Inhibitor | 5 mg | 686 |
| Cayman2015 | 14922 | Neutrophil Elastase Inhibitor | 50 mg | 5488 |
| Cayman2015 | 14928 | Cathepsin G Inhibitor I | 1 mg | 2100 |
| Cayman2015 | 14928 | Cathepsin G Inhibitor I | 5 mg | 8302 |
| Cayman2015 | 14928 | Cathepsin G Inhibitor I | 500 μg | 1106 |
| Cayman2015 | 14929 | MIF Antagonist | 1 mg | 350 |
| Cayman2015 | 14929 | MIF Antagonist | 5 mg | 1316 |
| Cayman2015 | 14930 | Vardenafil (hydrochloride hydrate) | 10 mg | 1190 |
| Cayman2015 | 14930 | Vardenafil (hydrochloride hydrate) | 100 mg | 7742 |
| Cayman2015 | 14930 | Vardenafil (hydrochloride hydrate) | 25 mg | 2534 |
| Cayman2015 | 14930 | Vardenafil (hydrochloride hydrate) | 50 mg | 4760 |
| Cayman2015 | 14931 | CUR 61414 | 10 mg | 2604 |
| Cayman2015 | 14931 | CUR 61414 | 5 mg | 1372 |
| Cayman2015 | 14932 | BX-795 | 10 mg | 1736 |
| Cayman2015 | 14932 | BX-795 | 25 mg | 3640 |
| Cayman2015 | 14932 | BX-795 | 5 mg | 910 |
| Cayman2015 | 14932 | BX-795 | 50 mg | 6832 |
| Cayman2015 | 14933 | SANT 1 | 1 mg | 686 |
| Cayman2015 | 14933 | SANT 1 | 10 mg | 1918 |
| Cayman2015 | 14933 | SANT 1 | 5 mg | 1204 |
| Cayman2015 | 14935 | XLR12 | 1 mg | 910 |
| Cayman2015 | 14935 | XLR12 | 10 mg | 7280 |
| Cayman2015 | 14935 | XLR12 | 5 mg | 4102 |
| Cayman2015 | 14938 | Finasteride | 100 mg | 546 |
| Cayman2015 | 14938 | Finasteride | 250 mg | 1274 |
| Cayman2015 | 14938 | Finasteride | 50 mg | 364 |
| Cayman2015 | 14939 | Rabeprazole (sodium salt) | 10 mg | 602 |
| Cayman2015 | 14939 | Rabeprazole (sodium salt) | 25 mg | 1316 |
| Cayman2015 | 14939 | Rabeprazole (sodium salt) | 5 mg | 350 |
| Cayman2015 | 14939 | Rabeprazole (sodium salt) | 50 mg | 2450 |
| Cayman2015 | 14940 | 20-ethyl Prostaglandin E2 | 1 mg | 714 |
| Cayman2015 | 14940 | 20-ethyl Prostaglandin E2 | 10 mg | 5712 |
| Cayman2015 | 14940 | 20-ethyl Prostaglandin E2 | 5 mg | 3220 |
| Cayman2015 | 14941 | Quinolinic Acid | 1 g | 350 |
| Cayman2015 | 14941 | Quinolinic Acid | 10 g | 532 |
| Cayman2015 | 14941 | Quinolinic Acid | 50 g | 1750 |
| Cayman2015 | 14943 | Desmosterol | 1 mg | 350 |
| Cayman2015 | 14943 | Desmosterol | 10 mg | 1232 |
| Cayman2015 | 14943 | Desmosterol | 25 mg | 2632 |
| Cayman2015 | 14943 | Desmosterol | 5 mg | 700 |
| Cayman2015 | 14944 | HMG-CoA Reductase (human recombinant) | 100 μg | 2450 |
| Cayman2015 | 14944 | HMG-CoA Reductase (human recombinant) | 250 μg | 3500 |
| Cayman2015 | 14944 | HMG-CoA Reductase (human recombinant) | 50 μg | 1750 |
| Cayman2015 | 14949 | FUB-PB-22 | 1 mg | 910 |
| Cayman2015 | 14949 | FUB-PB-22 | 10 mg | 5096 |
| Cayman2015 | 14949 | FUB-PB-22 | 5 mg | 3640 |
| Cayman2015 | 14950 | 20-hydroxy Prostaglandin E2 | 1 mg | 9800 |
| Cayman2015 | 14950 | 20-hydroxy Prostaglandin E2 | 100 μg | 1330 |
| Cayman2015 | 14950 | 20-hydroxy Prostaglandin E2 | 50 μg | 700 |
| Cayman2015 | 14950 | 20-hydroxy Prostaglandin E2 | 500 μg | 5600 |
| Cayman2015 | 14951 | Concanavalin A | 100 mg | 658 |
| Cayman2015 | 14951 | Concanavalin A | 250 mg | 1232 |
| Cayman2015 | 14951 | Concanavalin A | 50 mg | 546 |
| Cayman2015 | 14952 | Digitonin | 1 g | 4368 |
| Cayman2015 | 14952 | Digitonin | 100 mg | 546 |
| Cayman2015 | 14952 | Digitonin | 250 mg | 1302 |
| Cayman2015 | 14952 | Digitonin | 500 mg | 2464 |
| Cayman2015 | 14953 | Glutathione ethyl ester | 100 mg | 1526 |
| Cayman2015 | 14953 | Glutathione ethyl ester | 25 mg | 546 |
| Cayman2015 | 14953 | Glutathione ethyl ester | 50 mg | 826 |
| Cayman2015 | 14954 | 3C-P (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 14954 | 3C-P (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 14954 | 3C-P (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 14955 | HA-100 (hydrochloride) | 10 mg | 1568 |
| Cayman2015 | 14955 | HA-100 (hydrochloride) | 25 mg | 3724 |
| Cayman2015 | 14955 | HA-100 (hydrochloride) | 5 mg | 826 |
| Cayman2015 | 14955 | HA-100 (hydrochloride) | 50 mg | 7028 |
| Cayman2015 | 14956 | Imiquimod | 1 g | 3010 |
| Cayman2015 | 14956 | Imiquimod | 100 mg | 546 |
| Cayman2015 | 14956 | Imiquimod | 250 mg | 1162 |
| Cayman2015 | 14956 | Imiquimod | 500 mg | 1778 |
| Cayman2015 | 14957 | Adenosine 5'-(γ-thio)-triphosphate (lithium salt) | 1 mg | 308 |
| Cayman2015 | 14957 | Adenosine 5'-(γ-thio)-triphosphate (lithium salt) | 10 mg | 2058 |
| Cayman2015 | 14957 | Adenosine 5'-(γ-thio)-triphosphate (lithium salt) | 5 mg | 1106 |
| Cayman2015 | 14958 | BMPO | 10 mg | 1554 |
| Cayman2015 | 14958 | BMPO | 25 mg | 3318 |
| Cayman2015 | 14958 | BMPO | 5 mg | 1106 |
| Cayman2015 | 14958 | BMPO | 50 mg | 5530 |
| Cayman2015 | 14959 | CTAP | 1 mg | 1106 |
| Cayman2015 | 14960 | Fluo-3-Acetoxymethyl ester | 1 mg | 3472 |
| Cayman2015 | 14960 | Fluo-3-Acetoxymethyl ester | 500 μg | 2170 |
| Cayman2015 | 14961 | MTEP (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 14961 | MTEP (hydrochloride) | 10 mg | 1232 |
| Cayman2015 | 14961 | MTEP (hydrochloride) | 5 mg | 784 |
| Cayman2015 | 14961 | MTEP (hydrochloride) | 50 mg | 5250 |
| Cayman2015 | 14962 | Ryanodine | 1 mg | 1750 |
| Cayman2015 | 14963 | Tetrodotoxin | 1 mg | 1890 |
| Cayman2015 | 14964 | Tetrodotoxin Citrate | 1 mg | 2030 |
| Cayman2015 | 14965 | Furin Inhibitor I | 1 mg | 1792 |
| Cayman2015 | 14965 | Furin Inhibitor I | 5 mg | 8400 |
| Cayman2015 | 14965 | Furin Inhibitor I | 500 μg | 1050 |
| Cayman2015 | 14968 | FDU-PB-22 | 1 mg | 910 |
| Cayman2015 | 14968 | FDU-PB-22 | 10 mg | 5096 |
| Cayman2015 | 14968 | FDU-PB-22 | 5 mg | 3640 |
| Cayman2015 | 14979 | Polygodial | 1 mg | 350 |
| Cayman2015 | 14979 | Polygodial | 10 mg | 1750 |
| Cayman2015 | 14979 | Polygodial | 25 mg | 3934 |
| Cayman2015 | 14979 | Polygodial | 5 mg | 1050 |
| Cayman2015 | 14981 | Probenecid | 10 g | 532 |
| Cayman2015 | 14981 | Probenecid | 100 g | 3150 |
| Cayman2015 | 14981 | Probenecid | 25 g | 882 |
| Cayman2015 | 14981 | Probenecid | 5 g | 350 |
| Cayman2015 | 14982 | PTIO | 100 mg | 1260 |
| Cayman2015 | 14982 | PTIO | 25 mg | 350 |
| Cayman2015 | 14982 | PTIO | 250 mg | 2632 |
| Cayman2015 | 14982 | PTIO | 50 mg | 672 |
| Cayman2015 | 14983 | Sp-Cyclic AMPS (sodium salt) | 1 mg | 770 |
| Cayman2015 | 14983 | Sp-Cyclic AMPS (sodium salt) | 5 mg | 3472 |
| Cayman2015 | 14984 | Zoledronic Acid (hydrate) | 100 mg | 1918 |
| Cayman2015 | 14984 | Zoledronic Acid (hydrate) | 25 mg | 686 |
| Cayman2015 | 14984 | Zoledronic Acid (hydrate) | 50 mg | 1092 |
| Cayman2015 | 14984 | Zoledronic Acid (hydrate) | 500 mg | 4116 |
| Cayman2015 | 14985 | Clenbuterol (hydrochloride) | 10 mg | 364 |
| Cayman2015 | 14985 | Clenbuterol (hydrochloride) | 100 mg | 1820 |
| Cayman2015 | 14985 | Clenbuterol (hydrochloride) | 25 mg | 644 |
| Cayman2015 | 14985 | Clenbuterol (hydrochloride) | 50 mg | 1190 |
| Cayman2015 | 14986 | Ac-DEVD-AMC | 1 mg | 630 |
| Cayman2015 | 14986 | Ac-DEVD-AMC | 10 mg | 3150 |
| Cayman2015 | 14986 | Ac-DEVD-AMC | 5 mg | 1736 |
| Cayman2015 | 14987 | Z-AEVD-FMK | 1 mg | 2002 |
| Cayman2015 | 14987 | Z-AEVD-FMK | 5 mg | 8302 |
| Cayman2015 | 14987 | Z-AEVD-FMK | 500 μg | 1050 |
| Cayman2015 | 14988 | Ac-VDVAD-AFC | 1 mg | 966 |
| Cayman2015 | 14988 | Ac-VDVAD-AFC | 10 mg | 4830 |
| Cayman2015 | 14988 | Ac-VDVAD-AFC | 5 mg | 2660 |
| Cayman2015 | 14989 | Ac-VEID-AMC | 1 mg | 826 |
| Cayman2015 | 14989 | Ac-VEID-AMC | 10 mg | 2898 |
| Cayman2015 | 14989 | Ac-VEID-AMC | 5 mg | 1652 |
| Cayman2015 | 14990 | Prostaglandin E3 | 1 mg | 22540 |
| Cayman2015 | 14990 | Prostaglandin E3 | 100 μg | 3066 |
| Cayman2015 | 14990 | Prostaglandin E3 | 50 μg | 1610 |
| Cayman2015 | 14990 | Prostaglandin E3 | 500 μg | 12880 |
| Cayman2015 | 14991 | Ac-LETD-AFC | 1 mg | 826 |
| Cayman2015 | 14991 | Ac-LETD-AFC | 10 mg | 2898 |
| Cayman2015 | 14991 | Ac-LETD-AFC | 5 mg | 1652 |
| Cayman2015 | 14992 | Ac-WEHD-AFC | 1 mg | 966 |
| Cayman2015 | 14992 | Ac-WEHD-AFC | 10 mg | 4354 |
| Cayman2015 | 14992 | Ac-WEHD-AFC | 5 mg | 2422 |
| Cayman2015 | 14993 | Suc-AAPF-pNA | 10 mg | 490 |
| Cayman2015 | 14993 | Suc-AAPF-pNA | 100 mg | 2702 |
| Cayman2015 | 14993 | Suc-AAPF-pNA | 25 mg | 742 |
| Cayman2015 | 14994 | Metyrapone | 1 g | 616 |
| Cayman2015 | 14994 | Metyrapone | 250 mg | 238 |
| Cayman2015 | 14994 | Metyrapone | 500 mg | 406 |
| Cayman2015 | 14995 | 17-trans Prostaglandin E3 | 100 μg | 2940 |
| Cayman2015 | 14995 | 17-trans Prostaglandin E3 | 25 μg | 966 |
| Cayman2015 | 14995 | 17-trans Prostaglandin E3 | 50 μg | 1610 |
| Cayman2015 | 14996 | STA-21 | 1 mg | 2352 |
| Cayman2015 | 14996 | STA-21 | 5 mg | 10402 |
| Cayman2015 | 14996 | STA-21 | 500 μg | 1386 |
| Cayman2015 | 14997 | Phenformin (hydrochloride) | 10 g | 518 |
| Cayman2015 | 14997 | Phenformin (hydrochloride) | 100 g | 2072 |
| Cayman2015 | 14997 | Phenformin (hydrochloride) | 50 g | 1302 |
| Cayman2015 | 14998 | Paroxetine (hydrochloride) | 10 mg | 546 |
| Cayman2015 | 14998 | Paroxetine (hydrochloride) | 100 mg | 3822 |
| Cayman2015 | 14998 | Paroxetine (hydrochloride) | 25 mg | 1302 |
| Cayman2015 | 14998 | Paroxetine (hydrochloride) | 50 mg | 2464 |
| Cayman2015 | 14999 | Ondansetron (hydrochloride) | 10 mg | 770 |
| Cayman2015 | 14999 | Ondansetron (hydrochloride) | 100 mg | 1638 |
| Cayman2015 | 14999 | Ondansetron (hydrochloride) | 50 mg | 1162 |
| Cayman2015 | 14999 | Ondansetron (hydrochloride) | 500 mg | 5782 |
| Cayman2015 | 15001 | NNEI | 1 mg | 910 |
| Cayman2015 | 15001 | NNEI | 10 mg | 7280 |
| Cayman2015 | 15001 | NNEI | 5 mg | 4130 |
| Cayman2015 | 15003 | JC-1 | 1 mg | 770 |
| Cayman2015 | 15003 | JC-1 | 10 mg | 6160 |
| Cayman2015 | 15003 | JC-1 | 5 mg | 3472 |
| Cayman2015 | 15004 | Azithromycin | 100 mg | 2268 |
| Cayman2015 | 15004 | Azithromycin | 25 mg | 630 |
| Cayman2015 | 15004 | Azithromycin | 250 mg | 5362 |
| Cayman2015 | 15004 | Azithromycin | 50 mg | 1204 |
| Cayman2015 | 15005 | Bazedoxifene acetate | 10 mg | 2394 |
| Cayman2015 | 15005 | Bazedoxifene acetate | 25 mg | 5670 |
| Cayman2015 | 15005 | Bazedoxifene acetate | 5 mg | 1260 |
| Cayman2015 | 15005 | Bazedoxifene acetate | 50 mg | 8820 |
| Cayman2015 | 15006 | Clindamycin | 100 mg | 1512 |
| Cayman2015 | 15006 | Clindamycin | 25 mg | 686 |
| Cayman2015 | 15006 | Clindamycin | 50 mg | 1232 |
| Cayman2015 | 15007 | Doxorubicin (hydrochloride) | 10 mg | 630 |
| Cayman2015 | 15007 | Doxorubicin (hydrochloride) | 25 mg | 1232 |
| Cayman2015 | 15007 | Doxorubicin (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 15007 | Doxorubicin (hydrochloride) | 50 mg | 1400 |
| Cayman2015 | 15008 | Exemestane | 10 mg | 1470 |
| Cayman2015 | 15008 | Exemestane | 25 mg | 3416 |
| Cayman2015 | 15008 | Exemestane | 5 mg | 1050 |
| Cayman2015 | 15008 | Exemestane | 50 mg | 6300 |
| Cayman2015 | 15009 | Glyburide (potassium salt) | 10 g | 1918 |
| Cayman2015 | 15009 | Glyburide (potassium salt) | 5 g | 1008 |
| Cayman2015 | 15010 | Prostaglandin F1α | 1 mg | 518 |
| Cayman2015 | 15010 | Prostaglandin F1α | 10 mg | 4144 |
| Cayman2015 | 15010 | Prostaglandin F1α | 5 mg | 2338 |
| Cayman2015 | 15012 | Linezolid | 10 mg | 630 |
| Cayman2015 | 15012 | Linezolid | 100 mg | 11816 |
| Cayman2015 | 15012 | Linezolid | 25 mg | 2996 |
| Cayman2015 | 15012 | Linezolid | 50 mg | 5670 |
| Cayman2015 | 15013 | Methylprednisolone | 1 g | 2464 |
| Cayman2015 | 15013 | Methylprednisolone | 5 g | 10976 |
| Cayman2015 | 15013 | Methylprednisolone | 500 mg | 1372 |
| Cayman2015 | 15014 | Miglitol | 10 mg | 910 |
| Cayman2015 | 15014 | Miglitol | 100 mg | 3640 |
| Cayman2015 | 15014 | Miglitol | 25 mg | 1596 |
| Cayman2015 | 15014 | Miglitol | 50 mg | 2044 |
| Cayman2015 | 15015 | PF-03814735 | 1 mg | 490 |
| Cayman2015 | 15015 | PF-03814735 | 10 mg | 3682 |
| Cayman2015 | 15015 | PF-03814735 | 5 mg | 2086 |
| Cayman2015 | 15015 | PF-03814735 | 50 mg | 8582 |
| Cayman2015 | 15016 | PF-04418948 | 10 mg | 2128 |
| Cayman2015 | 15016 | PF-04418948 | 5 mg | 1120 |
| Cayman2015 | 15016 | PF-04418948 | 50 mg | 8960 |
| Cayman2015 | 15017 | PF-04691502 | 10 mg | 1876 |
| Cayman2015 | 15017 | PF-04691502 | 5 mg | 1246 |
| Cayman2015 | 15017 | PF-04691502 | 50 mg | 6860 |
| Cayman2015 | 15018 | PF-04708671 | 10 mg | 1050 |
| Cayman2015 | 15018 | PF-04708671 | 100 mg | 8400 |
| Cayman2015 | 15018 | PF-04708671 | 25 mg | 2492 |
| Cayman2015 | 15018 | PF-04708671 | 50 mg | 4732 |
| Cayman2015 | 15019 | PF-04981517 | 10 mg | 1834 |
| Cayman2015 | 15019 | PF-04981517 | 25 mg | 4354 |
| Cayman2015 | 15019 | PF-04981517 | 5 mg | 966 |
| Cayman2015 | 15019 | PF-04981517 | 50 mg | 7728 |
| Cayman2015 | 15020 | Prostaglandin F1α Alcohol | 1 mg | 616 |
| Cayman2015 | 15020 | Prostaglandin F1α Alcohol | 10 mg | 4928 |
| Cayman2015 | 15020 | Prostaglandin F1α Alcohol | 5 mg | 2772 |
| Cayman2015 | 15021 | β-Lapachone | 10 mg | 1246 |
| Cayman2015 | 15021 | β-Lapachone | 25 mg | 3010 |
| Cayman2015 | 15021 | β-Lapachone | 5 mg | 812 |
| Cayman2015 | 15021 | β-Lapachone | 50 mg | 4872 |
| Cayman2015 | 15022 | PF-05274857 (hydrochloride) | 1 mg | 770 |
| Cayman2015 | 15022 | PF-05274857 (hydrochloride) | 10 mg | 5390 |
| Cayman2015 | 15022 | PF-05274857 (hydrochloride) | 25 mg | 7700 |
| Cayman2015 | 15022 | PF-05274857 (hydrochloride) | 5 mg | 3472 |
| Cayman2015 | 15023 | Prazosin (hydrochloride) | 100 mg | 630 |
| Cayman2015 | 15023 | Prazosin (hydrochloride) | 250 mg | 1316 |
| Cayman2015 | 15023 | Prazosin (hydrochloride) | 50 mg | 350 |
| Cayman2015 | 15023 | Prazosin (hydrochloride) | 500 mg | 2450 |
| Cayman2015 | 15025 | Sulfasalazine | 10 g | 532 |
| Cayman2015 | 15025 | Sulfasalazine | 5 g | 350 |
| Cayman2015 | 15026 | Tigecycline | 10 mg | 1680 |
| Cayman2015 | 15026 | Tigecycline | 25 mg | 3934 |
| Cayman2015 | 15026 | Tigecycline | 5 mg | 1050 |
| Cayman2015 | 15027 | Tolterodine (tartrate) | 10 mg | 966 |
| Cayman2015 | 15027 | Tolterodine (tartrate) | 25 mg | 1834 |
| Cayman2015 | 15027 | Tolterodine (tartrate) | 50 mg | 3626 |
| Cayman2015 | 15028 | Torcetrapib | 10 mg | 1750 |
| Cayman2015 | 15028 | Torcetrapib | 5 mg | 1246 |
| Cayman2015 | 15028 | Torcetrapib | 50 mg | 7476 |
| Cayman2015 | 15030 | Varenicline (tartrate) | 10 mg | 2268 |
| Cayman2015 | 15030 | Varenicline (tartrate) | 25 mg | 5362 |
| Cayman2015 | 15030 | Varenicline (tartrate) | 5 mg | 1190 |
| Cayman2015 | 15030 | Varenicline (tartrate) | 50 mg | 9520 |
| Cayman2015 | 15031 | Ziprasidone (hydrochloride hydrate) | 10 mg | 882 |
| Cayman2015 | 15031 | Ziprasidone (hydrochloride hydrate) | 25 mg | 1960 |
| Cayman2015 | 15031 | Ziprasidone (hydrochloride hydrate) | 5 mg | 490 |
| Cayman2015 | 15031 | Ziprasidone (hydrochloride hydrate) | 50 mg | 2212 |
| Cayman2015 | 15032 | UR-144 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15033 | XLR11 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15034 | AKB48 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15035 | Cilostazol | 10 mg | 616 |
| Cayman2015 | 15035 | Cilostazol | 100 mg | 2464 |
| Cayman2015 | 15035 | Cilostazol | 250 mg | 5390 |
| Cayman2015 | 15035 | Cilostazol | 50 mg | 1386 |
| Cayman2015 | 15036 | JSH-23 | 1 mg | 546 |
| Cayman2015 | 15036 | JSH-23 | 10 mg | 2464 |
| Cayman2015 | 15036 | JSH-23 | 25 mg | 5460 |
| Cayman2015 | 15036 | JSH-23 | 5 mg | 1372 |
| Cayman2015 | 15037 | Mibefradil (hydrochloride) | 10 mg | 2142 |
| Cayman2015 | 15037 | Mibefradil (hydrochloride) | 25 mg | 5054 |
| Cayman2015 | 15037 | Mibefradil (hydrochloride) | 5 mg | 1190 |
| Cayman2015 | 15037 | Mibefradil (hydrochloride) | 50 mg | 9520 |
| Cayman2015 | 15038 | Reboxetine (mesylate) | 10 mg | 1162 |
| Cayman2015 | 15038 | Reboxetine (mesylate) | 25 mg | 2744 |
| Cayman2015 | 15038 | Reboxetine (mesylate) | 5 mg | 686 |
| Cayman2015 | 15038 | Reboxetine (mesylate) | 50 mg | 5152 |
| Cayman2015 | 15039 | Thymoquinone | 1 g | 462 |
| Cayman2015 | 15039 | Thymoquinone | 5 g | 1582 |
| Cayman2015 | 15039 | Thymoquinone | 500 mg | 350 |
| Cayman2015 | 15040 | SKF 52 (hydrochloride) | 1 g | 3150 |
| Cayman2015 | 15040 | SKF 52 (hydrochloride) | 100 mg | 630 |
| Cayman2015 | 15040 | SKF 52 (hydrochloride) | 250 mg | 1022 |
| Cayman2015 | 15040 | SKF 52 (hydrochloride) | 500 mg | 1890 |
| Cayman2015 | 15041 | Quinacrine (hydrochloride hydrate) | 1 g | 616 |
| Cayman2015 | 15041 | Quinacrine (hydrochloride hydrate) | 100 mg | 350 |
| Cayman2015 | 15041 | Quinacrine (hydrochloride hydrate) | 5 g | 1050 |
| Cayman2015 | 15041 | Quinacrine (hydrochloride hydrate) | 500 mg | 476 |
| Cayman2015 | 15042 | Proscillaridin A | 10 mg | 672 |
| Cayman2015 | 15042 | Proscillaridin A | 25 mg | 1582 |
| Cayman2015 | 15042 | Proscillaridin A | 5 mg | 350 |
| Cayman2015 | 15042 | Proscillaridin A | 50 mg | 2800 |
| Cayman2015 | 15043 | Probucol | 10 g | 1204 |
| Cayman2015 | 15043 | Probucol | 25 g | 2520 |
| Cayman2015 | 15043 | Probucol | 5 g | 630 |
| Cayman2015 | 15043 | Probucol | 50 g | 4732 |
| Cayman2015 | 15044 | Monastrol | 1 mg | 770 |
| Cayman2015 | 15044 | Monastrol | 10 mg | 1540 |
| Cayman2015 | 15044 | Monastrol | 5 mg | 1162 |
| Cayman2015 | 15044 | Monastrol | 50 mg | 5782 |
| Cayman2015 | 15045 | Dofetilide | 10 mg | 896 |
| Cayman2015 | 15045 | Dofetilide | 25 mg | 1890 |
| Cayman2015 | 15045 | Dofetilide | 5 mg | 686 |
| Cayman2015 | 15045 | Dofetilide | 50 mg | 3430 |
| Cayman2015 | 15046 | R-(-)-Deprenyl (hydrochloride) | 1 g | 1204 |
| Cayman2015 | 15046 | R-(-)-Deprenyl (hydrochloride) | 250 mg | 546 |
| Cayman2015 | 15047 | Wiskostatin | 1 mg | 770 |
| Cayman2015 | 15047 | Wiskostatin | 10 mg | 1778 |
| Cayman2015 | 15047 | Wiskostatin | 5 mg | 1316 |
| Cayman2015 | 15047 | Wiskostatin | 50 mg | 6930 |
| Cayman2015 | 15048 | (±)-Octanoylcarnitine (chloride) | 50 mg | 966 |
| Cayman2015 | 15049 | AB-PINACA N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 15049 | AB-PINACA N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 15049 | AB-PINACA N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 15050 | AB-PINACA N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 15050 | AB-PINACA N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 15050 | AB-PINACA N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 15051 | AB-PINACA pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 15051 | AB-PINACA pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 15051 | AB-PINACA pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 15052 | 5-fluoro AB-PINACA N-(4-hydroxypentyl) metabolite | 1 mg | 5460 |
| Cayman2015 | 15052 | 5-fluoro AB-PINACA N-(4-hydroxypentyl) metabolite | 100 μg | 910 |
| Cayman2015 | 15052 | 5-fluoro AB-PINACA N-(4-hydroxypentyl) metabolite | 500 μg | 3416 |
| Cayman2015 | 15053 | ADB-PINACA N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 15053 | ADB-PINACA N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 15053 | ADB-PINACA N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 15054 | ADB-PINACA N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 15054 | ADB-PINACA N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 15054 | ADB-PINACA N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 15055 | ADB-PINACA pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 15055 | ADB-PINACA pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 15055 | ADB-PINACA pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 15057 | AB-PINACA-d9 | 1 mg | 1736 |
| Cayman2015 | 15057 | AB-PINACA-d9 | 500 μg | 910 |
| Cayman2015 | 15060 | ADBICA N-(5-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 15060 | ADBICA N-(5-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 15060 | ADBICA N-(5-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 15061 | ADBICA N-pentanoic acid metabolite | 1 mg | 1330 |
| Cayman2015 | 15061 | ADBICA N-pentanoic acid metabolite | 10 mg | 4900 |
| Cayman2015 | 15061 | ADBICA N-pentanoic acid metabolite | 5 mg | 3150 |
| Cayman2015 | 15062 | PV9 (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 15062 | PV9 (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 15062 | PV9 (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 15063 | 4-fluoro PV9 (hydrochloride) | 1 mg | 826 |
| Cayman2015 | 15063 | 4-fluoro PV9 (hydrochloride) | 10 mg | 6608 |
| Cayman2015 | 15063 | 4-fluoro PV9 (hydrochloride) | 5 mg | 3724 |
| Cayman2015 | 15064 | 4-methoxy PV9 (hydrochloride) | 1 mg | 826 |
| Cayman2015 | 15064 | 4-methoxy PV9 (hydrochloride) | 10 mg | 6608 |
| Cayman2015 | 15064 | 4-methoxy PV9 (hydrochloride) | 5 mg | 3724 |
| Cayman2015 | 15065 | Cl2201 | 1 mg | 910 |
| Cayman2015 | 15065 | Cl2201 | 10 mg | 6832 |
| Cayman2015 | 15065 | Cl2201 | 25 mg | 13650 |
| Cayman2015 | 15065 | Cl2201 | 5 mg | 4102 |
| Cayman2015 | 15066 | HPOB | 1 mg | 350 |
| Cayman2015 | 15066 | HPOB | 10 mg | 2100 |
| Cayman2015 | 15066 | HPOB | 5 mg | 1134 |
| Cayman2015 | 15067 | (±)-SKF 81297 (hydrobromide) | 10 mg | 1666 |
| Cayman2015 | 15067 | (±)-SKF 81297 (hydrobromide) | 25 mg | 2492 |
| Cayman2015 | 15067 | (±)-SKF 81297 (hydrobromide) | 5 mg | 1106 |
| Cayman2015 | 15068 | Trifluoperazine (hydrochloride) | 1 g | 350 |
| Cayman2015 | 15068 | Trifluoperazine (hydrochloride) | 10 g | 1232 |
| Cayman2015 | 15068 | Trifluoperazine (hydrochloride) | 25 g | 2184 |
| Cayman2015 | 15068 | Trifluoperazine (hydrochloride) | 5 g | 784 |
| Cayman2015 | 15069 | Glucagon-like Peptide 1 (7-36) amide | 1 mg | 3864 |
| Cayman2015 | 15069 | Glucagon-like Peptide 1 (7-36) amide | 5 mg | 13202 |
| Cayman2015 | 15069 | Glucagon-like Peptide 1 (7-36) amide | 500 μg | 2030 |
| Cayman2015 | 15070 | Nociceptin | 1 mg | 980 |
| Cayman2015 | 15070 | Nociceptin | 5 mg | 3822 |
| Cayman2015 | 15070 | Nociceptin | 500 μg | 546 |
| Cayman2015 | 15071 | Neuropeptide Y (human, rat) | 1 mg | 2366 |
| Cayman2015 | 15071 | Neuropeptide Y (human, rat) | 5 mg | 9968 |
| Cayman2015 | 15071 | Neuropeptide Y (human, rat) | 500 μg | 1246 |
| Cayman2015 | 15072 | Ghrelin (human) | 1 mg | 3304 |
| Cayman2015 | 15072 | Ghrelin (human) | 5 mg | 13622 |
| Cayman2015 | 15072 | Ghrelin (human) | 500 μg | 1946 |
| Cayman2015 | 15073 | Orexin A (bovine, human, mouse, rat) | 1 mg | 5600 |
| Cayman2015 | 15073 | Orexin A (bovine, human, mouse, rat) | 5 mg | 26320 |
| Cayman2015 | 15073 | Orexin A (bovine, human, mouse, rat) | 500 μg | 3290 |
| Cayman2015 | 15074 | JWH 018 benzimidazole analog | 1 mg | 910 |
| Cayman2015 | 15074 | JWH 018 benzimidazole analog | 10 mg | 7280 |
| Cayman2015 | 15074 | JWH 018 benzimidazole analog | 5 mg | 4102 |
| Cayman2015 | 15075 | CCG-203971 | 10 mg | 938 |
| Cayman2015 | 15075 | CCG-203971 | 25 mg | 2086 |
| Cayman2015 | 15075 | CCG-203971 | 5 mg | 490 |
| Cayman2015 | 15075 | CCG-203971 | 50 mg | 3920 |
| Cayman2015 | 15076 | 1,2-Dilauroyl-sn-glycerol | 100 mg | 532 |
| Cayman2015 | 15076 | 1,2-Dilauroyl-sn-glycerol | 250 mg | 1064 |
| Cayman2015 | 15076 | 1,2-Dilauroyl-sn-glycerol | 500 mg | 2002 |
| Cayman2015 | 15077 | 1,2-Dimyristoyl-sn-glycerol | 100 mg | 532 |
| Cayman2015 | 15077 | 1,2-Dimyristoyl-sn-glycerol | 250 mg | 1064 |
| Cayman2015 | 15077 | 1,2-Dimyristoyl-sn-glycerol | 500 mg | 2002 |
| Cayman2015 | 15079 | 1,2-Distearoyl-sn-glycerol | 100 mg | 532 |
| Cayman2015 | 15079 | 1,2-Distearoyl-sn-glycerol | 250 mg | 1064 |
| Cayman2015 | 15079 | 1,2-Distearoyl-sn-glycerol | 500 mg | 2002 |
| Cayman2015 | 15080 | 1,2-Dilauroyl-sn-glycero-3-phosphate (sodium salt) | 100 mg | 532 |
| Cayman2015 | 15080 | 1,2-Dilauroyl-sn-glycero-3-phosphate (sodium salt) | 250 mg | 1064 |
| Cayman2015 | 15080 | 1,2-Dilauroyl-sn-glycero-3-phosphate (sodium salt) | 500 mg | 2002 |
| Cayman2015 | 15081 | 1,2-Dimyristoyl-sn-glycero-3-phosphate (sodium salt) | 100 mg | 532 |
| Cayman2015 | 15081 | 1,2-Dimyristoyl-sn-glycero-3-phosphate (sodium salt) | 250 mg | 1064 |
| Cayman2015 | 15081 | 1,2-Dimyristoyl-sn-glycero-3-phosphate (sodium salt) | 500 mg | 2002 |
| Cayman2015 | 15082 | 1,2-Dipalmitoyl-sn-glycero-3-phosphate (sodium salt) | 100 mg | 532 |
| Cayman2015 | 15082 | 1,2-Dipalmitoyl-sn-glycero-3-phosphate (sodium salt) | 250 mg | 1064 |
| Cayman2015 | 15082 | 1,2-Dipalmitoyl-sn-glycero-3-phosphate (sodium salt) | 500 mg | 2002 |
| Cayman2015 | 15083 | 1,2-Distearoyl-sn-glycero-3-phosphate (sodium salt) | 100 mg | 532 |
| Cayman2015 | 15083 | 1,2-Distearoyl-sn-glycero-3-phosphate (sodium salt) | 250 mg | 1064 |
| Cayman2015 | 15083 | 1,2-Distearoyl-sn-glycero-3-phosphate (sodium salt) | 500 mg | 2002 |
| Cayman2015 | 15084 | 1,2-Dilauroyl-sn-glycero-3-phospho-sn-glycerol (sodium salt) | 100 mg | 532 |
| Cayman2015 | 15084 | 1,2-Dilauroyl-sn-glycero-3-phospho-sn-glycerol (sodium salt) | 250 mg | 1064 |
| Cayman2015 | 15084 | 1,2-Dilauroyl-sn-glycero-3-phospho-sn-glycerol (sodium salt) | 500 mg | 2002 |
| Cayman2015 | 15085 | 1,2-Dimyristoyl-sn-glycero-3-PG (sodium salt) | 100 mg | 532 |
| Cayman2015 | 15085 | 1,2-Dimyristoyl-sn-glycero-3-PG (sodium salt) | 250 mg | 1064 |
| Cayman2015 | 15085 | 1,2-Dimyristoyl-sn-glycero-3-PG (sodium salt) | 500 mg | 2002 |
| Cayman2015 | 15086 | 1,2-Dipalmitoyl-sn-glycero-3-phospho-sn-1-glycerol (sodium salt) | 100 mg | 532 |
| Cayman2015 | 15086 | 1,2-Dipalmitoyl-sn-glycero-3-phospho-sn-1-glycerol (sodium salt) | 250 mg | 1064 |
| Cayman2015 | 15086 | 1,2-Dipalmitoyl-sn-glycero-3-phospho-sn-1-glycerol (sodium salt) | 500 mg | 2002 |
| Cayman2015 | 15087 | 1,2-Distearoyl-sn-glycero-3-PG (sodium salt) | 100 mg | 770 |
| Cayman2015 | 15087 | 1,2-Distearoyl-sn-glycero-3-PG (sodium salt) | 250 mg | 1736 |
| Cayman2015 | 15087 | 1,2-Distearoyl-sn-glycero-3-PG (sodium salt) | 500 mg | 3276 |
| Cayman2015 | 15088 | 1,2-Dipalmitoyl-sn-glycero-3-PS (sodium salt) | 100 mg | 1960 |
| Cayman2015 | 15088 | 1,2-Dipalmitoyl-sn-glycero-3-PS (sodium salt) | 25 mg | 546 |
| Cayman2015 | 15088 | 1,2-Dipalmitoyl-sn-glycero-3-PS (sodium salt) | 250 mg | 4368 |
| Cayman2015 | 15088 | 1,2-Dipalmitoyl-sn-glycero-3-PS (sodium salt) | 50 mg | 1036 |
| Cayman2015 | 15089 | 1,2-Dilauroyl-sn-glycero-3-PE | 100 mg | 532 |
| Cayman2015 | 15089 | 1,2-Dilauroyl-sn-glycero-3-PE | 250 mg | 1064 |
| Cayman2015 | 15089 | 1,2-Dilauroyl-sn-glycero-3-PE | 500 mg | 2002 |
| Cayman2015 | 15090 | 1,2-Dimyristoyl-sn-glycero-3-PE | 100 mg | 532 |
| Cayman2015 | 15090 | 1,2-Dimyristoyl-sn-glycero-3-PE | 250 mg | 1064 |
| Cayman2015 | 15090 | 1,2-Dimyristoyl-sn-glycero-3-PE | 500 mg | 2002 |
| Cayman2015 | 15091 | 1,2-Dioleoyl-sn-glycero-3-PE | 100 mg | 756 |
| Cayman2015 | 15091 | 1,2-Dioleoyl-sn-glycero-3-PE | 250 mg | 1036 |
| Cayman2015 | 15091 | 1,2-Dioleoyl-sn-glycero-3-PE | 500 mg | 1890 |
| Cayman2015 | 15092 | 1,2-Dipalmitoyl-sn-glycero-3-PE | 1 g | 3472 |
| Cayman2015 | 15092 | 1,2-Dipalmitoyl-sn-glycero-3-PE | 100 mg | 518 |
| Cayman2015 | 15092 | 1,2-Dipalmitoyl-sn-glycero-3-PE | 250 mg | 966 |
| Cayman2015 | 15092 | 1,2-Dipalmitoyl-sn-glycero-3-PE | 500 mg | 1820 |
| Cayman2015 | 15093 | 1,3-Dipalmitoyl-sn-glycero-2-PE | 100 mg | 1526 |
| Cayman2015 | 15093 | 1,3-Dipalmitoyl-sn-glycero-2-PE | 25 mg | 546 |
| Cayman2015 | 15093 | 1,3-Dipalmitoyl-sn-glycero-2-PE | 250 mg | 3220 |
| Cayman2015 | 15093 | 1,3-Dipalmitoyl-sn-glycero-2-PE | 50 mg | 1036 |
| Cayman2015 | 15094 | 1,2-Diphytanoyl-sn-glycero-3-PE | 100 mg | 2492 |
| Cayman2015 | 15094 | 1,2-Diphytanoyl-sn-glycero-3-PE | 250 mg | 5544 |
| Cayman2015 | 15094 | 1,2-Diphytanoyl-sn-glycero-3-PE | 50 mg | 1386 |
| Cayman2015 | 15094 | 1,2-Diphytanoyl-sn-glycero-3-PE | 500 mg | 9702 |
| Cayman2015 | 15095 | 1,2-Distearoyl-sn-glycero-3-PE | 100 mg | 532 |
| Cayman2015 | 15095 | 1,2-Distearoyl-sn-glycero-3-PE | 250 mg | 1064 |
| Cayman2015 | 15095 | 1,2-Distearoyl-sn-glycero-3-PE | 500 mg | 2002 |
| Cayman2015 | 15096 | 1,2-Diarachidoyl-sn-glycero-3-PC | 100 mg | 532 |
| Cayman2015 | 15096 | 1,2-Diarachidoyl-sn-glycero-3-PC | 250 mg | 1064 |
| Cayman2015 | 15096 | 1,2-Diarachidoyl-sn-glycero-3-PC | 500 mg | 2002 |
| Cayman2015 | 15097 | 1,2-Dimyristoyl-sn-glycerol-3-PC | 1 g | 1176 |
| Cayman2015 | 15097 | 1,2-Dimyristoyl-sn-glycerol-3-PC | 250 mg | 490 |
| Cayman2015 | 15097 | 1,2-Dimyristoyl-sn-glycerol-3-PC | 500 mg | 784 |
| Cayman2015 | 15098 | 1,2-Dioleoyl-sn-glycero-3-PC | 1 g | 1176 |
| Cayman2015 | 15098 | 1,2-Dioleoyl-sn-glycero-3-PC | 250 mg | 490 |
| Cayman2015 | 15098 | 1,2-Dioleoyl-sn-glycero-3-PC | 500 mg | 784 |
| Cayman2015 | 15099 | 1,2-Dipalmitoyl-sn-glycero-O-ethyl-3-PC (chloride) | 10 mg | 630 |
| Cayman2015 | 15099 | 1,2-Dipalmitoyl-sn-glycero-O-ethyl-3-PC (chloride) | 100 mg | 3150 |
| Cayman2015 | 15099 | 1,2-Dipalmitoyl-sn-glycero-O-ethyl-3-PC (chloride) | 25 mg | 1344 |
| Cayman2015 | 15099 | 1,2-Dipalmitoyl-sn-glycero-O-ethyl-3-PC (chloride) | 250 mg | 6300 |
| Cayman2015 | 15100 | 1,2-Distearoyl-sn-glycero-3-PC | 1 g | 1176 |
| Cayman2015 | 15100 | 1,2-Distearoyl-sn-glycero-3-PC | 250 mg | 490 |
| Cayman2015 | 15100 | 1,2-Distearoyl-sn-glycero-3-PC | 500 mg | 784 |
| Cayman2015 | 15101 | 1-Palmitoyl-2-lauroyl-sn-glycero-3-PC | 100 mg | 770 |
| Cayman2015 | 15101 | 1-Palmitoyl-2-lauroyl-sn-glycero-3-PC | 250 mg | 1638 |
| Cayman2015 | 15101 | 1-Palmitoyl-2-lauroyl-sn-glycero-3-PC | 500 mg | 3080 |
| Cayman2015 | 15102 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC | 100 mg | 770 |
| Cayman2015 | 15102 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC | 250 mg | 1638 |
| Cayman2015 | 15102 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC | 500 mg | 3080 |
| Cayman2015 | 15103 | 1-Stearoyl-2-myristoyl-sn-glycero-3-PC | 100 mg | 1568 |
| Cayman2015 | 15103 | 1-Stearoyl-2-myristoyl-sn-glycero-3-PC | 25 mg | 602 |
| Cayman2015 | 15103 | 1-Stearoyl-2-myristoyl-sn-glycero-3-PC | 250 mg | 3318 |
| Cayman2015 | 15103 | 1-Stearoyl-2-myristoyl-sn-glycero-3-PC | 50 mg | 1022 |
| Cayman2015 | 15104 | 1-Palmitoyl-3-oleoyl-sn-glycero-2-PE | 100 mg | 1526 |
| Cayman2015 | 15104 | 1-Palmitoyl-3-oleoyl-sn-glycero-2-PE | 25 mg | 546 |
| Cayman2015 | 15104 | 1-Palmitoyl-3-oleoyl-sn-glycero-2-PE | 250 mg | 3220 |
| Cayman2015 | 15104 | 1-Palmitoyl-3-oleoyl-sn-glycero-2-PE | 50 mg | 1036 |
| Cayman2015 | 15105 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PG (sodium salt) | 100 mg | 1960 |
| Cayman2015 | 15105 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PG (sodium salt) | 25 mg | 546 |
| Cayman2015 | 15105 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PG (sodium salt) | 250 mg | 4368 |
| Cayman2015 | 15105 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PG (sodium salt) | 50 mg | 1036 |
| Cayman2015 | 15106 | Cholesterol Sulfate (sodium salt) | 100 mg | 2100 |
| Cayman2015 | 15106 | Cholesterol Sulfate (sodium salt) | 25 mg | 616 |
| Cayman2015 | 15106 | Cholesterol Sulfate (sodium salt) | 250 mg | 4382 |
| Cayman2015 | 15106 | Cholesterol Sulfate (sodium salt) | 5 mg | 350 |
| Cayman2015 | 15107 | 1-Stearoyl-2-lyso-sn-glycero-3-PC | 100 mg | 532 |
| Cayman2015 | 15107 | 1-Stearoyl-2-lyso-sn-glycero-3-PC | 250 mg | 1064 |
| Cayman2015 | 15107 | 1-Stearoyl-2-lyso-sn-glycero-3-PC | 500 mg | 2002 |
| Cayman2015 | 15108 | 1-O-Octadecyl-2-O-methyl-sn-glycerol | 100 mg | 672 |
| Cayman2015 | 15108 | 1-O-Octadecyl-2-O-methyl-sn-glycerol | 250 mg | 1582 |
| Cayman2015 | 15108 | 1-O-Octadecyl-2-O-methyl-sn-glycerol | 50 mg | 350 |
| Cayman2015 | 15108 | 1-O-Octadecyl-2-O-methyl-sn-glycerol | 500 mg | 2982 |
| Cayman2015 | 15109 | 1,2-Dioleyloxy-3-dimethylamino-propane | 100 mg | 1302 |
| Cayman2015 | 15109 | 1,2-Dioleyloxy-3-dimethylamino-propane | 250 mg | 3094 |
| Cayman2015 | 15109 | 1,2-Dioleyloxy-3-dimethylamino-propane | 50 mg | 686 |
| Cayman2015 | 15109 | 1,2-Dioleyloxy-3-dimethylamino-propane | 500 mg | 5488 |
| Cayman2015 | 15110 | 1,2-Dioleoyl-3-trimethylammoniumpropane (chloride) | 100 mg | 1568 |
| Cayman2015 | 15110 | 1,2-Dioleoyl-3-trimethylammoniumpropane (chloride) | 250 mg | 3304 |
| Cayman2015 | 15110 | 1,2-Dioleoyl-3-trimethylammoniumpropane (chloride) | 50 mg | 826 |
| Cayman2015 | 15110 | 1,2-Dioleoyl-3-trimethylammoniumpropane (chloride) | 500 mg | 6202 |
| Cayman2015 | 15112 | ADB-PINACA-d9 | 1 mg | 1736 |
| Cayman2015 | 15112 | ADB-PINACA-d9 | 500 μg | 910 |
| Cayman2015 | 15113 | Phosphoramidon (sodium salt) | 1 mg | 966 |
| Cayman2015 | 15113 | Phosphoramidon (sodium salt) | 10 mg | 3388 |
| Cayman2015 | 15113 | Phosphoramidon (sodium salt) | 25 mg | 7252 |
| Cayman2015 | 15113 | Phosphoramidon (sodium salt) | 5 mg | 1932 |
| Cayman2015 | 15114 | Chymostatin | 1 mg | 406 |
| Cayman2015 | 15114 | Chymostatin | 10 mg | 1834 |
| Cayman2015 | 15114 | Chymostatin | 25 mg | 3556 |
| Cayman2015 | 15114 | Chymostatin | 5 mg | 1022 |
| Cayman2015 | 15115 | TPCA-1 | 1 mg | 1078 |
| Cayman2015 | 15115 | TPCA-1 | 10 mg | 2310 |
| Cayman2015 | 15115 | TPCA-1 | 5 mg | 1540 |
| Cayman2015 | 15115 | TPCA-1 | 500 μg | 770 |
| Cayman2015 | 15116 | Vitexin | 10 mg | 728 |
| Cayman2015 | 15116 | Vitexin | 25 mg | 1624 |
| Cayman2015 | 15116 | Vitexin | 5 mg | 406 |
| Cayman2015 | 15116 | Vitexin | 50 mg | 3052 |
| Cayman2015 | 15117 | Nevirapine | 10 mg | 826 |
| Cayman2015 | 15117 | Nevirapine | 25 mg | 1890 |
| Cayman2015 | 15117 | Nevirapine | 5 mg | 630 |
| Cayman2015 | 15117 | Nevirapine | 50 mg | 3150 |
| Cayman2015 | 15118 | Oltipraz | 1 g | 3878 |
| Cayman2015 | 15118 | Oltipraz | 100 mg | 1106 |
| Cayman2015 | 15118 | Oltipraz | 250 mg | 1666 |
| Cayman2015 | 15118 | Oltipraz | 500 mg | 2492 |
| Cayman2015 | 15119 | Psoralidin | 10 mg | 1526 |
| Cayman2015 | 15119 | Psoralidin | 100 mg | 8190 |
| Cayman2015 | 15119 | Psoralidin | 25 mg | 2926 |
| Cayman2015 | 15119 | Psoralidin | 5 mg | 1106 |
| Cayman2015 | 15120 | 2,3-dinor-6-keto Prostaglandin F1α (sodium salt) | 1 mg | 3248 |
| Cayman2015 | 15120 | 2,3-dinor-6-keto Prostaglandin F1α (sodium salt) | 100 μg | 406 |
| Cayman2015 | 15120 | 2,3-dinor-6-keto Prostaglandin F1α (sodium salt) | 5 mg | 14210 |
| Cayman2015 | 15120 | 2,3-dinor-6-keto Prostaglandin F1α (sodium salt) | 500 μg | 1834 |
| Cayman2015 | 15121 | Ursodeoxycholic Acid (sodium salt) | 1 g | 2548 |
| Cayman2015 | 15121 | Ursodeoxycholic Acid (sodium salt) | 250 mg | 910 |
| Cayman2015 | 15121 | Ursodeoxycholic Acid (sodium salt) | 5 g | 9100 |
| Cayman2015 | 15121 | Ursodeoxycholic Acid (sodium salt) | 500 mg | 1456 |
| Cayman2015 | 15122 | Zinpyr-1 | 1 mg | 546 |
| Cayman2015 | 15122 | Zinpyr-1 | 10 mg | 3010 |
| Cayman2015 | 15122 | Zinpyr-1 | 5 mg | 1638 |
| Cayman2015 | 15123 | Zanamivir | 1 mg | 364 |
| Cayman2015 | 15123 | Zanamivir | 10 mg | 1092 |
| Cayman2015 | 15123 | Zanamivir | 25 mg | 1638 |
| Cayman2015 | 15123 | Zanamivir | 5 mg | 644 |
| Cayman2015 | 15124 | Ilimaquinone | 100 μg | 1485 |
| Cayman2015 | 15125 | α-NETA | 25 mg | 2100 |
| Cayman2015 | 15125 | α-NETA | 5 mg | 525 |
| Cayman2015 | 15126 | Desomorphine | 10 mg | 1302 |
| Cayman2015 | 15126 | Desomorphine | 25 mg | 3094 |
| Cayman2015 | 15126 | Desomorphine | 5 mg | 686 |
| Cayman2015 | 15127 | (R)-(-)-MT-45 (hydrochloride) | 1 mg | 1736 |
| Cayman2015 | 15127 | (R)-(-)-MT-45 (hydrochloride) | 5 mg | 7280 |
| Cayman2015 | 15127 | (R)-(-)-MT-45 (hydrochloride) | 500 μg | 910 |
| Cayman2015 | 15128 | (S)-(+)-MT-45 (hydrochloride) | 1 mg | 1736 |
| Cayman2015 | 15128 | (S)-(+)-MT-45 (hydrochloride) | 5 mg | 7280 |
| Cayman2015 | 15128 | (S)-(+)-MT-45 (hydrochloride) | 500 μg | 910 |
| Cayman2015 | 15129 | CAY10678 | 1 mg | 826 |
| Cayman2015 | 15129 | CAY10678 | 10 mg | 6608 |
| Cayman2015 | 15129 | CAY10678 | 5 mg | 3724 |
| Cayman2015 | 15130 | GPR120 (N-Term) Polyclonal Antibody | 1 ea | 3766 |
| Cayman2015 | 15131 | 2,5-DMMA | 10 mg | 1736 |
| Cayman2015 | 15131 | 2,5-DMMA | 5 mg | 910 |
| Cayman2015 | 15131 | 2,5-DMMA | 50 mg | 7280 |
| Cayman2015 | 15132 | ?(R,S)-Anatabine (tartrate) | 10 mg | 1386 |
| Cayman2015 | 15132 | ?(R,S)-Anatabine (tartrate) | 100 mg | 10780 |
| Cayman2015 | 15132 | ?(R,S)-Anatabine (tartrate) | 5 mg | 770 |
| Cayman2015 | 15132 | ?(R,S)-Anatabine (tartrate) | 50 mg | 6160 |
| Cayman2015 | 15133 | Zinquin ethyl ester | 1 mg | 826 |
| Cayman2015 | 15133 | Zinquin ethyl ester | 10 mg | 3430 |
| Cayman2015 | 15133 | Zinquin ethyl ester | 5 mg | 1918 |
| Cayman2015 | 15133 | Zinquin ethyl ester | 500 μg | 490 |
| Cayman2015 | 15135 | Lck Inhibitor | 1 mg | 1050 |
| Cayman2015 | 15135 | Lck Inhibitor | 5 mg | 1736 |
| Cayman2015 | 15137 | eIF4E (human recombinant) | 100 μg | 5628 |
| Cayman2015 | 15137 | eIF4E (human recombinant) | 25 μg | 1876 |
| Cayman2015 | 15137 | eIF4E (human recombinant) | 50 μg | 3570 |
| Cayman2015 | 15138 | Nicotinamide N-Methyltransferase (human recombinant) | 100 μg | 3500 |
| Cayman2015 | 15138 | Nicotinamide N-Methyltransferase (human recombinant) | 25 μg | 2100 |
| Cayman2015 | 15139 | STING (human recombinant) | 100 μg | 8386 |
| Cayman2015 | 15139 | STING (human recombinant) | 25 μg | 2450 |
| Cayman2015 | 15139 | STING (human recombinant) | 50 μg | 4620 |
| Cayman2015 | 15141 | Roflumilast | 1 mg | 406 |
| Cayman2015 | 15141 | Roflumilast | 10 mg | 2268 |
| Cayman2015 | 15141 | Roflumilast | 25 mg | 5082 |
| Cayman2015 | 15141 | Roflumilast | 5 mg | 1232 |
| Cayman2015 | 15142 | PLX4720 | 1 mg | 490 |
| Cayman2015 | 15142 | PLX4720 | 10 mg | 1568 |
| Cayman2015 | 15142 | PLX4720 | 25 mg | 3430 |
| Cayman2015 | 15142 | PLX4720 | 5 mg | 1232 |
| Cayman2015 | 15143 | Z-Asp-CH2-DCB | 10 mg | 1120 |
| Cayman2015 | 15143 | Z-Asp-CH2-DCB | 25 mg | 2604 |
| Cayman2015 | 15143 | Z-Asp-CH2-DCB | 5 mg | 742 |
| Cayman2015 | 15143 | Z-Asp-CH2-DCB | 50 mg | 4830 |
| Cayman2015 | 15144 | Nelfinavir (mesylate) | 10 mg | 1456 |
| Cayman2015 | 15144 | Nelfinavir (mesylate) | 25 mg | 3388 |
| Cayman2015 | 15144 | Nelfinavir (mesylate) | 5 mg | 966 |
| Cayman2015 | 15144 | Nelfinavir (mesylate) | 50 mg | 5796 |
| Cayman2015 | 15145 | Ivacaftor | 1 mg | 490 |
| Cayman2015 | 15145 | Ivacaftor | 10 mg | 3682 |
| Cayman2015 | 15145 | Ivacaftor | 5 mg | 1960 |
| Cayman2015 | 15145 | Ivacaftor | 50 mg | 12250 |
| Cayman2015 | 15146 | JAK Inhibitor I | 1 mg | 1946 |
| Cayman2015 | 15146 | JAK Inhibitor I | 10 mg | 6972 |
| Cayman2015 | 15146 | JAK Inhibitor I | 5 mg | 4368 |
| Cayman2015 | 15146 | JAK Inhibitor I | 500 μg | 1246 |
| Cayman2015 | 15147 | Antalarmin (hydrochloride) | 10 mg | 1750 |
| Cayman2015 | 15147 | Antalarmin (hydrochloride) | 25 mg | 3738 |
| Cayman2015 | 15147 | Antalarmin (hydrochloride) | 5 mg | 1246 |
| Cayman2015 | 15147 | Antalarmin (hydrochloride) | 50 mg | 6230 |
| Cayman2015 | 15148 | Abiraterone Acetate | 10 mg | 2086 |
| Cayman2015 | 15148 | Abiraterone Acetate | 25 mg | 4508 |
| Cayman2015 | 15148 | Abiraterone Acetate | 5 mg | 1386 |
| Cayman2015 | 15148 | Abiraterone Acetate | 50 mg | 7630 |
| Cayman2015 | 15149 | Ro 3306 | 1 mg | 435 |
| Cayman2015 | 15149 | Ro 3306 | 5 mg | 1305 |
| Cayman2015 | 15150 | Indinavir (sulfate) | 1 g | 546 |
| Cayman2015 | 15150 | Indinavir (sulfate) | 5 g | 1190 |
| Cayman2015 | 15150 | Indinavir (sulfate) | 500 mg | 350 |
| Cayman2015 | 15152 | α-Crystallin (A Chain) (human recombinant) | 10 μg | 1080 |
| Cayman2015 | 15152 | α-Crystallin (A Chain) (human recombinant) | 25 μg | 2565 |
| Cayman2015 | 15152 | α-Crystallin (A Chain) (human recombinant) | 5 μg | 570 |
| Cayman2015 | 15153 | α-Crystallin (B Chain) (human recombinant) | 10 μg | 1485 |
| Cayman2015 | 15153 | α-Crystallin (B Chain) (human recombinant) | 25 μg | 3510 |
| Cayman2015 | 15153 | α-Crystallin (B Chain) (human recombinant) | 5 μg | 780 |
| Cayman2015 | 15154 | Cdk2 Inhibitor II | 1 mg | 630 |
| Cayman2015 | 15154 | Cdk2 Inhibitor II | 5 mg | 1890 |
| Cayman2015 | 15154 | Cdk2 Inhibitor II | 500 μg | 350 |
| Cayman2015 | 15155 | FAB-144 | 1 mg | 910 |
| Cayman2015 | 15155 | FAB-144 | 10 mg | 5096 |
| Cayman2015 | 15155 | FAB-144 | 5 mg | 3640 |
| Cayman2015 | 15156 | SDB-006 | 1 mg | 686 |
| Cayman2015 | 15156 | SDB-006 | 10 mg | 5488 |
| Cayman2015 | 15156 | SDB-006 | 5 mg | 3094 |
| Cayman2015 | 15157 | Flubromazepam | 1 mg | 546 |
| Cayman2015 | 15157 | Flubromazepam | 10 mg | 4368 |
| Cayman2015 | 15157 | Flubromazepam | 5 mg | 2464 |
| Cayman2015 | 15158 | Boldenone Cypionate | 10 mg | 1232 |
| Cayman2015 | 15158 | Boldenone Cypionate | 25 mg | 1680 |
| Cayman2015 | 15158 | Boldenone Cypionate | 5 mg | 686 |
| Cayman2015 | 15158 | Boldenone Cypionate | 50 mg | 3094 |
| Cayman2015 | 15159 | HQNO | 10 mg | 1316 |
| Cayman2015 | 15159 | HQNO | 5 mg | 770 |
| Cayman2015 | 15159 | HQNO | 50 mg | 5012 |
| Cayman2015 | 15160 | PPACK | 1 mg | 406 |
| Cayman2015 | 15160 | PPACK | 10 mg | 3052 |
| Cayman2015 | 15160 | PPACK | 25 mg | 7112 |
| Cayman2015 | 15160 | PPACK | 5 mg | 1722 |
| Cayman2015 | 15161 | Benzydamine | 1 mg | 686 |
| Cayman2015 | 15161 | Benzydamine | 10 mg | 5488 |
| Cayman2015 | 15161 | Benzydamine | 5 mg | 3094 |
| Cayman2015 | 15164 | 3,4-EDMA (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 15164 | 3,4-EDMA (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 15164 | 3,4-EDMA (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 15165 | 4-Fluorobuphedrone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 15165 | 4-Fluorobuphedrone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 15165 | 4-Fluorobuphedrone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 15166 | 4-fluoro-α-Pyrrolidinopentiophenone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 15166 | 4-fluoro-α-Pyrrolidinopentiophenone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 15166 | 4-fluoro-α-Pyrrolidinopentiophenone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 15167 | 3,4-EDMC (hydrochloride) | 10 mg | 1484 |
| Cayman2015 | 15167 | 3,4-EDMC (hydrochloride) | 25 mg | 3528 |
| Cayman2015 | 15167 | 3,4-EDMC (hydrochloride) | 5 mg | 784 |
| Cayman2015 | 15169 | ML-030 | 1 mg | 490 |
| Cayman2015 | 15169 | ML-030 | 10 mg | 2212 |
| Cayman2015 | 15169 | ML-030 | 25 mg | 4284 |
| Cayman2015 | 15169 | ML-030 | 5 mg | 1344 |
| Cayman2015 | 15170 | 3-methoxy Prostaglandin F1α | 1 mg | 714 |
| Cayman2015 | 15170 | 3-methoxy Prostaglandin F1α | 10 mg | 5712 |
| Cayman2015 | 15170 | 3-methoxy Prostaglandin F1α | 5 mg | 3220 |
| Cayman2015 | 15171 | ML-031 | 1 mg | 490 |
| Cayman2015 | 15171 | ML-031 | 10 mg | 2212 |
| Cayman2015 | 15171 | ML-031 | 25 mg | 4284 |
| Cayman2015 | 15171 | ML-031 | 5 mg | 1344 |
| Cayman2015 | 15172 | ML-090 | 10 mg | 350 |
| Cayman2015 | 15172 | ML-090 | 25 mg | 784 |
| Cayman2015 | 15172 | ML-090 | 50 mg | 1316 |
| Cayman2015 | 15173 | ML-095 (hydrochloride) | 1 mg | 490 |
| Cayman2015 | 15173 | ML-095 (hydrochloride) | 10 mg | 2212 |
| Cayman2015 | 15173 | ML-095 (hydrochloride) | 25 mg | 4284 |
| Cayman2015 | 15173 | ML-095 (hydrochloride) | 5 mg | 1344 |
| Cayman2015 | 15174 | ML-097 | 1 mg | 490 |
| Cayman2015 | 15174 | ML-097 | 10 mg | 2212 |
| Cayman2015 | 15174 | ML-097 | 25 mg | 4284 |
| Cayman2015 | 15174 | ML-097 | 5 mg | 1344 |
| Cayman2015 | 15175 | ML-098 | 1 mg | 490 |
| Cayman2015 | 15175 | ML-098 | 10 mg | 2212 |
| Cayman2015 | 15175 | ML-098 | 25 mg | 4284 |
| Cayman2015 | 15175 | ML-098 | 5 mg | 1344 |
| Cayman2015 | 15176 | ML-099 | 1 mg | 490 |
| Cayman2015 | 15176 | ML-099 | 10 mg | 2212 |
| Cayman2015 | 15176 | ML-099 | 25 mg | 4284 |
| Cayman2015 | 15176 | ML-099 | 5 mg | 1344 |
| Cayman2015 | 15177 | VU590 (hydrochloride) | 10 mg | 1386 |
| Cayman2015 | 15177 | VU590 (hydrochloride) | 25 mg | 3262 |
| Cayman2015 | 15177 | VU590 (hydrochloride) | 5 mg | 868 |
| Cayman2015 | 15179 | ML-161 | 1 mg | 350 |
| Cayman2015 | 15179 | ML-161 | 10 mg | 1750 |
| Cayman2015 | 15179 | ML-161 | 25 mg | 3850 |
| Cayman2015 | 15179 | ML-161 | 5 mg | 966 |
| Cayman2015 | 15180 | ML-179 | 1 mg | 490 |
| Cayman2015 | 15180 | ML-179 | 10 mg | 2212 |
| Cayman2015 | 15180 | ML-179 | 25 mg | 4284 |
| Cayman2015 | 15180 | ML-179 | 5 mg | 1344 |
| Cayman2015 | 15181 | ML-180 | 1 mg | 490 |
| Cayman2015 | 15181 | ML-180 | 10 mg | 2212 |
| Cayman2015 | 15181 | ML-180 | 25 mg | 4284 |
| Cayman2015 | 15181 | ML-180 | 5 mg | 1344 |
| Cayman2015 | 15182 | ML-191 | 1 mg | 490 |
| Cayman2015 | 15182 | ML-191 | 10 mg | 2212 |
| Cayman2015 | 15182 | ML-191 | 25 mg | 4284 |
| Cayman2015 | 15182 | ML-191 | 5 mg | 1344 |
| Cayman2015 | 15185 | ML-213 | 10 mg | 1470 |
| Cayman2015 | 15185 | ML-213 | 25 mg | 3276 |
| Cayman2015 | 15185 | ML-213 | 5 mg | 770 |
| Cayman2015 | 15185 | ML-213 | 50 mg | 6160 |
| Cayman2015 | 15186 | ML-216 | 1 mg | 350 |
| Cayman2015 | 15186 | ML-216 | 10 mg | 1372 |
| Cayman2015 | 15186 | ML-216 | 25 mg | 3066 |
| Cayman2015 | 15186 | ML-216 | 5 mg | 770 |
| Cayman2015 | 15187 | ML-233 | 1 mg | 490 |
| Cayman2015 | 15187 | ML-233 | 10 mg | 2212 |
| Cayman2015 | 15187 | ML-233 | 25 mg | 4284 |
| Cayman2015 | 15187 | ML-233 | 5 mg | 1344 |
| Cayman2015 | 15188 | ML-239 | 1 mg | 406 |
| Cayman2015 | 15188 | ML-239 | 10 mg | 1834 |
| Cayman2015 | 15188 | ML-239 | 25 mg | 4060 |
| Cayman2015 | 15188 | ML-239 | 5 mg | 1022 |
| Cayman2015 | 15189 | ML-243 | 1 mg | 490 |
| Cayman2015 | 15189 | ML-243 | 10 mg | 2212 |
| Cayman2015 | 15189 | ML-243 | 25 mg | 4284 |
| Cayman2015 | 15189 | ML-243 | 5 mg | 1344 |
| Cayman2015 | 15190 | CYM 5541 | 10 mg | 1834 |
| Cayman2015 | 15190 | CYM 5541 | 25 mg | 4256 |
| Cayman2015 | 15190 | CYM 5541 | 5 mg | 966 |
| Cayman2015 | 15190 | CYM 5541 | 50 mg | 8120 |
| Cayman2015 | 15192 | ML-261 | 1 mg | 406 |
| Cayman2015 | 15192 | ML-261 | 10 mg | 1834 |
| Cayman2015 | 15192 | ML-261 | 25 mg | 4060 |
| Cayman2015 | 15192 | ML-261 | 5 mg | 1022 |
| Cayman2015 | 15193 | ML-277 | 1 mg | 490 |
| Cayman2015 | 15193 | ML-277 | 10 mg | 2212 |
| Cayman2015 | 15193 | ML-277 | 25 mg | 4284 |
| Cayman2015 | 15193 | ML-277 | 5 mg | 1344 |
| Cayman2015 | 15194 | CID-1067700 | 1 mg | 406 |
| Cayman2015 | 15194 | CID-1067700 | 10 mg | 1834 |
| Cayman2015 | 15194 | CID-1067700 | 25 mg | 4060 |
| Cayman2015 | 15194 | CID-1067700 | 5 mg | 1022 |
| Cayman2015 | 15195 | ML-289 | 1 mg | 406 |
| Cayman2015 | 15195 | ML-289 | 10 mg | 1834 |
| Cayman2015 | 15195 | ML-289 | 25 mg | 4060 |
| Cayman2015 | 15195 | ML-289 | 5 mg | 1022 |
| Cayman2015 | 15196 | ML-335 | 1 mg | 490 |
| Cayman2015 | 15196 | ML-335 | 10 mg | 2212 |
| Cayman2015 | 15196 | ML-335 | 25 mg | 4284 |
| Cayman2015 | 15196 | ML-335 | 5 mg | 1344 |
| Cayman2015 | 15197 | Pentacosanoic Acid | 100 mg | 1204 |
| Cayman2015 | 15197 | Pentacosanoic Acid | 50 mg | 630 |
| Cayman2015 | 15197 | Pentacosanoic Acid | 500 mg | 3472 |
| Cayman2015 | 15199 | Ro 61-8048 | 10 mg | 1232 |
| Cayman2015 | 15199 | Ro 61-8048 | 25 mg | 2954 |
| Cayman2015 | 15199 | Ro 61-8048 | 5 mg | 910 |
| Cayman2015 | 15199 | Ro 61-8048 | 50 mg | 5460 |
| Cayman2015 | 15200 | HDAC6 Inhibitor | 1 mg | 1330 |
| Cayman2015 | 15200 | HDAC6 Inhibitor | 10 mg | 9800 |
| Cayman2015 | 15200 | HDAC6 Inhibitor | 5 mg | 5600 |
| Cayman2015 | 15200 | HDAC6 Inhibitor | 500 μg | 700 |
| Cayman2015 | 15201 | Myristicin | 100 mg | 1330 |
| Cayman2015 | 15201 | Myristicin | 25 mg | 392 |
| Cayman2015 | 15201 | Myristicin | 250 mg | 3136 |
| Cayman2015 | 15201 | Myristicin | 50 mg | 742 |
| Cayman2015 | 15202 | AM2201 benzimidazole analog | 1 mg | 910 |
| Cayman2015 | 15202 | AM2201 benzimidazole analog | 10 mg | 7280 |
| Cayman2015 | 15202 | AM2201 benzimidazole analog | 5 mg | 4102 |
| Cayman2015 | 15203 | E-4031 (hydrochloride) | 10 mg | 1386 |
| Cayman2015 | 15203 | E-4031 (hydrochloride) | 25 mg | 3248 |
| Cayman2015 | 15203 | E-4031 (hydrochloride) | 5 mg | 812 |
| Cayman2015 | 15203 | E-4031 (hydrochloride) | 50 mg | 6090 |
| Cayman2015 | 15204 | MoTP | 1 mg | 350 |
| Cayman2015 | 15204 | MoTP | 10 mg | 1582 |
| Cayman2015 | 15204 | MoTP | 25 mg | 3066 |
| Cayman2015 | 15204 | MoTP | 5 mg | 966 |
| Cayman2015 | 15205 | 2-hexyl-4-Pentynoic Acid | 1 g | 1092 |
| Cayman2015 | 15205 | 2-hexyl-4-Pentynoic Acid | 250 mg | 546 |
| Cayman2015 | 15205 | 2-hexyl-4-Pentynoic Acid | 5 g | 1960 |
| Cayman2015 | 15205 | 2-hexyl-4-Pentynoic Acid | 500 mg | 826 |
| Cayman2015 | 15206 | MNS | 10 mg | 532 |
| Cayman2015 | 15206 | MNS | 100 mg | 1974 |
| Cayman2015 | 15206 | MNS | 50 mg | 1064 |
| Cayman2015 | 15206 | MNS | 500 mg | 5852 |
| Cayman2015 | 15207 | A-967079 | 10 mg | 1386 |
| Cayman2015 | 15207 | A-967079 | 25 mg | 3276 |
| Cayman2015 | 15207 | A-967079 | 5 mg | 728 |
| Cayman2015 | 15207 | A-967079 | 50 mg | 5824 |
| Cayman2015 | 15208 | 16α-hydroxy Estrone | 1 mg | 1386 |
| Cayman2015 | 15208 | 16α-hydroxy Estrone | 10 mg | 7630 |
| Cayman2015 | 15208 | 16α-hydroxy Estrone | 5 mg | 4858 |
| Cayman2015 | 15209 | 19-hydroxy Cholesterol | 1 mg | 490 |
| Cayman2015 | 15209 | 19-hydroxy Cholesterol | 10 mg | 3682 |
| Cayman2015 | 15209 | 19-hydroxy Cholesterol | 5 mg | 1960 |
| Cayman2015 | 15210 | 6-keto Prostaglandin F1α | 1 mg | 1232 |
| Cayman2015 | 15210 | 6-keto Prostaglandin F1α | 10 mg | 9856 |
| Cayman2015 | 15210 | 6-keto Prostaglandin F1α | 5 mg | 5544 |
| Cayman2015 | 15210 | 6-keto Prostaglandin F1α | 50 mg | 43120 |
| Cayman2015 | 15211 | Shz-1 | 1 mg | 686 |
| Cayman2015 | 15211 | Shz-1 | 10 mg | 1652 |
| Cayman2015 | 15211 | Shz-1 | 5 mg | 1204 |
| Cayman2015 | 15211 | Shz-1 | 50 mg | 6860 |
| Cayman2015 | 15212 | Ketoconazole | 1 g | 1386 |
| Cayman2015 | 15212 | Ketoconazole | 100 mg | 630 |
| Cayman2015 | 15212 | Ketoconazole | 5 g | 4732 |
| Cayman2015 | 15212 | Ketoconazole | 500 mg | 952 |
| Cayman2015 | 15213 | Amiodarone (hydrochloride) | 1 g | 490 |
| Cayman2015 | 15213 | Amiodarone (hydrochloride) | 10 g | 2450 |
| Cayman2015 | 15213 | Amiodarone (hydrochloride) | 5 g | 1372 |
| Cayman2015 | 15213 | Amiodarone (hydrochloride) | 500 mg | 350 |
| Cayman2015 | 15214 | Epalrestat | 10 mg | 994 |
| Cayman2015 | 15214 | Epalrestat | 25 mg | 2268 |
| Cayman2015 | 15214 | Epalrestat | 5 mg | 826 |
| Cayman2015 | 15214 | Epalrestat | 50 mg | 4130 |
| Cayman2015 | 15215 | Ko 143 | 1 mg | 952 |
| Cayman2015 | 15215 | Ko 143 | 10 mg | 2856 |
| Cayman2015 | 15215 | Ko 143 | 25 mg | 5950 |
| Cayman2015 | 15215 | Ko 143 | 5 mg | 1666 |
| Cayman2015 | 15216 | Conduritol B epoxide | 25 mg | 2310 |
| Cayman2015 | 15216 | Conduritol B epoxide | 5 mg | 616 |
| Cayman2015 | 15216 | Conduritol B epoxide | 50 mg | 4312 |
| Cayman2015 | 15217 | MLN 4924 | 1 mg | 1386 |
| Cayman2015 | 15217 | MLN 4924 | 10 mg | 6370 |
| Cayman2015 | 15217 | MLN 4924 | 5 mg | 4858 |
| Cayman2015 | 15218 | FCCP | 10 mg | 826 |
| Cayman2015 | 15218 | FCCP | 50 mg | 3304 |
| Cayman2015 | 15219 | GSK 3787 | 10 mg | 1442 |
| Cayman2015 | 15219 | GSK 3787 | 25 mg | 3192 |
| Cayman2015 | 15219 | GSK 3787 | 5 mg | 798 |
| Cayman2015 | 15219 | GSK 3787 | 50 mg | 5586 |
| Cayman2015 | 15220 | Dovitinib | 10 mg | 2212 |
| Cayman2015 | 15220 | Dovitinib | 25 mg | 3598 |
| Cayman2015 | 15220 | Dovitinib | 5 mg | 1386 |
| Cayman2015 | 15220 | Dovitinib | 50 mg | 5824 |
| Cayman2015 | 15221 | HPI-1 | 10 mg | 1988 |
| Cayman2015 | 15221 | HPI-1 | 25 mg | 4704 |
| Cayman2015 | 15221 | HPI-1 | 5 mg | 1106 |
| Cayman2015 | 15221 | HPI-1 | 50 mg | 8302 |
| Cayman2015 | 15222 | ID-8 | 10 mg | 1232 |
| Cayman2015 | 15222 | ID-8 | 25 mg | 2744 |
| Cayman2015 | 15222 | ID-8 | 5 mg | 686 |
| Cayman2015 | 15223 | IPBT-5CA | 1 g | 2800 |
| Cayman2015 | 15223 | IPBT-5CA | 100 mg | 560 |
| Cayman2015 | 15223 | IPBT-5CA | 50 mg | 350 |
| Cayman2015 | 15223 | IPBT-5CA | 500 mg | 1750 |
| Cayman2015 | 15224 | P005091 | 10 mg | 1624 |
| Cayman2015 | 15224 | P005091 | 25 mg | 3808 |
| Cayman2015 | 15224 | P005091 | 5 mg | 952 |
| Cayman2015 | 15224 | P005091 | 50 mg | 5236 |
| Cayman2015 | 15225 | SL 01 | 1 g | 1050 |
| Cayman2015 | 15225 | SL 01 | 250 mg | 406 |
| Cayman2015 | 15225 | SL 01 | 500 mg | 770 |
| Cayman2015 | 15227 | WP1130 | 1 mg | 350 |
| Cayman2015 | 15227 | WP1130 | 10 mg | 1750 |
| Cayman2015 | 15227 | WP1130 | 5 mg | 966 |
| Cayman2015 | 15230 | Δ17-6-keto Prostaglandin F1α | 1 mg | 9408 |
| Cayman2015 | 15230 | Δ17-6-keto Prostaglandin F1α | 100 μg | 1176 |
| Cayman2015 | 15230 | Δ17-6-keto Prostaglandin F1α | 500 μg | 5292 |
| Cayman2015 | 15239 | Glucoraphanin (potassium salt) | 1 mg | 630 |
| Cayman2015 | 15239 | Glucoraphanin (potassium salt) | 10 mg | 2772 |
| Cayman2015 | 15239 | Glucoraphanin (potassium salt) | 5 mg | 1834 |
| Cayman2015 | 15240 | ADBICA N-(4-hydroxypentyl) metabolite | 1 mg | 1330 |
| Cayman2015 | 15240 | ADBICA N-(4-hydroxypentyl) metabolite | 10 mg | 4900 |
| Cayman2015 | 15240 | ADBICA N-(4-hydroxypentyl) metabolite | 5 mg | 3150 |
| Cayman2015 | 15243 | IWP-L6 | 10 mg | 1750 |
| Cayman2015 | 15243 | IWP-L6 | 5 mg | 924 |
| Cayman2015 | 15243 | IWP-L6 | 50 mg | 6468 |
| Cayman2015 | 15253 | 14(S)-HDoHE | 100 μg | 2212 |
| Cayman2015 | 15253 | 14(S)-HDoHE | 25 μg | 616 |
| Cayman2015 | 15253 | 14(S)-HDoHE | 250 μg | 4928 |
| Cayman2015 | 15253 | 14(S)-HDoHE | 50 μg | 1176 |
| Cayman2015 | 15259 | Acetyl * ToxBox Run Pack | 1 ea | 5250 |
| Cayman2015 | 15260 | Q-VD-OPH | 1 mg | 2235 |
| Cayman2015 | 15260 | Q-VD-OPH | 5 mg | 8940 |
| Cayman2015 | 15261 | AM580 | 1 mg | 350 |
| Cayman2015 | 15261 | AM580 | 10 mg | 1372 |
| Cayman2015 | 15261 | AM580 | 25 mg | 3066 |
| Cayman2015 | 15261 | AM580 | 5 mg | 1050 |
| Cayman2015 | 15262 | GSK 429286A | 1 mg | 350 |
| Cayman2015 | 15262 | GSK 429286A | 10 mg | 2100 |
| Cayman2015 | 15262 | GSK 429286A | 5 mg | 1134 |
| Cayman2015 | 15263 | (+)-BAY-K-8644 | 1 mg | 1190 |
| Cayman2015 | 15263 | (+)-BAY-K-8644 | 10 mg | 2982 |
| Cayman2015 | 15263 | (+)-BAY-K-8644 | 5 mg | 2380 |
| Cayman2015 | 15264 | BI-D1870 | 1 mg | 616 |
| Cayman2015 | 15264 | BI-D1870 | 10 mg | 3696 |
| Cayman2015 | 15264 | BI-D1870 | 5 mg | 2310 |
| Cayman2015 | 15265 | JK 184 | 1 mg | 350 |
| Cayman2015 | 15265 | JK 184 | 10 mg | 1232 |
| Cayman2015 | 15265 | JK 184 | 5 mg | 686 |
| Cayman2015 | 15265 | JK 184 | 50 mg | 5432 |
| Cayman2015 | 15266 | (±)-ORG 28611 | 1 mg | 910 |
| Cayman2015 | 15266 | (±)-ORG 28611 | 10 mg | 7280 |
| Cayman2015 | 15266 | (±)-ORG 28611 | 5 mg | 4102 |
| Cayman2015 | 15267 | PFI-3 | 1 mg | 350 |
| Cayman2015 | 15267 | PFI-3 | 10 mg | 1932 |
| Cayman2015 | 15267 | PFI-3 | 25 mg | 4382 |
| Cayman2015 | 15267 | PFI-3 | 5 mg | 1050 |
| Cayman2015 | 15269 | MLS-573151 | 1 mg | 490 |
| Cayman2015 | 15269 | MLS-573151 | 10 mg | 2310 |
| Cayman2015 | 15269 | MLS-573151 | 25 mg | 4900 |
| Cayman2015 | 15269 | MLS-573151 | 5 mg | 1330 |
| Cayman2015 | 15270 | 6,15-diketo-13,14-dihydro Prostaglandin F1α | 1 mg | 1932 |
| Cayman2015 | 15270 | 6,15-diketo-13,14-dihydro Prostaglandin F1α | 100 μg | 350 |
| Cayman2015 | 15270 | 6,15-diketo-13,14-dihydro Prostaglandin F1α | 5 mg | 7882 |
| Cayman2015 | 15270 | 6,15-diketo-13,14-dihydro Prostaglandin F1α | 500 μg | 1050 |
| Cayman2015 | 15271 | 2-hydroxy Flutamide | 10 mg | 1330 |
| Cayman2015 | 15271 | 2-hydroxy Flutamide | 25 mg | 2506 |
| Cayman2015 | 15271 | 2-hydroxy Flutamide | 5 mg | 910 |
| Cayman2015 | 15271 | 2-hydroxy Flutamide | 50 mg | 4102 |
| Cayman2015 | 15278 | Clotrimazole | 1 g | 630 |
| Cayman2015 | 15278 | Clotrimazole | 100 mg | 462 |
| Cayman2015 | 15278 | Clotrimazole | 50 mg | 350 |
| Cayman2015 | 15279 | CAL-101 | 10 mg | 1456 |
| Cayman2015 | 15279 | CAL-101 | 25 mg | 3388 |
| Cayman2015 | 15279 | CAL-101 | 5 mg | 966 |
| Cayman2015 | 15279 | CAL-101 | 50 mg | 5796 |
| Cayman2015 | 15280 | ADBICA-d9 | 1 mg | 1736 |
| Cayman2015 | 15280 | ADBICA-d9 | 500 μg | 910 |
| Cayman2015 | 15281 | 4,4'-Dimethylaminorex (hydrochloride) | 1 mg | 1330 |
| Cayman2015 | 15281 | 4,4'-Dimethylaminorex (hydrochloride) | 10 mg | 10640 |
| Cayman2015 | 15281 | 4,4'-Dimethylaminorex (hydrochloride) | 5 mg | 5992 |
| Cayman2015 | 15282 | 5-EAPB (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 15282 | 5-EAPB (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 15282 | 5-EAPB (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 15284 | Atglistatin | 1 mg | 448 |
| Cayman2015 | 15284 | Atglistatin | 10 mg | 3136 |
| Cayman2015 | 15284 | Atglistatin | 25 mg | 5600 |
| Cayman2015 | 15284 | Atglistatin | 5 mg | 1792 |
| Cayman2015 | 15292 | AB-FUBINACA-d4 | 1 mg | 1736 |
| Cayman2015 | 15292 | AB-FUBINACA-d4 | 500 μg | 910 |
| Cayman2015 | 15293 | Cannabigerol | 10 mg | 2198 |
| Cayman2015 | 15293 | Cannabigerol | 25 mg | 5152 |
| Cayman2015 | 15293 | Cannabigerol | 5 mg | 1372 |
| Cayman2015 | 15293 | Cannabigerol | 50 mg | 9604 |
| Cayman2015 | 15294 | FG-4592 | 10 mg | 868 |
| Cayman2015 | 15294 | FG-4592 | 25 mg | 2044 |
| Cayman2015 | 15294 | FG-4592 | 5 mg | 546 |
| Cayman2015 | 15294 | FG-4592 | 50 mg | 3556 |
| Cayman2015 | 15297 | BAY-85-3934 | 1 mg | 490 |
| Cayman2015 | 15297 | BAY-85-3934 | 10 mg | 3920 |
| Cayman2015 | 15297 | BAY-85-3934 | 25 mg | 8582 |
| Cayman2015 | 15297 | BAY-85-3934 | 5 mg | 2212 |
| Cayman2015 | 15300 | IPTG (dioxane free) | 1 g | 350 |
| Cayman2015 | 15300 | IPTG (dioxane free) | 10 g | 2100 |
| Cayman2015 | 15300 | IPTG (dioxane free) | 25 g | 3934 |
| Cayman2015 | 15300 | IPTG (dioxane free) | 5 g | 1134 |
| Cayman2015 | 15301 | trans-Vaccenic Acid | 1 g | 7280 |
| Cayman2015 | 15301 | trans-Vaccenic Acid | 100 mg | 1456 |
| Cayman2015 | 15301 | trans-Vaccenic Acid | 50 mg | 910 |
| Cayman2015 | 15301 | trans-Vaccenic Acid | 500 mg | 4550 |
| Cayman2015 | 15302 | Minoxidil | 1 g | 3780 |
| Cayman2015 | 15302 | Minoxidil | 100 mg | 686 |
| Cayman2015 | 15302 | Minoxidil | 250 mg | 1540 |
| Cayman2015 | 15302 | Minoxidil | 500 mg | 2744 |
| Cayman2015 | 15303 | Disulfiram | 100 g | 560 |
| Cayman2015 | 15303 | Disulfiram | 250 g | 882 |
| Cayman2015 | 15303 | Disulfiram | 50 g | 350 |
| Cayman2015 | 15312 | LY2157299 | 1 mg | 546 |
| Cayman2015 | 15312 | LY2157299 | 10 mg | 3556 |
| Cayman2015 | 15312 | LY2157299 | 5 mg | 2184 |
| Cayman2015 | 15312 | LY2157299 | 50 mg | 9562 |
| Cayman2015 | 15313 | Captopril | 1 g | 392 |
| Cayman2015 | 15313 | Captopril | 10 g | 1456 |
| Cayman2015 | 15313 | Captopril | 25 g | 3430 |
| Cayman2015 | 15313 | Captopril | 5 g | 1078 |
| Cayman2015 | 15314 | (-)-Cotinine | 100 mg | 826 |
| Cayman2015 | 15314 | (-)-Cotinine | 250 mg | 1036 |
| Cayman2015 | 15314 | (-)-Cotinine | 50 mg | 630 |
| Cayman2015 | 15314 | (-)-Cotinine | 500 mg | 1890 |
| Cayman2015 | 15316 | Auranofin | 100 mg | 826 |
| Cayman2015 | 15316 | Auranofin | 25 mg | 532 |
| Cayman2015 | 15316 | Auranofin | 500 mg | 3724 |
| Cayman2015 | 15317 | CID-2011756 | 10 mg | 1638 |
| Cayman2015 | 15317 | CID-2011756 | 25 mg | 3864 |
| Cayman2015 | 15317 | CID-2011756 | 5 mg | 966 |
| Cayman2015 | 15318 | DBeQ | 10 mg | 1358 |
| Cayman2015 | 15318 | DBeQ | 25 mg | 3136 |
| Cayman2015 | 15318 | DBeQ | 5 mg | 966 |
| Cayman2015 | 15318 | DBeQ | 50 mg | 5796 |
| Cayman2015 | 15319 | Ginsenoside Rb1 | 10 mg | 2002 |
| Cayman2015 | 15319 | Ginsenoside Rb1 | 25 mg | 4466 |
| Cayman2015 | 15319 | Ginsenoside Rb1 | 5 mg | 1050 |
| Cayman2015 | 15321 | Kanamycin A (sulfate) | 10 g | 770 |
| Cayman2015 | 15321 | Kanamycin A (sulfate) | 25 g | 1232 |
| Cayman2015 | 15321 | Kanamycin A (sulfate) | 5 g | 546 |
| Cayman2015 | 15322 | Kasugamycin (hydrochloride) | 1 g | 490 |
| Cayman2015 | 15322 | Kasugamycin (hydrochloride) | 10 g | 3290 |
| Cayman2015 | 15322 | Kasugamycin (hydrochloride) | 5 g | 2212 |
| Cayman2015 | 15323 | PKR Inhibitor | 1 mg | 350 |
| Cayman2015 | 15323 | PKR Inhibitor | 10 mg | 1582 |
| Cayman2015 | 15323 | PKR Inhibitor | 25 mg | 3500 |
| Cayman2015 | 15323 | PKR Inhibitor | 5 mg | 882 |
| Cayman2015 | 15324 | SMER3 | 10 mg | 1372 |
| Cayman2015 | 15324 | SMER3 | 25 mg | 2282 |
| Cayman2015 | 15324 | SMER3 | 5 mg | 910 |
| Cayman2015 | 15324 | SMER3 | 50 mg | 4914 |
| Cayman2015 | 15325 | STO-609 (acetate) | 1 mg | 350 |
| Cayman2015 | 15325 | STO-609 (acetate) | 10 mg | 1932 |
| Cayman2015 | 15325 | STO-609 (acetate) | 5 mg | 1050 |
| Cayman2015 | 15326 | Validamycin A | 1 g | 1876 |
| Cayman2015 | 15326 | Validamycin A | 500 mg | 1246 |
| Cayman2015 | 15327 | Vancomycin (hydrochloride) | 1 g | 1092 |
| Cayman2015 | 15327 | Vancomycin (hydrochloride) | 250 mg | 546 |
| Cayman2015 | 15327 | Vancomycin (hydrochloride) | 5 g | 2506 |
| Cayman2015 | 15328 | bk-2C-B (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 15328 | bk-2C-B (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 15328 | bk-2C-B (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 15329 | Ginsenoside Rd | 1 mg | 350 |
| Cayman2015 | 15329 | Ginsenoside Rd | 10 mg | 2100 |
| Cayman2015 | 15329 | Ginsenoside Rd | 5 mg | 1582 |
| Cayman2015 | 15330 | Ginsenoside Re | 1 mg | 350 |
| Cayman2015 | 15330 | Ginsenoside Re | 10 mg | 1582 |
| Cayman2015 | 15330 | Ginsenoside Re | 5 mg | 1232 |
| Cayman2015 | 15331 | Ginsenoside Rg2 | 1 mg | 686 |
| Cayman2015 | 15331 | Ginsenoside Rg2 | 10 mg | 3010 |
| Cayman2015 | 15331 | Ginsenoside Rg2 | 5 mg | 2198 |
| Cayman2015 | 15331 | Ginsenoside Rg2 | 500 μg | 406 |
| Cayman2015 | 15332 | Ginsenoside Rg3 | 10 mg | 2002 |
| Cayman2015 | 15332 | Ginsenoside Rg3 | 25 mg | 4466 |
| Cayman2015 | 15332 | Ginsenoside Rg3 | 5 mg | 1050 |
| Cayman2015 | 15334 | NM2201 | 1 mg | 910 |
| Cayman2015 | 15334 | NM2201 | 10 mg | 7280 |
| Cayman2015 | 15334 | NM2201 | 5 mg | 4102 |
| Cayman2015 | 15338 | JIB-04 | 10 mg | 1638 |
| Cayman2015 | 15338 | JIB-04 | 25 mg | 3192 |
| Cayman2015 | 15338 | JIB-04 | 5 mg | 910 |
| Cayman2015 | 15338 | JIB-04 | 50 mg | 4550 |
| Cayman2015 | 15350 | 8-iso Prostaglandin F1α | 1 mg | 1176 |
| Cayman2015 | 15350 | 8-iso Prostaglandin F1α | 10 mg | 9408 |
| Cayman2015 | 15350 | 8-iso Prostaglandin F1α | 5 mg | 5292 |
| Cayman2015 | 15352 | YZ9 | 10 mg | 840 |
| Cayman2015 | 15352 | YZ9 | 100 mg | 4900 |
| Cayman2015 | 15352 | YZ9 | 5 mg | 490 |
| Cayman2015 | 15352 | YZ9 | 50 mg | 3430 |
| Cayman2015 | 15353 | 5-fluoro SDB-005 | 1 mg | 910 |
| Cayman2015 | 15353 | 5-fluoro SDB-005 | 10 mg | 7280 |
| Cayman2015 | 15353 | 5-fluoro SDB-005 | 5 mg | 4102 |
| Cayman2015 | 15354 | 4-methoxy-α-Pyrrolidinobutiophenone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 15354 | 4-methoxy-α-Pyrrolidinobutiophenone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 15354 | 4-methoxy-α-Pyrrolidinobutiophenone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 15355 | Diclofensine (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 15355 | Diclofensine (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 15355 | Diclofensine (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 15356 | 4-fluoro PV8 (hydrochloride) | 1 mg | 826 |
| Cayman2015 | 15356 | 4-fluoro PV8 (hydrochloride) | 10 mg | 6608 |
| Cayman2015 | 15356 | 4-fluoro PV8 (hydrochloride) | 5 mg | 3724 |
| Cayman2015 | 15358 | α-Pyrrolidinobutiothiophenone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 15358 | α-Pyrrolidinobutiothiophenone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 15358 | α-Pyrrolidinobutiothiophenone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 15359 | RGDS Peptide | 10 mg | 1036 |
| Cayman2015 | 15359 | RGDS Peptide | 25 mg | 1540 |
| Cayman2015 | 15359 | RGDS Peptide | 5 mg | 686 |
| Cayman2015 | 15359 | RGDS Peptide | 50 mg | 2744 |
| Cayman2015 | 15360 | PPACKII (trifluoroacetate salt) | 1 mg | 406 |
| Cayman2015 | 15360 | PPACKII (trifluoroacetate salt) | 10 mg | 3052 |
| Cayman2015 | 15360 | PPACKII (trifluoroacetate salt) | 25 mg | 7112 |
| Cayman2015 | 15360 | PPACKII (trifluoroacetate salt) | 5 mg | 1722 |
| Cayman2015 | 15361 | Harringtonine | 1 mg | 490 |
| Cayman2015 | 15361 | Harringtonine | 10 mg | 1960 |
| Cayman2015 | 15361 | Harringtonine | 5 mg | 1232 |
| Cayman2015 | 15363 | EGFR Inhibitor | 1 mg | 1050 |
| Cayman2015 | 15363 | EGFR Inhibitor | 25 mg | 11032 |
| Cayman2015 | 15363 | EGFR Inhibitor | 5 mg | 3150 |
| Cayman2015 | 15364 | Colcemid | 1 mg | 375 |
| Cayman2015 | 15364 | Colcemid | 10 mg | 1695 |
| Cayman2015 | 15364 | Colcemid | 25 mg | 2820 |
| Cayman2015 | 15364 | Colcemid | 5 mg | 1035 |
| Cayman2015 | 15365 | Clencyclohexerol | 1 mg | 546 |
| Cayman2015 | 15365 | Clencyclohexerol | 10 mg | 1862 |
| Cayman2015 | 15365 | Clencyclohexerol | 5 mg | 1232 |
| Cayman2015 | 15366 | Fura-PE3-Acetoxymethyl ester | 1 mg | 1764 |
| Cayman2015 | 15366 | Fura-PE3-Acetoxymethyl ester | 50 μg | 490 |
| Cayman2015 | 15367 | 5'-Iodoresiniferatoxin | 1 mg | 3206 |
| Cayman2015 | 15368 | SF1670 | 1 mg | 686 |
| Cayman2015 | 15368 | SF1670 | 5 mg | 1610 |
| Cayman2015 | 15369 | Amprenavir | 100 mg | 13650 |
| Cayman2015 | 15369 | Amprenavir | 25 mg | 4466 |
| Cayman2015 | 15369 | Amprenavir | 5 mg | 1050 |
| Cayman2015 | 15369 | Amprenavir | 50 mg | 8400 |
| Cayman2015 | 15370 | 8-iso Prostaglandin F1β | 1 mg | 980 |
| Cayman2015 | 15370 | 8-iso Prostaglandin F1β | 10 mg | 7840 |
| Cayman2015 | 15370 | 8-iso Prostaglandin F1β | 5 mg | 4410 |
| Cayman2015 | 15371 | Butein | 1 mg | 350 |
| Cayman2015 | 15371 | Butein | 10 mg | 2282 |
| Cayman2015 | 15371 | Butein | 5 mg | 1582 |
| Cayman2015 | 15372 | Ebastine | 1 g | 1078 |
| Cayman2015 | 15372 | Ebastine | 5 g | 4102 |
| Cayman2015 | 15372 | Ebastine | 500 mg | 630 |
| Cayman2015 | 15373 | Ro 106-9920 | 1 mg | 546 |
| Cayman2015 | 15373 | Ro 106-9920 | 10 mg | 1806 |
| Cayman2015 | 15373 | Ro 106-9920 | 5 mg | 1232 |
| Cayman2015 | 15374 | Taurolidine | 10 mg | 602 |
| Cayman2015 | 15374 | Taurolidine | 25 mg | 1316 |
| Cayman2015 | 15374 | Taurolidine | 5 mg | 350 |
| Cayman2015 | 15374 | Taurolidine | 50 mg | 2100 |
| Cayman2015 | 15375 | Arctiin | 100 mg | 2464 |
| Cayman2015 | 15375 | Arctiin | 25 mg | 686 |
| Cayman2015 | 15375 | Arctiin | 50 mg | 1302 |
| Cayman2015 | 15376 | Roquefortine C | 1 mg | 3375 |
| Cayman2015 | 15376 | Roquefortine C | 500 μg | 1875 |
| Cayman2015 | 15377 | Venturicidin A | 1 mg | 2506 |
| Cayman2015 | 15377 | Venturicidin A | 5 mg | 10150 |
| Cayman2015 | 15378 | Siomycin A | 500 μg | 3710 |
| Cayman2015 | 15379 | Piericidin A | 10 mg | 5684 |
| Cayman2015 | 15379 | Piericidin A | 2 mg | 1750 |
| Cayman2015 | 15381 | Ophiobolin A | 1 mg | 3206 |
| Cayman2015 | 15381 | Ophiobolin A | 5 mg | 12824 |
| Cayman2015 | 15382 | Enniatin B | 1 mg | 1806 |
| Cayman2015 | 15382 | Enniatin B | 5 mg | 8134 |
| Cayman2015 | 15383 | Calphostin C | 100 μg | 1372 |
| Cayman2015 | 15383 | Calphostin C | 500 μg | 6174 |
| Cayman2015 | 15384 | Bicyclomycin Benzoate | 25 mg | 6874 |
| Cayman2015 | 15384 | Bicyclomycin Benzoate | 5 mg | 1512 |
| Cayman2015 | 15385 | Indolmycin | 1 mg | 4410 |
| Cayman2015 | 15385 | Indolmycin | 5 mg | 16758 |
| Cayman2015 | 15386 | Ikarugamycin | 2.5 mg | 8904 |
| Cayman2015 | 15386 | Ikarugamycin | 500 μg | 2226 |
| Cayman2015 | 15387 | Galiellalactone | 2.5 mg | 11914 |
| Cayman2015 | 15387 | Galiellalactone | 500 μg | 4410 |
| Cayman2015 | 15388 | Mepirapim (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 15388 | Mepirapim (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 15388 | Mepirapim (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 15389 | SDB-005 | 1 mg | 686 |
| Cayman2015 | 15389 | SDB-005 | 10 mg | 5488 |
| Cayman2015 | 15389 | SDB-005 | 5 mg | 3094 |
| Cayman2015 | 15390 | 5-fluoro SDB-006 | 1 mg | 910 |
| Cayman2015 | 15390 | 5-fluoro SDB-006 | 10 mg | 7280 |
| Cayman2015 | 15390 | 5-fluoro SDB-006 | 5 mg | 4102 |
| Cayman2015 | 15392 | PAF C-16 Carboxylic Acid | 1 mg | 2632 |
| Cayman2015 | 15392 | PAF C-16 Carboxylic Acid | 10 mg | 19404 |
| Cayman2015 | 15392 | PAF C-16 Carboxylic Acid | 5 mg | 11088 |
| Cayman2015 | 15392 | PAF C-16 Carboxylic Acid | 500 μg | 1386 |
| Cayman2015 | 15393 | BQCA | 10 mg | 1092 |
| Cayman2015 | 15393 | BQCA | 25 mg | 2576 |
| Cayman2015 | 15393 | BQCA | 5 mg | 686 |
| Cayman2015 | 15393 | BQCA | 50 mg | 4802 |
| Cayman2015 | 15395 | Heat Shock Protein Inhibitor I | 1 mg | 490 |
| Cayman2015 | 15395 | Heat Shock Protein Inhibitor I | 10 mg | 3430 |
| Cayman2015 | 15395 | Heat Shock Protein Inhibitor I | 25 mg | 7350 |
| Cayman2015 | 15395 | Heat Shock Protein Inhibitor I | 5 mg | 1834 |
| Cayman2015 | 15397 | ML-60218 | 1 mg | 1246 |
| Cayman2015 | 15397 | ML-60218 | 10 mg | 3360 |
| Cayman2015 | 15397 | ML-60218 | 5 mg | 2184 |
| Cayman2015 | 15398 | Stauprimide | 1 mg | 1302 |
| Cayman2015 | 15398 | Stauprimide | 5 mg | 3430 |
| Cayman2015 | 15398 | Stauprimide | 500 μg | 686 |
| Cayman2015 | 15399 | Xanthohumol | 1 mg | 490 |
| Cayman2015 | 15399 | Xanthohumol | 10 mg | 1960 |
| Cayman2015 | 15399 | Xanthohumol | 25 mg | 4284 |
| Cayman2015 | 15399 | Xanthohumol | 5 mg | 1106 |
| Cayman2015 | 15400 | Zerumbone | 10 mg | 720 |
| Cayman2015 | 15400 | Zerumbone | 5 mg | 450 |
| Cayman2015 | 15400 | Zerumbone | 50 mg | 2880 |
| Cayman2015 | 15402 | PSI-7977 | 1 mg | 812 |
| Cayman2015 | 15402 | PSI-7977 | 10 mg | 3654 |
| Cayman2015 | 15402 | PSI-7977 | 5 mg | 2030 |
| Cayman2015 | 15403 | CAY10683 | 10 mg | 1008 |
| Cayman2015 | 15403 | CAY10683 | 25 mg | 2240 |
| Cayman2015 | 15403 | CAY10683 | 5 mg | 560 |
| Cayman2015 | 15403 | CAY10683 | 50 mg | 4032 |
| Cayman2015 | 15405 | Amikacin | 1 g | 350 |
| Cayman2015 | 15405 | Amikacin | 5 g | 1050 |
| Cayman2015 | 15406 | AZD 5363 | 1 mg | 630 |
| Cayman2015 | 15406 | AZD 5363 | 10 mg | 2646 |
| Cayman2015 | 15406 | AZD 5363 | 25 mg | 4732 |
| Cayman2015 | 15406 | AZD 5363 | 5 mg | 1890 |
| Cayman2015 | 15407 | Budesonide | 100 mg | 742 |
| Cayman2015 | 15407 | Budesonide | 250 mg | 1722 |
| Cayman2015 | 15407 | Budesonide | 50 mg | 490 |
| Cayman2015 | 15407 | Budesonide | 500 mg | 3192 |
| Cayman2015 | 15408 | Metanephrine | 10 mg | 952 |
| Cayman2015 | 15408 | Metanephrine | 5 mg | 616 |
| Cayman2015 | 15408 | Metanephrine | 50 mg | 3696 |
| Cayman2015 | 15409 | LY2109761 | 1 mg | 686 |
| Cayman2015 | 15409 | LY2109761 | 10 mg | 4466 |
| Cayman2015 | 15409 | LY2109761 | 5 mg | 2744 |
| Cayman2015 | 15410 | Prostaglandin F1β | 1 mg | 714 |
| Cayman2015 | 15410 | Prostaglandin F1β | 10 mg | 5712 |
| Cayman2015 | 15410 | Prostaglandin F1β | 5 mg | 3220 |
| Cayman2015 | 15411 | GW 2580 | 1 mg | 406 |
| Cayman2015 | 15411 | GW 2580 | 10 mg | 1624 |
| Cayman2015 | 15411 | GW 2580 | 25 mg | 3556 |
| Cayman2015 | 15411 | GW 2580 | 5 mg | 910 |
| Cayman2015 | 15412 | N-tert-butyl-α-Phenylnitrone | 1 g | 490 |
| Cayman2015 | 15412 | N-tert-butyl-α-Phenylnitrone | 500 mg | 350 |
| Cayman2015 | 15413 | (S)-MG115 | 1 mg | 406 |
| Cayman2015 | 15413 | (S)-MG115 | 5 mg | 1022 |
| Cayman2015 | 15414 | Pitavastatin (calcium salt) | 10 mg | 686 |
| Cayman2015 | 15414 | Pitavastatin (calcium salt) | 100 mg | 3094 |
| Cayman2015 | 15414 | Pitavastatin (calcium salt) | 25 mg | 1120 |
| Cayman2015 | 15414 | Pitavastatin (calcium salt) | 50 mg | 1890 |
| Cayman2015 | 15415 | GSK 126 | 1 mg | 686 |
| Cayman2015 | 15415 | GSK 126 | 10 mg | 2058 |
| Cayman2015 | 15415 | GSK 126 | 5 mg | 1372 |
| Cayman2015 | 15416 | Pinacidil (hydrate) | 100 mg | 1036 |
| Cayman2015 | 15416 | Pinacidil (hydrate) | 50 mg | 546 |
| Cayman2015 | 15416 | Pinacidil (hydrate) | 500 mg | 4102 |
| Cayman2015 | 15417 | Modafinil | 10 mg | 742 |
| Cayman2015 | 15417 | Modafinil | 25 mg | 1722 |
| Cayman2015 | 15417 | Modafinil | 5 mg | 490 |
| Cayman2015 | 15417 | Modafinil | 50 mg | 3192 |
| Cayman2015 | 15418 | Carvedilol | 100 mg | 630 |
| Cayman2015 | 15418 | Carvedilol | 250 mg | 1316 |
| Cayman2015 | 15418 | Carvedilol | 50 mg | 350 |
| Cayman2015 | 15419 | 3-AP | 1 mg | 350 |
| Cayman2015 | 15419 | 3-AP | 10 mg | 1372 |
| Cayman2015 | 15419 | 3-AP | 25 mg | 3066 |
| Cayman2015 | 15419 | 3-AP | 5 mg | 784 |
| Cayman2015 | 15420 | Miconazole (nitrate) | 1 g | 364 |
| Cayman2015 | 15420 | Miconazole (nitrate) | 10 g | 1820 |
| Cayman2015 | 15420 | Miconazole (nitrate) | 25 g | 3276 |
| Cayman2015 | 15420 | Miconazole (nitrate) | 5 g | 1092 |
| Cayman2015 | 15421 | Nobiletin | 10 mg | 1162 |
| Cayman2015 | 15421 | Nobiletin | 25 mg | 1442 |
| Cayman2015 | 15421 | Nobiletin | 5 mg | 826 |
| Cayman2015 | 15421 | Nobiletin | 50 mg | 2478 |
| Cayman2015 | 15422 | Carbamazepine | 1 g | 238 |
| Cayman2015 | 15422 | Carbamazepine | 10 g | 518 |
| Cayman2015 | 15422 | Carbamazepine | 25 g | 896 |
| Cayman2015 | 15422 | Carbamazepine | 5 g | 392 |
| Cayman2015 | 15424 | Nitrocefin | 1 mg | 630 |
| Cayman2015 | 15424 | Nitrocefin | 10 mg | 2016 |
| Cayman2015 | 15424 | Nitrocefin | 25 mg | 4564 |
| Cayman2015 | 15424 | Nitrocefin | 5 mg | 1106 |
| Cayman2015 | 15425 | Ticagrelor | 10 mg | 560 |
| Cayman2015 | 15425 | Ticagrelor | 25 mg | 882 |
| Cayman2015 | 15425 | Ticagrelor | 5 mg | 350 |
| Cayman2015 | 15425 | Ticagrelor | 50 mg | 1232 |
| Cayman2015 | 15426 | Brimonidine (tartrate) | 10 mg | 630 |
| Cayman2015 | 15426 | Brimonidine (tartrate) | 100 mg | 1582 |
| Cayman2015 | 15426 | Brimonidine (tartrate) | 25 mg | 868 |
| Cayman2015 | 15426 | Brimonidine (tartrate) | 50 mg | 1260 |
| Cayman2015 | 15427 | Apixaban | 1 mg | 686 |
| Cayman2015 | 15427 | Apixaban | 10 mg | 4326 |
| Cayman2015 | 15427 | Apixaban | 5 mg | 2408 |
| Cayman2015 | 15427 | Apixaban | 50 mg | 13384 |
| Cayman2015 | 15428 | Lamotrigine | 10 mg | 630 |
| Cayman2015 | 15428 | Lamotrigine | 100 mg | 3024 |
| Cayman2015 | 15428 | Lamotrigine | 25 mg | 910 |
| Cayman2015 | 15428 | Lamotrigine | 50 mg | 1736 |
| Cayman2015 | 15429 | Metoprolol (succinate) | 100 mg | 4788 |
| Cayman2015 | 15429 | Metoprolol (succinate) | 25 mg | 1330 |
| Cayman2015 | 15429 | Metoprolol (succinate) | 250 mg | 9310 |
| Cayman2015 | 15429 | Metoprolol (succinate) | 50 mg | 2534 |
| Cayman2015 | 15434 | AB-CHMINACA | 1 mg | 490 |
| Cayman2015 | 15434 | AB-CHMINACA | 10 mg | 3920 |
| Cayman2015 | 15434 | AB-CHMINACA | 5 mg | 2212 |
| Cayman2015 | 15435 | KMN-80 | 1 mg | 1890 |
| Cayman2015 | 15435 | KMN-80 | 100 μg | 630 |
| Cayman2015 | 15435 | KMN-80 | 500 μg | 1204 |
| Cayman2015 | 15438 | bpV(HOpic) (potassium salt, technical grade) | 25 mg | 2184 |
| Cayman2015 | 15438 | bpV(HOpic) (potassium salt, technical grade) | 5 mg | 490 |
| Cayman2015 | 15439 | AB-PINACA N-(2-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 15439 | AB-PINACA N-(2-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 15439 | AB-PINACA N-(2-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 15440 | AB-PINACA N-(3-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 15440 | AB-PINACA N-(3-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 15440 | AB-PINACA N-(3-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 15441 | AB-PINACA N-(4-fluoropentyl) isomer | 1 mg | 3528 |
| Cayman2015 | 15441 | AB-PINACA N-(4-fluoropentyl) isomer | 100 μg | 784 |
| Cayman2015 | 15441 | AB-PINACA N-(4-fluoropentyl) isomer | 500 μg | 2156 |
| Cayman2015 | 15442 | JWH 019 N-(2-fluorohexyl) isomer | 1 mg | 3528 |
| Cayman2015 | 15442 | JWH 019 N-(2-fluorohexyl) isomer | 100 μg | 448 |
| Cayman2015 | 15442 | JWH 019 N-(2-fluorohexyl) isomer | 500 μg | 1988 |
| Cayman2015 | 15443 | JWH 019 N-(3-fluorohexyl) isomer | 1 mg | 3528 |
| Cayman2015 | 15443 | JWH 019 N-(3-fluorohexyl) isomer | 100 μg | 448 |
| Cayman2015 | 15443 | JWH 019 N-(3-fluorohexyl) isomer | 500 μg | 1988 |
| Cayman2015 | 15444 | JWH 019 N-(4-fluorohexyl) isomer | 1 mg | 3528 |
| Cayman2015 | 15444 | JWH 019 N-(4-fluorohexyl) isomer | 100 μg | 448 |
| Cayman2015 | 15444 | JWH 019 N-(4-fluorohexyl) isomer | 500 μg | 1988 |
| Cayman2015 | 15445 | JWH 019 N-(5-fluorohexyl) isomer | 1 mg | 3528 |
| Cayman2015 | 15445 | JWH 019 N-(5-fluorohexyl) isomer | 100 μg | 448 |
| Cayman2015 | 15445 | JWH 019 N-(5-fluorohexyl) isomer | 500 μg | 1988 |
| Cayman2015 | 15446 | JWH 019 N-(6-fluorohexyl) isomer | 1 mg | 3528 |
| Cayman2015 | 15446 | JWH 019 N-(6-fluorohexyl) isomer | 100 μg | 448 |
| Cayman2015 | 15446 | JWH 019 N-(6-fluorohexyl) isomer | 500 μg | 1988 |
| Cayman2015 | 15450 | 11β-Prostaglandin F1β | 1 mg | 882 |
| Cayman2015 | 15450 | 11β-Prostaglandin F1β | 500 μg | 630 |
| Cayman2015 | 15451 | 2-Fluoropentylindole | 1 mg | 3528 |
| Cayman2015 | 15451 | 2-Fluoropentylindole | 100 μg | 448 |
| Cayman2015 | 15451 | 2-Fluoropentylindole | 500 μg | 1988 |
| Cayman2015 | 15452 | 3-Fluoropentylindole | 1 mg | 686 |
| Cayman2015 | 15452 | 3-Fluoropentylindole | 10 mg | 5488 |
| Cayman2015 | 15452 | 3-Fluoropentylindole | 5 mg | 3094 |
| Cayman2015 | 15453 | 4-Fluoropentylindole | 1 mg | 686 |
| Cayman2015 | 15453 | 4-Fluoropentylindole | 10 mg | 5488 |
| Cayman2015 | 15453 | 4-Fluoropentylindole | 5 mg | 3094 |
| Cayman2015 | 15454 | 5-Fluoropentylindole | 1 mg | 686 |
| Cayman2015 | 15454 | 5-Fluoropentylindole | 10 mg | 5488 |
| Cayman2015 | 15454 | 5-Fluoropentylindole | 5 mg | 3094 |
| Cayman2015 | 15467 | CBX3 (human recombinant) | 100 μg | 3486 |
| Cayman2015 | 15467 | CBX3 (human recombinant) | 25 μg | 1246 |
| Cayman2015 | 15467 | CBX3 (human recombinant) | 50 μg | 2114 |
| Cayman2015 | 15475 | Idebenone | 10 mg | 546 |
| Cayman2015 | 15475 | Idebenone | 100 mg | 3822 |
| Cayman2015 | 15475 | Idebenone | 25 mg | 1162 |
| Cayman2015 | 15475 | Idebenone | 50 mg | 2184 |
| Cayman2015 | 15476 | Oxaprozin | 10 mg | 644 |
| Cayman2015 | 15476 | Oxaprozin | 5 mg | 378 |
| Cayman2015 | 15476 | Oxaprozin | 50 mg | 1330 |
| Cayman2015 | 15477 | Cyclosporin D | 1 mg | 1190 |
| Cayman2015 | 15477 | Cyclosporin D | 5 mg | 2744 |
| Cayman2015 | 15478 | Extracellular Death Factor | 1 mg | 686 |
| Cayman2015 | 15478 | Extracellular Death Factor | 5 mg | 2646 |
| Cayman2015 | 15479 | CPI-203 | 1 mg | 630 |
| Cayman2015 | 15479 | CPI-203 | 10 mg | 4732 |
| Cayman2015 | 15479 | CPI-203 | 25 mg | 7084 |
| Cayman2015 | 15479 | CPI-203 | 5 mg | 2842 |
| Cayman2015 | 15480 | W-18 | 1 mg | 686 |
| Cayman2015 | 15480 | W-18 | 10 mg | 5488 |
| Cayman2015 | 15480 | W-18 | 5 mg | 3094 |
| Cayman2015 | 15481 | Hsp70 Polyclonal Antibody | 100 μL | 5820 |
| Cayman2015 | 15481 | Hsp70 Polyclonal Antibody | 25 μL | 2900 |
| Cayman2015 | 15482 | Hsp90 Polyclonal Antiserum | 100 μL | 4940 |
| Cayman2015 | 15482 | Hsp90 Polyclonal Antiserum | 25 μL | 2240 |
| Cayman2015 | 15483 | Pirinixic Acid Aminothiazole | 1 mg | 826 |
| Cayman2015 | 15483 | Pirinixic Acid Aminothiazole | 10 mg | 5950 |
| Cayman2015 | 15483 | Pirinixic Acid Aminothiazole | 25 mg | 13006 |
| Cayman2015 | 15483 | Pirinixic Acid Aminothiazole | 5 mg | 3514 |
| Cayman2015 | 15484 | MS-436 | 10 mg | 2534 |
| Cayman2015 | 15484 | MS-436 | 5 mg | 1330 |
| Cayman2015 | 15484 | MS-436 | 50 mg | 10640 |
| Cayman2015 | 15488 | AMB | 1 mg | 686 |
| Cayman2015 | 15488 | AMB | 10 mg | 5488 |
| Cayman2015 | 15488 | AMB | 5 mg | 3094 |
| Cayman2015 | 15489 | 5-fluoro AMB | 1 mg | 686 |
| Cayman2015 | 15489 | 5-fluoro AMB | 10 mg | 5488 |
| Cayman2015 | 15489 | 5-fluoro AMB | 5 mg | 3094 |
| Cayman2015 | 15490 | BW 755C | 10 mg | 938 |
| Cayman2015 | 15490 | BW 755C | 100 mg | 6860 |
| Cayman2015 | 15490 | BW 755C | 5 mg | 490 |
| Cayman2015 | 15490 | BW 755C | 50 mg | 3920 |
| Cayman2015 | 15491 | L-Glutathione, oxidized (sodium salt) | 1 g | 1946 |
| Cayman2015 | 15491 | L-Glutathione, oxidized (sodium salt) | 100 mg | 406 |
| Cayman2015 | 15491 | L-Glutathione, oxidized (sodium salt) | 250 mg | 686 |
| Cayman2015 | 15491 | L-Glutathione, oxidized (sodium salt) | 500 mg | 1316 |
| Cayman2015 | 15492 | Zidovudine | 1 g | 2100 |
| Cayman2015 | 15492 | Zidovudine | 100 mg | 980 |
| Cayman2015 | 15492 | Zidovudine | 25 mg | 350 |
| Cayman2015 | 15492 | Zidovudine | 250 mg | 1400 |
| Cayman2015 | 15493 | Thioredoxin Activity Fluorescent V2 Assay Kit | 1 ea | 6062 |
| Cayman2015 | 15494 | Fluorescent Substrate for Thioredoxin Reductase Activity Assay | 1 ea | 3850 |
| Cayman2015 | 15495 | Fluorescent Substrate for Thioredoxin V2 Assay | 1 ea | 2268 |
| Cayman2015 | 15496 | * (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 15496 | * (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 15496 | * (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 15497 | 4-methoxy PV8 (hydrochloride) | 1 mg | 826 |
| Cayman2015 | 15497 | 4-methoxy PV8 (hydrochloride) | 10 mg | 6608 |
| Cayman2015 | 15497 | 4-methoxy PV8 (hydrochloride) | 5 mg | 3724 |
| Cayman2015 | 15498 | ATM4 4-acetoxy analog | 1 mg | 1568 |
| Cayman2015 | 15498 | ATM4 4-acetoxy analog | 10 mg | 12544 |
| Cayman2015 | 15498 | ATM4 4-acetoxy analog | 5 mg | 7056 |
| Cayman2015 | 15500 | Cercosporamide | 2.5 mg | 11634 |
| Cayman2015 | 15500 | Cercosporamide | 500 μg | 2450 |
| Cayman2015 | 15501 | Chlorothricin | 1 mg | 2030 |
| Cayman2015 | 15501 | Chlorothricin | 5 mg | 6300 |
| Cayman2015 | 15502 | Concanamycin B | 1 mg | 13678 |
| Cayman2015 | 15502 | Concanamycin B | 250 μg | 4886 |
| Cayman2015 | 15503 | Fidaxomycin | 1 mg | 4186 |
| Cayman2015 | 15503 | Fidaxomycin | 5 mg | 12558 |
| Cayman2015 | 15504 | Herbimycin A | 2.5 mg | 13608 |
| Cayman2015 | 15504 | Herbimycin A | 500 μg | 4186 |
| Cayman2015 | 15505 | Lasalocid | 25 mg | 6776 |
| Cayman2015 | 15505 | Lasalocid | 5 mg | 1806 |
| Cayman2015 | 15506 | Moenomycin Complex | 25 mg | 5152 |
| Cayman2015 | 15506 | Moenomycin Complex | 5 mg | 1372 |
| Cayman2015 | 15507 | Platensimycin | 1 mg | 12544 |
| Cayman2015 | 15507 | Platensimycin | 250 μg | 3486 |
| Cayman2015 | 15508 | Pseudoerythromycin A enol ether | 1 mg | 1330 |
| Cayman2015 | 15508 | Pseudoerythromycin A enol ether | 5 mg | 4984 |
| Cayman2015 | 15509 | Puromycin Aminonucleoside | 10 mg | 686 |
| Cayman2015 | 15509 | Puromycin Aminonucleoside | 100 mg | 4802 |
| Cayman2015 | 15509 | Puromycin Aminonucleoside | 25 mg | 1540 |
| Cayman2015 | 15509 | Puromycin Aminonucleoside | 50 mg | 2576 |
| Cayman2015 | 15510 | 11-deoxy Prostaglandin F1β | 1 mg | 588 |
| Cayman2015 | 15510 | 11-deoxy Prostaglandin F1β | 10 mg | 4704 |
| Cayman2015 | 15510 | 11-deoxy Prostaglandin F1β | 5 mg | 2646 |
| Cayman2015 | 15511 | Teicoplanin Complex | 100 mg | 1246 |
| Cayman2015 | 15511 | Teicoplanin Complex | 25 mg | 826 |
| Cayman2015 | 15512 | 11-deoxy Prostaglandin F1α | 1 mg | 588 |
| Cayman2015 | 15512 | 11-deoxy Prostaglandin F1α | 10 mg | 4704 |
| Cayman2015 | 15512 | 11-deoxy Prostaglandin F1α | 5 mg | 2646 |
| Cayman2015 | 15513 | Thioredoxin 1 Truncated (human) Monoclonal Antibody (Clone 4H9) | 1 ea | 4326 |
| Cayman2015 | 15516 | 4-fluoro-α-Pyrrolidinobutiophenone (hydrochloride) | 10 mg | 1638 |
| Cayman2015 | 15516 | 4-fluoro-α-Pyrrolidinobutiophenone (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 15516 | 4-fluoro-α-Pyrrolidinobutiophenone (hydrochloride) | 50 mg | 6146 |
| Cayman2015 | 15518 | Diphenidine (hydrochloride) | 1 mg | 490 |
| Cayman2015 | 15518 | Diphenidine (hydrochloride) | 10 mg | 2730 |
| Cayman2015 | 15518 | Diphenidine (hydrochloride) | 5 mg | 1736 |
| Cayman2015 | 15519 | Methoxphenidine (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 15519 | Methoxphenidine (hydrochloride) | 10 mg | 7280 |
| Cayman2015 | 15519 | Methoxphenidine (hydrochloride) | 5 mg | 4102 |
| Cayman2015 | 15520 | Naltrexone (hydrochloride) | 100 mg | 546 |
| Cayman2015 | 15520 | Naltrexone (hydrochloride) | 250 mg | 1302 |
| Cayman2015 | 15521 | Lorcaserin (hydrochloride) | 10 mg | 966 |
| Cayman2015 | 15521 | Lorcaserin (hydrochloride) | 100 mg | 3864 |
| Cayman2015 | 15521 | Lorcaserin (hydrochloride) | 25 mg | 1330 |
| Cayman2015 | 15521 | Lorcaserin (hydrochloride) | 50 mg | 2170 |
| Cayman2015 | 15526 | ALK5 Inhibitor II (hydrochloride) | 1 mg | 490 |
| Cayman2015 | 15526 | ALK5 Inhibitor II (hydrochloride) | 10 mg | 1722 |
| Cayman2015 | 15526 | ALK5 Inhibitor II (hydrochloride) | 25 mg | 3682 |
| Cayman2015 | 15526 | ALK5 Inhibitor II (hydrochloride) | 5 mg | 980 |
| Cayman2015 | 15529 | AB-FUBINACA metabolite 2 | 1 mg | 2268 |
| Cayman2015 | 15529 | AB-FUBINACA metabolite 2 | 5 mg | 9520 |
| Cayman2015 | 15529 | AB-FUBINACA metabolite 2 | 500 μg | 1190 |
| Cayman2015 | 15533 | EG-018 | 1 mg | 910 |
| Cayman2015 | 15533 | EG-018 | 10 mg | 7280 |
| Cayman2015 | 15533 | EG-018 | 5 mg | 4102 |
| Cayman2015 | 15535 | NPB-22 | 1 mg | 910 |
| Cayman2015 | 15535 | NPB-22 | 10 mg | 7280 |
| Cayman2015 | 15535 | NPB-22 | 5 mg | 4102 |
| Cayman2015 | 15536 | 5-fluoro NPB-22 | 1 mg | 910 |
| Cayman2015 | 15536 | 5-fluoro NPB-22 | 10 mg | 7280 |
| Cayman2015 | 15536 | 5-fluoro NPB-22 | 5 mg | 4102 |
| Cayman2015 | 15537 | FUB-144 | 1 mg | 910 |
| Cayman2015 | 15537 | FUB-144 | 10 mg | 5096 |
| Cayman2015 | 15537 | FUB-144 | 5 mg | 3640 |
| Cayman2015 | 15538 | Tetrahydrocannabivarin | 1 mg | 2072 |
| Cayman2015 | 15538 | Tetrahydrocannabivarin | 500 μg | 1092 |
| Cayman2015 | 15539 | Bradykinin (acetate) | 10 mg | 630 |
| Cayman2015 | 15539 | Bradykinin (acetate) | 25 mg | 1316 |
| Cayman2015 | 15539 | Bradykinin (acetate) | 5 mg | 350 |
| Cayman2015 | 15539 | Bradykinin (acetate) | 50 mg | 1932 |
| Cayman2015 | 15544 | FR180204 | 1 mg | 686 |
| Cayman2015 | 15544 | FR180204 | 10 mg | 2408 |
| Cayman2015 | 15544 | FR180204 | 25 mg | 5488 |
| Cayman2015 | 15544 | FR180204 | 5 mg | 1372 |
| Cayman2015 | 15545 | CFTR Inhibitor-172 | 10 mg | 1736 |
| Cayman2015 | 15545 | CFTR Inhibitor-172 | 25 mg | 4102 |
| Cayman2015 | 15545 | CFTR Inhibitor-172 | 5 mg | 910 |
| Cayman2015 | 15545 | CFTR Inhibitor-172 | 50 mg | 6370 |
| Cayman2015 | 15546 | Aminoethoxyvinyl Glycine (hydrochloride) | 1 mg | 546 |
| Cayman2015 | 15546 | Aminoethoxyvinyl Glycine (hydrochloride) | 10 mg | 2730 |
| Cayman2015 | 15546 | Aminoethoxyvinyl Glycine (hydrochloride) | 25 mg | 4368 |
| Cayman2015 | 15546 | Aminoethoxyvinyl Glycine (hydrochloride) | 5 mg | 1638 |
| Cayman2015 | 15547 | Hoechst 33342 (hydrochloride) | 100 mg | 840 |
| Cayman2015 | 15547 | Hoechst 33342 (hydrochloride) | 25 mg | 350 |
| Cayman2015 | 15547 | Hoechst 33342 (hydrochloride) | 50 mg | 602 |
| Cayman2015 | 15547 | Hoechst 33342 (hydrochloride) | 500 mg | 1932 |
| Cayman2015 | 15548 | Ramosetron (hydrochloride) | 10 mg | 770 |
| Cayman2015 | 15548 | Ramosetron (hydrochloride) | 100 mg | 6160 |
| Cayman2015 | 15548 | Ramosetron (hydrochloride) | 25 mg | 1736 |
| Cayman2015 | 15548 | Ramosetron (hydrochloride) | 50 mg | 3276 |
| Cayman2015 | 15549 | Phleomycin | 10 mg | 1386 |
| Cayman2015 | 15549 | Phleomycin | 25 mg | 3220 |
| Cayman2015 | 15549 | Phleomycin | 5 mg | 826 |
| Cayman2015 | 15549 | Phleomycin | 50 mg | 5782 |
| Cayman2015 | 15550 | UCF 101 | 1 mg | 350 |
| Cayman2015 | 15550 | UCF 101 | 10 mg | 1372 |
| Cayman2015 | 15550 | UCF 101 | 25 mg | 3066 |
| Cayman2015 | 15550 | UCF 101 | 5 mg | 966 |
| Cayman2015 | 15551 | BAPTA-Acetoxymethyl ester | 10 mg | 882 |
| Cayman2015 | 15551 | BAPTA-Acetoxymethyl ester | 25 mg | 1232 |
| Cayman2015 | 15551 | BAPTA-Acetoxymethyl ester | 5 mg | 490 |
| Cayman2015 | 15554 | Diclazepam | 1 mg | 406 |
| Cayman2015 | 15554 | Diclazepam | 10 mg | 2030 |
| Cayman2015 | 15554 | Diclazepam | 5 mg | 1316 |
| Cayman2015 | 15555 | Kemptide | 1 mg | 490 |
| Cayman2015 | 15555 | Kemptide | 10 mg | 2940 |
| Cayman2015 | 15555 | Kemptide | 25 mg | 6734 |
| Cayman2015 | 15555 | Kemptide | 5 mg | 1596 |
| Cayman2015 | 15556 | Paliperidone | 100 mg | 2646 |
| Cayman2015 | 15556 | Paliperidone | 25 mg | 826 |
| Cayman2015 | 15556 | Paliperidone | 50 mg | 1568 |
| Cayman2015 | 15556 | Paliperidone | 500 mg | 9912 |
| Cayman2015 | 15558 | Ramipril | 1 g | 1988 |
| Cayman2015 | 15558 | Ramipril | 100 mg | 686 |
| Cayman2015 | 15558 | Ramipril | 5 g | 7896 |
| Cayman2015 | 15558 | Ramipril | 500 mg | 1204 |
| Cayman2015 | 15559 | Mdivi 1 | 10 mg | 1036 |
| Cayman2015 | 15559 | Mdivi 1 | 25 mg | 2184 |
| Cayman2015 | 15559 | Mdivi 1 | 5 mg | 546 |
| Cayman2015 | 15559 | Mdivi 1 | 50 mg | 4102 |
| Cayman2015 | 15560 | Tat-Beclin 1 Peptide | 1 mg | 2464 |
| Cayman2015 | 15563 | Catechol O-Methyltransferase (human recombinant) | 100 μg | 4550 |
| Cayman2015 | 15563 | Catechol O-Methyltransferase (human recombinant) | 25 μg | 1750 |
| Cayman2015 | 15563 | Catechol O-Methyltransferase (human recombinant) | 50 μg | 2450 |
| Cayman2015 | 15564 | eIF4E (human recombinant; GST-tagged) | 100 μg | 5250 |
| Cayman2015 | 15564 | eIF4E (human recombinant; GST-tagged) | 25 μg | 1750 |
| Cayman2015 | 15564 | eIF4E (human recombinant; GST-tagged) | 50 μg | 3332 |
| Cayman2015 | 15566 | (±)-Lefetamine (hydrochloride) | 1 mg | 910 |
| Cayman2015 | 15566 | (±)-Lefetamine (hydrochloride) | 10 mg | 2730 |
| Cayman2015 | 15566 | (±)-Lefetamine (hydrochloride) | 5 mg | 1736 |
| Cayman2015 | 15567 | Neoruscogenin | 1 mg | 1372 |
| Cayman2015 | 15567 | Neoruscogenin | 10 mg | 9604 |
| Cayman2015 | 15567 | Neoruscogenin | 5 mg | 5488 |
| Cayman2015 | 15568 | AG-538 | 1 mg | 350 |
| Cayman2015 | 15568 | AG-538 | 5 mg | 1050 |
| Cayman2015 | 15576 | Becatecarin | 1 mg | 7155 |
| Cayman2015 | 15576 | Becatecarin | 250 μg | 2385 |
| Cayman2015 | 15577 | BzATP (triethylammonium salt) | 1 mg | 490 |
| Cayman2015 | 15578 | CHIR98014 | 1 mg | 910 |
| Cayman2015 | 15578 | CHIR98014 | 10 mg | 3640 |
| Cayman2015 | 15578 | CHIR98014 | 25 mg | 7742 |
| Cayman2015 | 15578 | CHIR98014 | 5 mg | 2044 |
| Cayman2015 | 15579 | Compound E | 1 mg | 3825 |
| Cayman2015 | 15579 | Compound E | 250 μg | 1275 |
| Cayman2015 | 15579 | Compound E | 5 mg | 11985 |
| Cayman2015 | 15580 | 5-Bromo-2'-deoxyuridine | 1 g | 1064 |
| Cayman2015 | 15580 | 5-Bromo-2'-deoxyuridine | 250 mg | 392 |
| Cayman2015 | 15580 | 5-Bromo-2'-deoxyuridine | 50 mg | 266 |
| Cayman2015 | 15580 | 5-Bromo-2'-deoxyuridine | 500 mg | 672 |
| Cayman2015 | 15581 | Dexmedetomidine (hydrochloride) | 10 mg | 1456 |
| Cayman2015 | 15581 | Dexmedetomidine (hydrochloride) | 25 mg | 3416 |
| Cayman2015 | 15581 | Dexmedetomidine (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 15581 | Dexmedetomidine (hydrochloride) | 50 mg | 6370 |
| Cayman2015 | 15582 | Dobutamine (hydrochloride) | 10 mg | 616 |
| Cayman2015 | 15582 | Dobutamine (hydrochloride) | 50 mg | 1848 |
| Cayman2015 | 15583 | Elaiophylin | 1 mg | 1785 |
| Cayman2015 | 15583 | Elaiophylin | 5 mg | 3840 |
| Cayman2015 | 15584 | Formoterol (hemifumarate) | 10 mg | 1232 |
| Cayman2015 | 15584 | Formoterol (hemifumarate) | 50 mg | 4928 |
| Cayman2015 | 15585 | Ganglioside GD1a (sodium salt) | 1 mg | 825 |
| Cayman2015 | 15585 | Ganglioside GD1a (sodium salt) | 5 mg | 3420 |
| Cayman2015 | 15586 | Ganglioside GM1 Asialo | 1 mg | 2835 |
| Cayman2015 | 15586 | Ganglioside GM1 Asialo | 500 μg | 1575 |
| Cayman2015 | 15587 | Ganglioside GM3 (sodium salt) | 1 mg | 2685 |
| Cayman2015 | 15588 | Ganglioside GT1b (sodium salt) | 1 mg | 1335 |
| Cayman2015 | 15588 | Ganglioside GT1b (sodium salt) | 5 mg | 4335 |
| Cayman2015 | 15589 | Ganglioside GQ1b (sodium salt) | 100 μg | 1335 |
| Cayman2015 | 15589 | Ganglioside GQ1b (sodium salt) | 500 μg | 5475 |
| Cayman2015 | 15590 | (Glp1)-Apelin-13 | 1 mg | 1526 |
| Cayman2015 | 15591 | ICI 118551 (hydrochloride) | 10 mg | 1554 |
| Cayman2015 | 15591 | ICI 118551 (hydrochloride) | 25 mg | 3640 |
| Cayman2015 | 15591 | ICI 118551 (hydrochloride) | 5 mg | 910 |
| Cayman2015 | 15591 | ICI 118551 (hydrochloride) | 50 mg | 6650 |
| Cayman2015 | 15592 | Isoproterenol (hydrochloride) | 100 mg | 364 |
| Cayman2015 | 15592 | Isoproterenol (hydrochloride) | 250 mg | 826 |
| Cayman2015 | 15592 | Isoproterenol (hydrochloride) | 500 mg | 1456 |
| Cayman2015 | 15593 | 5'-Deoxy-5'-methylthioadenosine | 100 mg | 1302 |
| Cayman2015 | 15593 | 5'-Deoxy-5'-methylthioadenosine | 25 mg | 406 |
| Cayman2015 | 15593 | 5'-Deoxy-5'-methylthioadenosine | 50 mg | 770 |
| Cayman2015 | 15594 | Naloxone (hydrochloride) | 100 mg | 672 |
| Cayman2015 | 15594 | Naloxone (hydrochloride) | 250 mg | 1232 |
| Cayman2015 | 15594 | Naloxone (hydrochloride) | 50 mg | 350 |
| Cayman2015 | 15595 | PP3 | 1 mg | 630 |
| Cayman2015 | 15595 | PP3 | 10 mg | 1764 |
| Cayman2015 | 15595 | PP3 | 5 mg | 1330 |
| Cayman2015 | 15596 | Rauwolscine (hydrochloride) | 100 mg | 546 |
| Cayman2015 | 15596 | Rauwolscine (hydrochloride) | 250 mg | 1316 |
| Cayman2015 | 15596 | Rauwolscine (hydrochloride) | 50 mg | 350 |
| Cayman2015 | 15597 | (±)-Salsolinol (hydrochloride) | 100 mg | 546 |
| Cayman2015 | 15597 | (±)-Salsolinol (hydrochloride) | 500 mg | 2590 |
| Cayman2015 | 15598 | SL 327 | 1 mg | 630 |
| Cayman2015 | 15598 | SL 327 | 10 mg | 1582 |
| Cayman2015 | 15598 | SL 327 | 25 mg | 3150 |
| Cayman2015 | 15598 | SL 327 | 5 mg | 910 |
| Cayman2015 | 15599 | SNC 80 | 100 mg | 9900 |
| Cayman2015 | 15599 | SNC 80 | 25 mg | 3510 |
| Cayman2015 | 15599 | SNC 80 | 5 mg | 825 |
| Cayman2015 | 15600 | Thiorphan | 25 mg | 3332 |
| Cayman2015 | 15600 | Thiorphan | 5 mg | 784 |
| Cayman2015 | 15601 | Thaxtomin A | 1 mg | 2835 |
| Cayman2015 | 15601 | Thaxtomin A | 5 mg | 9210 |
| Cayman2015 | 15602 | UDP-Glucose (sodium salt) | 1 g | 2744 |
| Cayman2015 | 15602 | UDP-Glucose (sodium salt) | 100 mg | 686 |
| Cayman2015 | 15603 | Vecuronium (bromide) | 10 mg | 672 |
| Cayman2015 | 15603 | Vecuronium (bromide) | 250 mg | 5712 |
| Cayman2015 | 15603 | Vecuronium (bromide) | 50 mg | 1344 |
| Cayman2015 | 15604 | Ranolazine (hydrochloride) | 100 mg | 1554 |
| Cayman2015 | 15604 | Ranolazine (hydrochloride) | 250 mg | 3416 |
| Cayman2015 | 15604 | Ranolazine (hydrochloride) | 50 mg | 910 |
| Cayman2015 | 15604 | Ranolazine (hydrochloride) | 500 mg | 5012 |
| Cayman2015 | 15605 | Conoidin A | 100 mg | 1260 |
| Cayman2015 | 15605 | Conoidin A | 25 mg | 630 |
| Cayman2015 | 15605 | Conoidin A | 250 mg | 2842 |
| Cayman2015 | 15605 | Conoidin A | 50 mg | 952 |
| Cayman2015 | 15606 | Misonidazole | 1 mg | 686 |
| Cayman2015 | 15606 | Misonidazole | 10 mg | 1722 |
| Cayman2015 | 15606 | Misonidazole | 5 mg | 1204 |
| Cayman2015 | 15606 | Misonidazole | 50 mg | 4116 |
| Cayman2015 | 15609 | 4-Methyl-α-ethylaminopentiophenone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 15609 | 4-Methyl-α-ethylaminopentiophenone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 15609 | 4-Methyl-α-ethylaminopentiophenone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 15610 | 13,14-dihydro Prostaglandin F1α | 1 mg | 714 |
| Cayman2015 | 15610 | 13,14-dihydro Prostaglandin F1α | 10 mg | 5712 |
| Cayman2015 | 15610 | 13,14-dihydro Prostaglandin F1α | 5 mg | 3220 |
| Cayman2015 | 15611 | CGP 37157 | 10 mg | 1610 |
| Cayman2015 | 15611 | CGP 37157 | 50 mg | 7084 |
| Cayman2015 | 15612 | 2-Chloroadenosine | 10 mg | 350 |
| Cayman2015 | 15612 | 2-Chloroadenosine | 250 mg | 1582 |
| Cayman2015 | 15612 | 2-Chloroadenosine | 50 mg | 882 |
| Cayman2015 | 15613 | Cimaterol | 10 mg | 1106 |
| Cayman2015 | 15613 | Cimaterol | 50 mg | 4704 |
| Cayman2015 | 15614 | CyPPA | 10 mg | 1526 |
| Cayman2015 | 15614 | CyPPA | 50 mg | 7014 |
| Cayman2015 | 15615 | Daptomycin | 10 mg | 672 |
| Cayman2015 | 15615 | Daptomycin | 25 mg | 1316 |
| Cayman2015 | 15615 | Daptomycin | 5 mg | 350 |
| Cayman2015 | 15615 | Daptomycin | 50 mg | 2282 |
| Cayman2015 | 15616 | Eplerenone | 10 mg | 1036 |
| Cayman2015 | 15616 | Eplerenone | 25 mg | 2226 |
| Cayman2015 | 15616 | Eplerenone | 5 mg | 686 |
| Cayman2015 | 15616 | Eplerenone | 50 mg | 4116 |
| Cayman2015 | 15617 | Fluvoxamine Maleate | 10 mg | 350 |
| Cayman2015 | 15617 | Fluvoxamine Maleate | 100 mg | 2800 |
| Cayman2015 | 15617 | Fluvoxamine Maleate | 25 mg | 826 |
| Cayman2015 | 15617 | Fluvoxamine Maleate | 50 mg | 1582 |
| Cayman2015 | 15618 | CAY10680 | 10 mg | 1470 |
| Cayman2015 | 15618 | CAY10680 | 25 mg | 3346 |
| Cayman2015 | 15618 | CAY10680 | 5 mg | 826 |
| Cayman2015 | 15618 | CAY10680 | 50 mg | 6034 |
| Cayman2015 | 15621 | PSB-SB1202 | 1 mg | 910 |
| Cayman2015 | 15621 | PSB-SB1202 | 10 mg | 7280 |
| Cayman2015 | 15621 | PSB-SB1202 | 5 mg | 4102 |
| Cayman2015 | 15622 | GBR 12909 (hydrochloride) | 10 mg | 686 |
| Cayman2015 | 15622 | GBR 12909 (hydrochloride) | 25 mg | 1624 |
| Cayman2015 | 15622 | GBR 12909 (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 15622 | GBR 12909 (hydrochloride) | 50 mg | 2842 |
| Cayman2015 | 15623 | IEM 1460 | 10 mg | 1190 |
| Cayman2015 | 15623 | IEM 1460 | 50 mg | 4466 |
| Cayman2015 | 15624 | JNK Inhibitor IX | 10 mg | 1372 |
| Cayman2015 | 15624 | JNK Inhibitor IX | 50 mg | 6174 |
| Cayman2015 | 15625 | Loratadine | 10 mg | 882 |
| Cayman2015 | 15625 | Loratadine | 25 mg | 1470 |
| Cayman2015 | 15625 | Loratadine | 5 mg | 490 |
| Cayman2015 | 15625 | Loratadine | 50 mg | 2212 |
| Cayman2015 | 15627 | Pelitinib | 25 mg | 4662 |
| Cayman2015 | 15627 | Pelitinib | 5 mg | 1330 |
| Cayman2015 | 15631 | SCH 23390 (hydrochloride) | 10 mg | 1372 |
| Cayman2015 | 15631 | SCH 23390 (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 15632 | SN 38 | 10 mg | 1036 |
| Cayman2015 | 15632 | SN 38 | 25 mg | 2324 |
| Cayman2015 | 15632 | SN 38 | 5 mg | 546 |
| Cayman2015 | 15632 | SN 38 | 50 mg | 4102 |
| Cayman2015 | 15633 | Voriconazole | 10 mg | 924 |
| Cayman2015 | 15633 | Voriconazole | 25 mg | 2044 |
| Cayman2015 | 15633 | Voriconazole | 5 mg | 546 |
| Cayman2015 | 15633 | Voriconazole | 50 mg | 3822 |
| Cayman2015 | 15634 | N-Formylmethamphetamine | 10 mg | 1330 |
| Cayman2015 | 15634 | N-Formylmethamphetamine | 5 mg | 784 |
| Cayman2015 | 15634 | N-Formylmethamphetamine | 50 mg | 5880 |
| Cayman2015 | 15635 | dsDNA Monoclonal Antibody (Clone 2C4) | 1 ea | 3206 |
| Cayman2015 | 15637 | LL-37 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 15638 | Myeloperoxidase Monoclonal Antibody (Clone 2C8) | 1 ea | 3206 |
| Cayman2015 | 15639 | Myeloperoxidase Monoclonal Antibody (Clone 4E9) | 1 ea | 3206 |
| Cayman2015 | 15640 | Myeloperoxidase Monoclonal Antibody (Clone 5F6) | 1 ea | 3206 |
| Cayman2015 | 15641 | Lysozyme C Monoclonal Antibody (Clone 4C3) | 1 ea | 3206 |
| Cayman2015 | 15642 | PS-48 | 1 mg | 490 |
| Cayman2015 | 15642 | PS-48 | 10 mg | 1372 |
| Cayman2015 | 15642 | PS-48 | 5 mg | 910 |
| Cayman2015 | 15642 | PS-48 | 50 mg | 4830 |
| Cayman2015 | 15643 | Rucaparib | 1 mg | 350 |
| Cayman2015 | 15643 | Rucaparib | 10 mg | 2800 |
| Cayman2015 | 15643 | Rucaparib | 25 mg | 6132 |
| Cayman2015 | 15643 | Rucaparib | 5 mg | 1582 |
| Cayman2015 | 15645 | Testosterone | 1 g | 490 |
| Cayman2015 | 15645 | Testosterone | 5 g | 980 |
| Cayman2015 | 15646 | MBOAT2 (C-Term) Polyclonal Antibody | 1 ea | 4606 |
| Cayman2015 | 15647 | MBOAT2 (Internal) Polyclonal Antibody | 1 ea | 4606 |
| Cayman2015 | 15648 | HHATL Polyclonal Antibody | 1 ea | 4186 |
| Cayman2015 | 15650 | D-Amphetamine (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15654 | DL-Cathinone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15655 | (-)-(S)-Cathinone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15656 | Methcathinone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15657 | Mephedrone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15658 | N-Ethylamphetamine (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15659 | N,N-DMA (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15662 | JWH 250 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15663 | RCS-8 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15664 | JWH 019 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15665 | JWH 081 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15666 | RCS-4 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15667 | JWH 122 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15668 | AM2201 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15669 | JWH 203 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15670 | 13,14-dihydro-15-keto Prostaglandin F1α | 1 mg | 686 |
| Cayman2015 | 15670 | 13,14-dihydro-15-keto Prostaglandin F1α | 10 mg | 5096 |
| Cayman2015 | 15670 | 13,14-dihydro-15-keto Prostaglandin F1α | 5 mg | 2912 |
| Cayman2015 | 15670 | 13,14-dihydro-15-keto Prostaglandin F1α | 500 μg | 364 |
| Cayman2015 | 15671 | α-Ethyltryptamine (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15672 | 2C-T-7 (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15673 | Cannabidiolic Acid (exempt preparation) | 1 mg | 1568 |
| Cayman2015 | 15674 | Δ8-THC (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15675 | Δ9-THC (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15679 | THCA-A (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15680 | Mescaline (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15681 | 2C-T-2 (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15682 | 3,4,5-Trimethoxyamphetamine (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15683 | 4-bromo-2,5-DMA (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15684 | 2C-B (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15685 | 2,5-DMA (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15686 | JWH 398 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15687 | MDA (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15688 | N-hydroxy MDA (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15689 | 3,4-MDEA (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15690 | 3,4-MDMA (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15691 | 4-Methoxyamphetamine (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15692 | α-Methyltryptamine (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15693 | 5-hydroxy DMT (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15694 | N,N-DMT (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15696 | 4-hydroxy DMT (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15697 | 5-methoxy DiPT (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15698 | BZP (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15699 | 2C-E (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15700 | 2C-I (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15703 | DOM (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15704 | DOET (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15710 | 15-keto Prostaglandin F1α | 1 mg | 714 |
| Cayman2015 | 15710 | 15-keto Prostaglandin F1α | 10 mg | 5712 |
| Cayman2015 | 15710 | 15-keto Prostaglandin F1α | 5 mg | 3220 |
| Cayman2015 | 15713 | Heroin (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15714 | Desomorphine (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15715 | 2C-H (hydrochloride) (exempt preparation) | 1 mg | 686 |
我们公司zui大优势是强大的采购，
1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，
2： 货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，
3：提供加急服务，一般1-2周到货，超过时限加急费全免
4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.
5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司
6：我们还是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;......几十家国外公司授权代理
7：我们还从事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批发
